Enrichment analysis report,,,,,,,,,
Enrichment by Pathway Maps,,,,,down_genes_070120_genelist,,,,
#,Maps,Total,pValue,Min FDR,p-value,FDR,In Data,"Network Objects from
Active Data",
1,Development_Regulation of epithelial-to-mesenchymal transition (EMT),64,2.207E-13,3.105E-10,2.207E-13,3.105E-10,28,"HGF, IL-1 beta, HEY1, N-cadherin, TGF-beta 2, WNT, TGF-beta receptor type II, SLUG, EGFR, SIP1 (ZFHX1B), MMP-2, NOTCH4, Caldesmon, ACTA2, FGF2, PDGF-R-alpha, TWIST1, HGF receptor (Met), Fibronectin, Jagged1, Vimentin, TCF8, Claudin-1, MMP-9, Frizzled, EDNRA, PDGF-R-beta, TNF-alpha",
2,Cell adhesion_ECM remodeling,55,1.491E-12,6.993E-10,1.491E-12,6.993E-10,25,"MMP-13, CD44, SERPINE2, Caveolin-2, PLAT (TPA), MSN (moesin), IL-8, EGFR, MMP-14, MMP-2, Versican, Matrilysin (MMP-7), PLAUR (uPAR), alpha-5/beta-1 integrin, Actin cytoskeletal, alpha-1/beta-1 integrin, Collagen IV, Fibronectin, Kallikrein 1, Nidogen, LAMA4, MMP-9, PLAU (UPA), Syndecan-2, Collagen III",
3,"Immune response_T cell co-signaling receptors, schema",55,1.491E-12,6.993E-10,1.491E-12,6.993E-10,25,"TIM-1, Collagen XIII, BPAG2, MHC class II, PD-L2, LAIR1, CD70(TNFSF7), GITRL, Nectin-3, DNAM1, TIM-4, PD-1, CTLA-4, CD137 ligand(TNFSF9), OX40(TNFRSF4), DPP4, Collagen XXIII, Collagen V, CD137(TNFRSF9), LIGHT(TNFSF14), ICOS, Collagen VI, Galectin-9, PD-L1, Collagen III",
4,Putative roles of SETDB1 and PLU-1 in melanoma,23,2.574E-12,9.055E-10,2.574E-12,9.055E-10,16,"HOXA6, HOXA13, HOXA4, p14ARF, HOXA10, HOXA2, LMO2, HOXA9, HOXA7, HOXA3, HOXA5, TSLP, p16INK4, Jagged1, HOXA11, CDK6",
5,Rheumatoid arthritis (general schema),50,8.644E-12,2.433E-09,8.644E-12,2.433E-09,23,"IL-15, IL-1 beta, TNF-R2, HLA-DRB1, MHC class II, VCAM1, alpha-4/beta-1 integrin, IL-18, ICAM1, HLA-DRB, RANKL(TNFSF11), TLR4, IL-6, TGF-beta, FGF2, MMP-8, PTPN22, CSF1, MHC class II beta chain, IL-2R alpha chain, MMP-9, TLR2, TNF-alpha",
6,Role of stellate cells in progression of pancreatic cancer,60,1.150E-10,2.696E-08,1.150E-10,2.696E-08,24,"GRO-2, NGF, PI3K cat class IA, RECK, MMP-13, CCL2, IL-8, TGF-beta receptor type II, EGFR, MMP-2, IL-6, Galectin-1, ACTA2, alpha-5/beta-1 integrin, FGF2, COL1A2, CTGF, PDGF-R-alpha, AKT(PKB), PDGF receptor, OSF-2, Fibronectin, PDGF-R-beta, Collagen III",
7,Inhibition of remyelination in multiple sclerosis: role of cell-cell and ECM-cell interactions,47,1.388E-10,2.771E-08,1.388E-10,2.771E-08,21,"NGF, ITGB1, Myelin basic protein, Claudin-11, NGFR(TNFRSF16), TrkA, Tetraspanin-2, NCAM1, PKC, Tenascin-R, CD44, Connexin 26, Connexin 32, Connexin 47, Connexin 30, Actin cytoskeletal, Fyn, Connexin 45, Fibronectin, MMP-9, TLR2",
8,Role of osteoblasts in bone lesions formation in multiple myeloma,35,1.575E-10,2.771E-08,1.575E-10,2.771E-08,18,"HGF, VCAM1, RUNX2, alpha-4/beta-1 integrin, RANKL(TNFSF11), SFRP2, WNT, FasR(CD95), ALPL, TAZ, FasL(TNFSF6), Apo-2L(TNFSF10), Osteoprotegerin, TCF7 (TCF1), BMP2, Frizzled, RANK(TNFRSF11A), TNF-alpha",
9,Glomerular injury in Lupus Nephritis,92,2.251E-10,3.520E-08,2.251E-10,3.520E-08,30,"GRO-2, IL-1 beta, VCAM1, GRO-1, iNOS, IP10, Decorin, ICAM1, CCL2, PKC-alpha, IFN-alpha, IL-8, NGAL, GM-CSF, FasR(CD95), IL-6, TGF-beta, FasL(TNFSF6), AKT(PKB), CSF1, TLR3, Fibronectin, C3a, GRO-3, A20, IFN-beta, MMP-9, IFI56, PDGF-R-beta, TNF-alpha",
10,Eosinophil survival in asthma,67,2.774E-10,3.903E-08,2.774E-10,3.903E-08,25,"TRUNDD(TNFRSF10D), Syk, IL-15, PGE2R2, NGF, c-IAP2, TrkA, iNOS, Eotaxin-2, ICAM1, PGD2R, Lyn, GM-CSF, IL-33, Eotaxin-3, STAT5, CRLF2, Apo-2L(TNFSF10), Eotaxin, TrkB, TSLP, Fibronectin, NT-3, TNF-alpha, TSLPR",
11,Vascular endothelial cell damage in SLE,63,3.825E-10,4.892E-08,3.825E-10,4.892E-08,24,"HGF, IL-1 beta, IL-1 alpha, PD-L2, VCAM1, iNOS, alpha-4/beta-1 integrin, IL-18, ICAM1, CCL2, IFN-alpha, IL-8, GM-CSF, IL-6, PD-1, alpha-5/beta-1 integrin, CSF1, Tissue factor, Caspase-1, Fibronectin, C3a, P-selectin, PD-L1, TNF-alpha",
12,TGF-beta 1-mediated induction of EMT in normal and asthmatic airway epithelium,44,2.150E-09,2.521E-07,2.150E-09,2.521E-07,19,"IL-1 beta, N-cadherin, CD44, Tenascin-C, ITGB3, ETS1, TGF-beta receptor type II, BMP4, SLUG, MMP-2, ACTA2, HMGA2, CTGF, TWIST1, Fibronectin, Jagged1, Vimentin, MMP-9, TNF-alpha",
13,Development_Positive regulation of WNT/Beta-catenin signaling at the receptor level,64,3.380E-09,3.658E-07,3.380E-09,3.658E-07,23,"Biglycan, R-spondin 1, TrkA, RECK, CD44, LGR6, Tenascin-C, Glypican-3, Tcf(Lef), WNT7A, SFRP2, WNT, EGFR, CRIPTO, FZD5, R-spondins, WLS, LGR5, SFRP1, Caveolin-1, GPR124, WNT5B, Frizzled",
14,TNF-alpha and IL-1 beta-mediated regulation of contraction and secretion of inflammatory factors in normal and asthmatic airway smooth muscle,65,4.787E-09,4.810E-07,4.787E-09,4.810E-07,23,"COX-2 (PTGS2), GRO-2, IL-1 beta, VCAM1, GRO-1, TRPC3, CCL2, PKC-alpha, CD38, IL-8, EGFR, GM-CSF, IL-6, PA24A, Eotaxin, AKT(PKB), PLA2, c-Src, GRO-3, MMP-9, PDGF-R-beta, CCL7, TNF-alpha",
15,Expression targets of Tissue factor signaling in cancer,22,6.111E-09,5.732E-07,6.111E-09,5.732E-07,13,"PTX3, ITGB1, GRO-1, GFPT2, IL-8, GM-CSF, Cyr61, PLAUR (uPAR), PAR1, CTGF, CSF1, Tissue factor, PLAU (UPA)",
16,Canonical WNT signaling pathway in colorectal cancer,66,6.722E-09,5.911E-07,6.722E-09,5.911E-07,23,"PI3K cat class IA, iNOS, I-FABP, CD44, FZD10, SFRP2, WNT, BMP4, SLUG, WNT2, Axin2, Matrilysin (MMP-7), SFRP1, Carbonic anhydrase II, HGF receptor (Met), FZD7, DACT3, Axin, SFRP5, TCF7 (TCF1), Frizzled, WNT1, WNT6",
17,TGF-beta signaling via SMADs in breast cancer,47,8.165E-09,6.757E-07,8.165E-09,6.757E-07,19,"TGF-beta 2, Cyclin A1, MMP-13, RUNX2, CD44, IL-8, ETS1, TGF-beta receptor type II, SLUG, CD44 soluble, Fascin, MMP-14, PTHrP, HMGA2, CTGF, TWIST1, FOXQ1 (HFH1), MMP-9, GLI-2",
18,Inter-cellular relations in COPD (general schema),30,9.031E-09,6.936E-07,9.031E-09,6.936E-07,15,"IL-1 beta, GRO-1, IP10, CCL2, I-TAC, IL-8, EGFR, GM-CSF, IL-6, TGF-beta, TGF-alpha, CTGF, MMP-9, Perforin, TNF-alpha",
19,Inflammatory mechanisms of pancreatic cancerogenesis,67,9.366E-09,6.936E-07,9.366E-09,6.936E-07,23,"COX-2 (PTGS2), IL-1 beta, TNF-R2, CCL20, IL-1 alpha, GRO-1, iNOS, ICAM1, CCL2, IL-8, EGFR, G-protein alpha-i family, TLR4, ENA-78, MMP-2, IL-32 (NK4), IL-6, Mucin 4, TGF-alpha, Angiotensin II, MMP-9, PLAU (UPA), TNF-alpha",
20,Development_TGF-beta-dependent induction of EMT via SMADs ,35,1.486E-08,9.956E-07,1.486E-08,9.956E-07,16,"HEY1, N-cadherin, TGF-beta 2, ETS1, TGF-beta receptor type II, SLUG, SIP1 (ZFHX1B), MMP-2, TGF-beta, HMGA2, TWIST1, Fibronectin, Jagged1, Vimentin, TCF8, Claudin-1",
21,Role of adhesion of SCLC cells in tumor progression,35,1.486E-08,9.956E-07,1.486E-08,9.956E-07,16,"N-cadherin, ITGB1, VCAM1, NCAM1, alpha-4/beta-1 integrin, ICAM1, Tenascin-C, MMP-14, MMP-2, alpha-5/beta-1 integrin, PTHrP, Caveolin-1, Collagen IV, Fibronectin, P-selectin, ACM3",
22,Immune response_CCL2 signaling,54,1.969E-08,1.246E-06,1.969E-08,1.246E-06,20,"IL-1 beta, IL-1 alpha, iNOS, alpha-4/beta-1 integrin, ICAM1, CCL2, PKC-alpha, ITGB3, ETS1, G-protein alpha-i family, MMP-14, MMP-2, IL-6, alpha-5/beta-1 integrin, Actin cytoskeletal, Caveolin-1, DARC, CDH19, PI3K cat class IA (p110-delta), TNF-alpha",
23,WNT signaling in HCC,40,2.037E-08,1.246E-06,2.037E-08,1.246E-06,17,"NOTUM, Prickle-1, p14ARF, Glypican-3, Tcf(Lef), SFRP2, WNT, EGFR, WNT3, LGR5, SFRP1, FZD7, Axin, SFRP5, Frizzled, WNT1, DACT1",
24,Beta-catenin-dependent transcription regulation in colorectal cancer,36,2.450E-08,1.379E-06,2.450E-08,1.379E-06,16,"COX-2 (PTGS2), LAMC2, LAMC2 (80kDa), CD44, Tenascin-C, IL-8, CDX2, CD44 soluble, Fascin, MMP-14, CD44 (EXT), PLAUR (uPAR), LAMC2 (100kDa), Claudin-1, PLAU (UPA), MDR1",
25,WNT signaling in gastric cancer,36,2.450E-08,1.379E-06,2.450E-08,1.379E-06,16,"CD44, DKK3, Tcf(Lef), WNT7A, SFRP2, WNT, WNT 8A, WNT2, WNT3, Matrilysin (MMP-7), WNT10A, SFRP1, Axin, Frizzled, WNT1, TNF-alpha",
26,Basophil migration in asthma,55,2.832E-08,1.487E-06,2.832E-08,1.487E-06,20,"FPRL1, Secretoneurin, VCAM1, Eotaxin-2, alpha-4/beta-1 integrin, ICAM1, CCL2, IL-8, G-protein alpha-i family, GM-CSF, IL-33, Eotaxin-3, PLAUR (uPAR), Eotaxin, Fibronectin, PI3K reg class IB (p101), P-selectin, MMP-9, PLAU (UPA), CCL7",
27,Release of pro-inflammatory mediators and elastolytic enzymes by alveolar macrophages in COPD,28,2.854E-08,1.487E-06,2.854E-08,1.487E-06,14,"CHI3L1, IL-1 beta, IP10, CCL2, IL-8, TLR4, GM-CSF, MMP-2, IL-6, Matrilysin (MMP-7), Cathepsin S, MMP-9, TLR2, TNF-alpha",
28,Immune response_IL-1 signaling pathway,82,3.298E-08,1.657E-06,3.298E-08,1.657E-06,25,"COX-2 (PTGS2), IL-1 beta, c-IAP2, PI3K cat class IA, IL-1 alpha, GRO-1, MMP-13, iNOS, RUNX2, IP10, ICAM1, CD44, CCL2, RANKL(TNFSF11), IL-8, GM-CSF, IL-6, FGF2, AKT(PKB), MYLK1, IFN-beta, MMP-9, PLAU (UPA), CCL7, TNF-alpha",
29,Multiple sclerosis (general schema),21,4.033E-08,1.957E-06,4.033E-08,1.957E-06,12,"NGF, VCAM1, ICAM1, LIF, CTLA-4, FGF2, FasL(TNFSF6), Apo-2L(TNFSF10), Fibronectin, Jagged1, IFN-beta, TNF-alpha",
30,Stromal-epithelial interaction in Prostate Cancer,42,4.905E-08,2.156E-06,4.905E-08,2.156E-06,17,"HGF, Keratin 17, TGF-beta 2, Tenascin-C, TGF-beta receptor type II, MMP-2, Versican, IL-6, ACTA2, FGF2, PDGF-R-alpha, HIC5, HGF receptor (Met), Fibronectin, Vimentin, MMP-9, PDGF-R-beta",
31,IL-1 signaling in melanoma,42,4.905E-08,2.156E-06,4.905E-08,2.156E-06,17,"COX-2 (PTGS2), GRO-2, IL-1 beta, IL-1 alpha, PD-L2, VCAM1, GRO-1, iNOS, alpha-4/beta-1 integrin, IL-18, ICAM1, CCL2, IL-8, IL-6, GRO-3, MMP-9, PD-L1",
32,Hedgehog signaling in gastric cancer,29,5.057E-08,2.156E-06,5.057E-08,2.156E-06,14,"N-cadherin, PTCH1, CDX2, BMP4, SLUG, SIP1 (ZFHX1B), MEF2C, GLI-1, SFRP1, HNF3-beta, EDNRA, TWIST2, GLI-2, PDGF-R-beta",
33,Bone metastases in Prostate Cancer,29,5.057E-08,2.156E-06,5.057E-08,2.156E-06,14,"Osteopontin, RUNX2, CCL2, RANKL(TNFSF11), WNT, G-protein alpha-i family, PTHrP, Osteoprotegerin, c-Src, MMP-9, Frizzled, EDNRA, RANK(TNFRSF11A), IBP3",
34,"Chemokines in inflammation in adipose tissue and liver in obesity, type 2 diabetes and metabolic syndrome X",48,8.069E-08,3.339E-06,8.069E-08,3.339E-06,18,"IL-1 beta, MHC class II, VCAM1, ITGA4, ICAM1, CD44, CCL2, CMKLR1, CD3, IL-8, TLR4, IL-6, PLAUR (uPAR), TIG2, EMR1, P-selectin, TLR2, TNF-alpha",
35,Stellate cells activation and liver fibrosis,70,1.199E-07,4.820E-06,1.199E-07,4.820E-06,22,"GRO-2, IL-1 beta, Biglycan, TNF-R2, PI3K cat class IA, PTCH1, ICAM1, CCL2, Tcf(Lef), TGF-beta receptor type II, MMP-2, ACTA2, IRAK1/2, COL1A2, GLI-1, PDGF-R-alpha, AKT(PKB), PDGF receptor, Frizzled, TLR2, PDGF-R-beta, TNF-alpha",
36,TGF-beta 1-induced transactivation of membrane receptors signaling in HCC,50,1.671E-07,6.532E-06,1.671E-07,6.532E-06,18,"ITGB1, PI3K cat class IA, Cyclin E, TGF-beta receptor type II, SLUG, Cyclin A, alpha-5/beta-1 integrin, TGF-beta, PDGF-R-alpha, AKT(PKB), PDGF receptor, ITGA5, Fibronectin, c-Src, Actin, Axin, Cofilin, PDGF-R-beta",
37,"Development_Hedgehog, BMP and Parathyroid hormone in osteogenesis",51,2.366E-07,8.996E-06,2.366E-07,8.996E-06,18,"EGR2 (Krox20), Osteopontin, B-Raf, RUNX2, PTCH1, BMP6, RANKL(TNFSF11), Adenylate cyclase, ALPL, SMAD9 (SMAD8), TAZ, PTHrP, GLI-1, Osteoprotegerin, G-protein alpha-q/11, DLX5, BMP2, GLI-2",
38,Signal transduction_WNT/Beta-catenin signaling in tissue homeostasis,42,3.302E-07,1.195E-05,3.302E-07,1.195E-05,16,"COX-2 (PTGS2), PPCKC, FGF18, iNOS, Tcf(Lef), IL-8, WNT, SLUG, MMP-2, Versican, NeuroD1, ACADL, MMP-9, TCF7 (TCF1), CDX1, Frizzled",
39,Influence of bone marrow cell environment on progression of multiple myeloma,52,3.313E-07,1.195E-05,3.313E-07,1.195E-05,18,"HGF, IL-1 beta, ITGB1, PI3K cat class IA, VCAM1, HAS1, alpha-4/beta-1 integrin, PTCH1, CD44, PKC-alpha, IL-6, alpha-5/beta-1 integrin, FGF2, CD21, HGF receptor (Met), Fibronectin, PI3K reg class IB (p101), TNF-alpha",
40,Development_Schema: FGF signaling in embryonic stem cell self-renewal and differentiation,47,3.404E-07,1.197E-05,3.404E-07,1.197E-05,17,"SOX1, NCAM1, PTCH1, Activin A, Gremlin, BMP4, SOX17, FGF1, Mixl1, WNT3, Nestin, FGF2, SPRY2, HNF4-alpha, HNF3-beta, BMP2, PAX6",
41,Cell adhesion_Tight junctions,38,4.480E-07,1.501E-05,4.480E-07,1.501E-05,15,"ITGB1, Claudin-18, Claudin-11, Actomyosin, F-Actin, Tcf(Lef), CDX2, Claudin-16, Myosin II, Claudin-14, Caveolin-1, Claudin-8, Claudin-1, Actin, CDX1",
42,Development_Neural stem cell lineage commitment (schema),38,4.480E-07,1.501E-05,4.480E-07,1.501E-05,15,"Myelin basic protein, MAP-1B, PTCH1, WNT7A, BMP4, S100B, MAP2, LIF, Nestin, MCT1 (SLC16A1), FZD9, PDGF-R-alpha, Vimentin, GLAST1/EAAT1, BMP2",
43,Immune response_HMGB1/RAGE signaling pathway,53,4.595E-07,1.504E-05,4.595E-07,1.504E-05,18,"IL-1 beta, Secretogranin 1, PI3K cat class IA, IL-1 alpha, VCAM1, iNOS, ICAM1, PLAT (TPA), IL-8, TLR4, MEF2C, IL-6, AKT(PKB), Tissue factor, c-Src, Secretogranin II, TLR2, TNF-alpha",
44,Development_WNT/Beta-catenin signaling in embryogenesis,43,4.818E-07,1.510E-05,4.818E-07,1.510E-05,16,"p14ARF, Oct-3/4, SP5, Tcf(Lef), WNT, CDX2, SOX17, LBH, p15, Mixl1, FGF8, p16INK4, En1, TCF7 (TCF1), CDX1, Frizzled",
45,Stimulation of TGF-beta signaling in lung cancer,48,4.829E-07,1.510E-05,4.829E-07,1.510E-05,17,"COX-2 (PTGS2), IL-1 beta, N-cadherin, TGF-beta 2, ITGB1, TGF-beta receptor type II, SLUG, IRAKM, MMP-2, ACTA2, TGF-beta, Fyn, AKT(PKB), Fibronectin, Vimentin, MMP-9, Tropomyosin-2",
46,TGF-beta-induced fibroblast/ myofibroblast migration and extracellular matrix production in asthmatic airways,64,4.970E-07,1.520E-05,4.970E-07,1.520E-05,20,"ITGA1, Biglycan, TGF-beta 2, ITGB1, PI3K cat class IA, COL4A1, MMP-13, Decorin, HAS1, Tenascin-C, TGF-beta receptor type II, MMP-2, COL1A2, AKT(PKB), COL5A1, Collagen IV, ITGA5, Fibronectin, MMP-9, Collagen III",
47,Disruption of epithelial layer restitution in asthma,34,5.876E-07,1.759E-05,5.876E-07,1.759E-05,14,"HGF, IL-1 beta, TGF-beta 2, ITGB1, IL-1 alpha, EGFR, PLAUR (uPAR), alpha-5/beta-1 integrin, HGF receptor (Met), Fibronectin, MMP-9, PLAU (UPA), EDNRA, TNF-alpha",
48,Renal tubulointerstitial injury in Lupus Nephritis ,65,6.572E-07,1.926E-05,6.572E-07,1.926E-05,20,"IL-1 beta, TNF-R2, MHC class II, VCAM1, alpha-4/beta-1 integrin, ICAM1, CD44, CCL2, CMKLR1, IFN-alpha, IL-8, GM-CSF, IL-6, CSF1, TIG2, Fibronectin, Vimentin, PLAU (UPA), TNF-alpha, Collagen III",
49,Development_WNT/Beta-catenin signaling in organogenesis,30,7.356E-07,1.990E-05,7.356E-07,1.990E-05,13,"PROX1, Oct-3/4, Tcf(Lef), IL-8, WNT, Neuropilin-1, FOXC2, LBH, PLA2G7, FGF8, En1, BMP2, Frizzled",
50,Cell adhesion_Gap junctions,30,7.356E-07,1.990E-05,7.356E-07,1.990E-05,13,"Tubulin beta, Connexin 37, PKC, Connexin 26, Connexin 32, Connexin 50, Connexin 36, Connexin 45, Caveolin-1, Connexin 46, c-Src, Actin, Connexin 31",
51,Regulation of IGF family activity in colorectal cancer,30,7.356E-07,1.990E-05,7.356E-07,1.990E-05,13,"COX-2 (PTGS2), IL-1 beta, Cystatin SN, IL-6, Matrilysin (MMP-7), PLAUR (uPAR), PCSK5, IBP6, c-Src, MMP-9, IBP, PLAU (UPA), IBP3",
52,Development_WNT/Beta-catenin signaling in cell differentiation,30,7.356E-07,1.990E-05,7.356E-07,1.990E-05,13,"BMP3, PROX1, FGF18, PAX8, Tcf(Lef), WNT, EMX2, SLUG, NeuroD1, TCF7 (TCF1), CDX1, BMP2, Frizzled",
53,Immune response_IL-17 signaling pathways,60,7.611E-07,2.021E-05,7.611E-07,2.021E-05,19,"COX-2 (PTGS2), IL-1 beta, PI3K cat class IA, CCL20, GRO-1, iNOS, GCP2, ICAM1, CCL2, RANKL(TNFSF11), IL-8, NGAL, IL-17F, GM-CSF, ENA-78, IL-6, AKT(PKB), MMP-9, CCL7",
54,Muscle contraction_GPCRs in the regulation of smooth muscle tone,83,7.833E-07,2.041E-05,7.833E-07,2.041E-05,23,"PGE2R2, Histamine H1 receptor, TRPC5, TRPC3, Adenosine A2b receptor, PKC-alpha, V1a receptor, NCX1, G-protein alpha-i family, Adenylate cyclase, MRLC, HTR2A, Telokin, Myosin II, Beta-2 adrenergic receptor, TRPC6, G-protein alpha-q/11, Angiotensin II, MELC, MyHC, MLCK, EDNRA, ACM3",
55,Interleukins-induced inflammatory response in asthmatic airway fibroblasts,35,8.979E-07,2.210E-05,8.979E-07,2.210E-05,14,"COX-2 (PTGS2), GRO-2, IL-1 beta, NGF, IL-1 alpha, VCAM1, GRO-1, ICAM1, CCL2, IL-8, GM-CSF, IL-33, IL-6, Eotaxin",
56,Development_Extraembryonic differentiation of embryonic stem cells,35,8.979E-07,2.210E-05,8.979E-07,2.210E-05,14,"HEY1, SOX1, NCAM1, HNF4, Transferrin, Gremlin, CGB3, BMP4, MAP2, SMAD9 (SMAD8), Nestin, ID4, BMP2, PAX6",
57,Cell adhesion_Plasmin signaling,35,8.979E-07,2.210E-05,8.979E-07,2.210E-05,14,"TGF-beta 2, PI3K cat class IA, MMP-13, TFPI-2, PLAT (TPA), C1 inhibitor, TGF-beta receptor type II, Neuroserpin, FGF2, Collagen IV, Plasma kallikrein, Fibronectin, PZP, PLAU (UPA)",
58,Role of fibroblasts in the sensitization phase of allergic contact dermatitis,22,9.109E-07,2.210E-05,9.109E-07,2.210E-05,11,"IL-1 beta, IL-1 alpha, Elastin, IL-8, MMP-2, IL-6, Collagen IV, Fibronectin, MMP-9, TNF-alpha, Collagen III",
59,IL-1 beta- and Endothelin-1-induced fibroblast/ myofibroblast migration and extracellular matrix production in asthmatic airways,40,9.785E-07,2.333E-05,9.785E-07,2.333E-05,15,"IL-1 beta, IL-1 alpha, COL4A1, Decorin, HAS1, CCL2, MMP-2, Versican, COL1A2, CTGF, PDGF-R-alpha, Fibronectin, EDNRA, PDGF-R-beta, Collagen III",
60,Airway smooth muscle contraction in asthma,56,1.160E-06,2.721E-05,1.160E-06,2.721E-05,18,"PGE2R2, Histamine H1 receptor, TRPC3, PKC-alpha, G-protein alpha-i family, Adenylate cyclase, MRLC, Telokin, PGF2aR, Myosin II, Beta-2 adrenergic receptor, TRPC6, CPI-17, G-protein alpha-q/11, MELC, MyHC, MLCK, ACM3",
61,Neurophysiological process_Receptor-mediated axon growth repulsion,46,1.386E-06,3.197E-05,1.386E-06,3.197E-05,16,"B-Raf, Plexin A2, Semaphorin 3A, EGFR, F-Actin cytoskeleton, Neuropilin-1, Actin cytoskeletal, Fyn, Ephrin-A receptors, CRMP2, c-Fes, Ephrin-A, c-Src, Pleiotrophin (OSF1), Ephrin-A receptor 2, Cofilin",
62,Eosinophil adhesion and transendothelial migration in asthma,68,1.462E-06,3.317E-05,1.462E-06,3.317E-05,20,"Osteopontin, VCAM1, PKC, Eotaxin-2, alpha-4/beta-1 integrin, ICAM1, CD44, GM-CSF, HTR2A, Eotaxin-3, PLAUR (uPAR), alpha-1/beta-1 integrin, Eotaxin, Collagen IV, Fibronectin, C3a, P-selectin, MMP-9, PLAU (UPA), CCL7",
63,Role of IL-8 in colorectal cancer,19,1.582E-06,3.532E-05,1.582E-06,3.532E-05,10,"HGF, IL-1 beta, PI3K cat class IA, ICAM1, CD44, IL-8, EGFR, MMP-2, HGF receptor (Met), TNF-alpha",
64,Immune response_IL-18 signaling,63,1.753E-06,3.807E-05,1.753E-06,3.807E-05,19,"COX-2 (PTGS2), IL-1 beta, IL-18R1, PI3K cat class IA, IL-1 alpha, VCAM1, iNOS, IL-18, ICAM1, CCL2, IL-8, IL18RAP, IL-6, FasL(TNFSF6), AKT(PKB), Fibronectin, c-Src, MMP-9, TNF-alpha",
65,Th2 cytokine- and TNF-alpha-induced profibrotic response in asthmatic airway fibroblasts/ myofibroblasts,52,1.759E-06,3.807E-05,1.759E-06,3.807E-05,17,"COX-2 (PTGS2), IL-1 beta, NGF, Biglycan, TrkA, Decorin, HAS1, Tenascin-C, ETS1, MMP-2, ACTA2, COL1A2, PDGF-R-alpha, AKT(PKB), MMP-9, TNF-alpha, Collagen III",
66,Development_MAG-dependent inhibition of neurite outgrowth,37,1.987E-06,4.236E-05,1.987E-06,4.236E-05,14,"NGF, NGFR (ICD), NGFR(TNFRSF16), TrkA, NGFR (CTF), MRLC, Myosin II, Actin cytoskeletal, RASGRF1, TrkB, MELC, MyHC, Cofilin, NT-3",
67,Immune response_IFN-alpha/beta signaling via JAK/STAT,64,2.283E-06,4.794E-05,2.283E-06,4.794E-05,19,"IFI17, TAP1 (PSF1), GBP1, IFI27, IP10, ISG15, STAT4, CCL2, I-TAC, IFN-alpha, ISG54, RIG-G, STAT5, RSAD2, Apo-2L(TNFSF10), GBP4, ERAP140, IFN-beta, XAF1",
68,Immune response_Classical complement pathway,53,2.372E-06,4.837E-05,2.372E-06,4.837E-05,17,"C1r, C4a, C1 inhibitor, C6, CRP, C3, Factor I, C3b, C3c, C4b, C7, iC3b, C3dg, CD21, C3a, C4, C1s",
69,Chemotaxis_Inhibitory action of lipoxins on IL-8- and Leukotriene B4-induced neutrophil migration,53,2.372E-06,4.837E-05,2.372E-06,4.837E-05,17,"FPRL1, Actomyosin, ITGB2, ICAM1, IL-8, G-protein alpha-i family, MRLC, Myosin II, Actin cytoskeletal, Rac2, AKT(PKB), MELC, MYLK1, PI3K reg class IB (p101), Actin, MLCK, Cofilin",
70,Endothelin-1- and TNF-alpha-induced inflammatory response in asthmatic airway fibroblasts,20,2.906E-06,5.840E-05,2.906E-06,5.840E-05,10,"COX-2 (PTGS2), IL-1 beta, NGF, TGF-beta 2, ICAM1, IL-33, ADAM33, IL-6, EDNRA, TNF-alpha",
71,NK cells in allergic contact dermatitis,34,4.035E-06,7.885E-05,4.035E-06,7.885E-05,13,"MHC class II, CCL20, NCAM1, IP10, ICAM1, CCL2, FasR(CD95), STAT5, HLA-DRA1, FasL(TNFSF6), KLRK1 (NKG2D), Perforin, TNF-alpha",
72,Development_Role of cell-cell and ECM-cell interactions in oligodendrocyte differentiation and myelination,34,4.035E-06,7.885E-05,4.035E-06,7.885E-05,13,"ITGB1, Myelin basic protein, Claudin-11, NGFR(TNFRSF16), Tetraspanin-2, NCAM1, Tenascin-R, Connexin 26, Connexin 32, Connexin 47, Connexin 30, Fyn, Connexin 45",
73,B-regulatory cells and tumor cells intercellular interaction,67,4.858E-06,9.363E-05,4.858E-06,9.363E-05,19,"FPRL1, IL-1 beta, TNF-R2, MCAM, EBI3, CCL2, TLR4, GM-CSF, IL-33, FasR(CD95), IL-6, PD-1, OX40(TNFRSF4), TLR7, FasL(TNFSF6), CD5, PD-L1, IL-12RB2, TNF-alpha",
74,"Signal transduction_Angiotensin II/ AGTR1 signaling via p38, ERK and PI3K",98,5.015E-06,9.435E-05,5.015E-06,9.435E-05,24,"Syk, COX-2 (PTGS2), Osteopontin, PI3K cat class IA, RECK, CCL2, WISP1, ETS1, cPLA2, EGFR, TLR4, MEF2C, MMP-14, MMP-2, CMYA3, PDGF-C, IL-6, PPARGC1 (PGC1-alpha), Fyn, AKT(PKB), Angiotensin II, OSF-2, c-Src, PDGF-R-beta",
75,Probable BMP4-mediated induction of EMT in airway epithelium,21,5.096E-06,9.435E-05,5.096E-06,9.435E-05,10,"N-cadherin, BMP4, SLUG, SIP1 (ZFHX1B), MMP-2, SMAD9 (SMAD8), TWIST1, COL5A1, TCF8, MMP-9",
76,Inflammatory response in ischemia-reperfusion injury during myocardial infarction,21,5.096E-06,9.435E-05,5.096E-06,9.435E-05,10,"IL-1 beta, ICAM1, CCL2, IL-8, TLR4, IL-6, C3a, P-selectin, TLR2, TNF-alpha",
77,Th2 cytokine- and TNF-alpha-induced inflammatory response in asthmatic airway fibroblasts,35,5.888E-06,1.076E-04,5.888E-06,1.076E-04,13,"COX-2 (PTGS2), ITGB1, VCAM1, ICAM1, CCL2, IL-8, GM-CSF, IL-6, Eotaxin-3, alpha-5/beta-1 integrin, Eotaxin, ITGA5, TNF-alpha",
78,Glucocorticoid-induced elevation of intraocular pressure as glaucoma risk factor,62,5.969E-06,1.077E-04,5.969E-06,1.077E-04,18,"COX-2 (PTGS2), ITGB1, PI3K cat class IA, COL4A1, PLAT (TPA), ITGB3, Elastin, Antileukoproteinase 1, EGFR, WNT2, MMP-2, Actin cytoskeletal, LAMB3, Collagen IV, HGF receptor (Met), Fibronectin, c-Src, MLCK",
79,Macrophage and dendritic cell phenotype shift in cancer,100,7.297E-06,1.300E-04,7.297E-06,1.300E-04,24,"COX-2 (PTGS2), PGE2R2, MFGE8, IL-1 beta, HPRG, IDO1, MHC class II, iNOS, IP10, Activin A, PLGF, IFN-alpha, TLR4, GM-CSF, IL-6, CD137 ligand(TNFSF9), TLR7, Apo-2L(TNFSF10), CSF1, OSF-2, Jagged1, IFN-beta, TLR2, TNF-alpha",
80,Maturation and migration of dendritic cells in skin sensitization,41,8.108E-06,1.426E-04,8.108E-06,1.426E-04,14,"MHC class II alpha chain, IL-1 beta, TNF-R2, HLA-DRB1, MHC class II, ICAM1, HLA-DRB, IL-8, IL-6, CD83, HLA-DRA1, HLA-DRB5, MHC class II beta chain, TNF-alpha",
81,Type 2 diabetes (general schema),14,8.249E-06,1.433E-04,8.249E-06,1.433E-04,8,"IL-1 beta, Glucagon, CCL2, GLP-1 (7-36) amide, IL-6, GLP-1 (7-37), GIP, TNF-alpha",
82,E-cadherin signaling and its regulation in gastric cancer,36,8.455E-06,1.451E-04,8.455E-06,1.451E-04,13,"HGF, WNT, SLUG, EGFR, SIP1 (ZFHX1B), FGF1, TWIST1, HGF receptor (Met), c-Src, TCF8, Actin, BMP2, Frizzled",
83,Development_Role of proteases in hematopoietic stem cell mobilization,18,9.305E-06,1.569E-04,9.305E-06,1.569E-04,9,"VCAM1, alpha-4/beta-1 integrin, CD44, MMP-14, MMP-2, alpha-5/beta-1 integrin, DPP4, Fibronectin, MMP-9",
84,Cytoskeleton remodeling_Regulation of actin cytoskeleton organization by the kinase effectors of Rho GTPases,58,9.367E-06,1.569E-04,9.367E-06,1.569E-04,17,"Actomyosin, PAK, Rac1-related, Cdc42 subfamily, RhoJ, MSN (moesin), ERM proteins, F-Actin cytoskeleton, MRLC, Myosin II, Caldesmon, Actin cytoskeletal, Rac2, CPI-17, MyHC, MLCK, Cofilin",
85,Eosinophil chemotaxis in asthma,64,9.759E-06,1.615E-04,9.759E-06,1.615E-04,18,"NGF, Secretoneurin, S1P1 receptor, NGFR(TNFRSF16), TrkA, CCL20, IP10, Eotaxin-2, IL-8, G-protein alpha-i family, GM-CSF, HTR2A, Eotaxin-3, VIP, Eotaxin, C3a, PI3K reg class IB (p101), CCL7",
86,Regulation of mast cell survival in asthma,47,9.945E-06,1.627E-04,9.945E-06,1.627E-04,15,"Syk, NGF, TNF-R2, TrkA, GM-CSF, FasR(CD95), IL-6, BFL1, STAT5, alpha-5/beta-1 integrin, FasL(TNFSF6), Apo-2L(TNFSF10), AKT(PKB), Fibronectin, TNF-alpha",
87,Role of IFN-beta in the improvement of blood-brain barrier integrity in multiple sclerosis,27,1.098E-05,1.762E-04,1.098E-05,1.762E-04,11,"sVCAM1, TNF-R2, VCAM1, ITGA4, alpha-4/beta-1 integrin, ICAM1, sICAM1, 5'-NTD, IFN-beta, MMP-9, TNF-alpha",
88,FAK1 signaling in melanoma,42,1.115E-05,1.762E-04,1.115E-05,1.762E-04,14,"ITGB1, ARCGAP22, B-Raf, PKC-alpha, ITGB3, MMP-14, MMP-2, alpha-5/beta-1 integrin, Actin cytoskeletal, Caveolin-1, ITGA5, Fibronectin, c-Src, PLAU (UPA)",
89,Development_TGF-beta family mediated differentiation of embryonic stem cells,42,1.115E-05,1.762E-04,1.115E-05,1.762E-04,14,"SOX1, Activin A, Oct-3/4, TGF-beta receptor type II, BMP4, CRIPTO, SOX17, Mixl1, Nestin, TAZ, Lefty-2, HOXA1, HNF3-beta, PAX6",
90,Immune response_Inhibitory PD-1 signaling in T cells,53,1.127E-05,1.762E-04,1.127E-05,1.762E-04,16,"Syk, MHC class II, PI3K cat class IA, PD-L2, PKC-theta, ICAM1, ZAP70, CD3, Cyclin E, T-bet, CD3 zeta, p15, PD-1, FYB1, AKT(PKB), PD-L1",
91,Role of activation of WNT signaling in the progression of lung cancer,77,1.187E-05,1.820E-04,1.187E-05,1.820E-04,20,"iNOS, RUNX3, Oct-3/4, DKK3, NKD1, Tcf(Lef), SFRP2, WNT, FZD5, WNT2, Axin2, WNT3, Matrilysin (MMP-7), FZD9, SFRP1, FZD7, Axin, SFRP5, Frizzled, WNT1",
92,Development_Early embryonal hypaxial myogenesis,37,1.196E-05,1.820E-04,1.196E-05,1.820E-04,13,"PKC, PTCH1, WNT7A, BMP4, Adenylate cyclase, WNT11, MSX1, GLI-1, FZD7, Frizzled, GLI-2, Paraxis, WNT6",
93,Immunological synapse between dendritic and CD8+ T cells in allergic contact dermatitis,32,1.203E-05,1.820E-04,1.203E-05,1.820E-04,12,"PD-L2, ICAM1, RANKL(TNFSF11), CD70(TNFSF7), PD-1, CTLA-4, CD137 ligand(TNFSF9), OX40(TNFRSF4), CD137(TNFRSF9), ICOS, RANK(TNFRSF11A), PD-L1",
94,Role of Tissue factor-induced Thrombin signaling in cancerogenesis,65,1.236E-05,1.851E-04,1.236E-05,1.851E-04,18,"GRO-1, MMP-13, PKC-alpha, IL-8, EGFR, G-protein alpha-i family, MRLC, MMP-2, Angiopoietin 1, Actin cytoskeletal, PAR1, AKT(PKB), G-protein alpha-q/11, Tissue factor, MELC, c-Src, P-selectin, MLCK",
95,Development_Schema: Embryonal cardiomyogenesis,8,1.323E-05,1.944E-04,1.323E-05,1.944E-04,6,"WNT 8A, WNT11, Jagged1, SFRP5, BMP2, WNT1",
96,Protein folding and maturation_Angiotensin system maturation,48,1.326E-05,1.944E-04,1.326E-05,1.944E-04,15,"MC-CPA, Angiotensin I, Neprilysin, AGTR2, Angiotensin (1-7), Angiotensin (1-9), Angiotensin III, Angiotensin (2-10), Angiotensinogen, Angiotensin IV, MMP-8, Angiotensin II, Kallikrein 1, ACE2, CD13",
97,Eosinophil granule protein release in asthma,54,1.468E-05,2.107E-04,1.468E-05,2.107E-04,16,"FPRL1, NGF, cPKC (conventional), PKC, PKC-alpha, GM-CSF, IL-33, CRLF2, Eotaxin, TSLP, ECP (RNase 3), C3a, FPR, NT-3, TNF-alpha, TSLPR",
98,Th17 cells in CF,54,1.468E-05,2.107E-04,1.468E-05,2.107E-04,16,"IL-1 beta, MHC class II, CCL20, VCAM1, GRO-1, GCP2, ICAM1, LBP, IL23A, IL-8, IL-17F, TGF-beta receptor type II, TLR4, GM-CSF, MD-2, IL-6",
99,Role of cell adhesion in vaso-occlusion in Sickle cell disease,43,1.517E-05,2.156E-04,1.517E-05,2.156E-04,14,"IL-1 beta, IL-1 alpha, VCAM1, ITGB2, alpha-4/beta-1 integrin, ICAM1, CD44, CD3, IL-8, iC3b, Fc gamma RII alpha, Fibronectin, P-selectin, TNF-alpha",
100,Tumor-stroma interactions in pancreatic cancer,28,1.661E-05,2.278E-04,1.661E-05,2.278E-04,11,"HGF, PTCH1, MMP-2, alpha-5/beta-1 integrin, FGF2, COL1A2, GLI-1, OSF-2, HGF receptor (Met), Fibronectin, PDGF-R-beta",
101,Putative pathways of activation of classical complement system in major depressive disorder,28,1.661E-05,2.278E-04,1.661E-05,2.278E-04,11,"IL-1 beta, C6, C3, C4B protein, C3b, C4b, IL-6, C7, C4A protein, C4, TNF-alpha",
102,Role of TGF-beta 1 in fibrosis development after myocardial infarction,38,1.668E-05,2.278E-04,1.668E-05,2.278E-04,13,"Biglycan, AGTR2, Tenascin-C, TGF-beta receptor type II, MMP-2, ACTA2, COL1A2, CTGF, Angiotensin II, Fibronectin, MMP-9, EDNRA, Collagen III",
103,Neutrophil chemotaxis in asthma,38,1.668E-05,2.278E-04,1.668E-05,2.278E-04,13,"GRO-2, FPRL1, GRO-1, CCL2, PLGF, IL-8, G-protein alpha-i family, Tissue kallikreins, ENA-78, PI3K reg class IB (p101), GRO-3, TLR2, CCL7",
104,Breakdown of CD4+ T cell peripheral tolerance in type 1 diabetes mellitus,49,1.752E-05,2.371E-04,1.752E-05,2.371E-04,15,"HLA-DRB1, MHC class II, STAT4, ZAP70, CD3, T-bet, STAT5, PD-1, CTLA-4, PTPN22, ICOS, LAT, HLA-DQA1, IL-2R alpha chain, PD-L1",
105,Role of CD8+ Tc1 cells in COPD,44,2.040E-05,2.708E-04,2.040E-05,2.708E-04,14,"CD69, IL-15, IL-18R1, IP10, IL-18, STAT4, CCL2, Antileukoproteinase 1, T-bet, KLRK1 (NKG2D), Cathepsin S, MMP-9, Perforin, TNF-alpha",
106,Inhibition of remyelination in multiple sclerosis: regulation of cytoskeleton proteins,44,2.040E-05,2.708E-04,2.040E-05,2.708E-04,14,"Tubulin beta, Myelin basic protein, NGFR(TNFRSF16), PKC-alpha, MRLC, Tubulin beta 4, Myosin II, TGF-beta, Actin cytoskeletal, Fyn, MELC, Fibronectin, Cofilin, TNF-alpha",
107,Hedgehog signaling in breast cancer,24,2.198E-05,2.890E-04,2.198E-05,2.890E-04,10,"Osteopontin, PTCH1, Cyclin E, Cyr61, MMP-2, PTHrP, GLI-1, MMP-9, MDR1, GLI-2",
108,Immune response_Differentiation and clonal expansion of CD8+ T cells,39,2.295E-05,2.963E-04,2.295E-05,2.963E-04,13,"MHC class II, ICAM1, STAT4, IFN-alpha, T-bet, CD70(TNFSF7), CD137 ligand(TNFSF9), OX40(TNFRSF4), FasL(TNFSF6), CD137(TNFRSF9), IFN-beta, Perforin, IL-12RB2",
109,Protein folding and maturation_Posttranslational processing of neuroendocrine peptides,50,2.295E-05,2.963E-04,2.295E-05,2.963E-04,15,"PAM, Trypsin, LargeNN, GRP(1-27), NT, GRP(18-27), PC1, GRP(1-27)Gly, GRP precursor, PCSK5, LargeNT, GRP(1-17), NN, NT/NN, ProGRP",
110,Development_YAP/TAZ-mediated co-regulation of transcription,56,2.435E-05,3.114E-04,2.435E-05,3.114E-04,16,"p63, RUNX2, ITGB2, TBX5, Oct-3/4, UFO, CDX2, SLUG, SIP1 (ZFHX1B), Cyr61, HBP17, TAZ, CTGF, TWIST1, UCA1, CDK6",
111,Immune response_IL-10 signaling pathway,62,2.473E-05,3.135E-04,2.473E-05,3.135E-04,17,"COX-2 (PTGS2), IL-1 beta, MHC class II, PI3K cat class IA, IL-1 alpha, iNOS, ICAM1, IRS-2, IL-8, GM-CSF, CRP2, IL-6, STAT5, AKT(PKB), Fc gamma RII alpha, MMP-9, TNF-alpha",
112,Differentiation of Th2 cells in asthma,45,2.716E-05,3.413E-04,2.716E-05,3.413E-04,14,"Histamine H1 receptor, MHC class II, PI3K cat class IA, CCL20, IP10, CCL2, CD3, GM-CSF, OX40(TNFRSF4), AKT(PKB), Histamine H2 receptor, TSLP, Jagged1, TSLPR",
113,SLE genetic marker-specific pathways in T cells,101,2.800E-05,3.487E-04,2.800E-05,3.487E-04,23,"HLA-DRB1, MHC class II, Ikaros, PKC-theta, TCR beta subunit, CalDAG-GEFIII, RUNX3, STAT4, ZAP70, CD3, HLA-DRB, IFN-alpha, ETS1, T-bet, CD3 zeta, PD-1, OX40(TNFRSF4), PTPN22, MHC class II beta chain, LAT, KLRK1 (NKG2D), A20, IFN-beta",
114,Immune response_TLR2 and TLR4 signaling pathways,69,3.014E-05,3.688E-04,3.014E-05,3.688E-04,18,"COX-2 (PTGS2), IL-1 beta, TLR1, PI3K cat class IA, Pellino 1, iNOS, Pellino 2, TLR10, IL-8, TLR6, Lyn, TLR4, MD-2, IRAK2, IL-6, AKT(PKB), TLR2, TNF-alpha",
115,Chemotaxis_CXCR3-A signaling,69,3.014E-05,3.688E-04,3.014E-05,3.688E-04,18,"IP10, STAT4, ZAP70, CD3, I-TAC, IL-8, T-bet, MMP-2, STAT5, AKT(PKB), LAT, PF4, PI3K reg class IB (p101), c-Src, MMP-9, PF4V1, PREX2, Perforin",
116,Epigenetic alterations in ovarian cancer,82,3.226E-05,3.913E-04,3.226E-05,3.913E-04,20,"GSTP1, N-cadherin, Maspin, TrkA, HOXA10, OBCAM, AL1A1, MMP-2, SF1, p15, L1TD1, GLI-1, TWIST1, p16INK4, DACT3, Ephrin-A receptor 2, MMP-9, GLI-2, CYP11A1, CDK6",
117,Plasminogen activators signaling in pancreatic cancer,35,3.437E-05,4.064E-04,3.437E-05,4.064E-04,12,"HGF, IL-1 alpha, Fra-1, PLAT (TPA), EGFR, MMP-14, MMP-2, Galectin-1, PLAUR (uPAR), HGF receptor (Met), MMP-9, PLAU (UPA)",
118,Langerhans cell migration to lymph nodes in allergic contact dermatitis,35,3.437E-05,4.064E-04,3.437E-05,4.064E-04,12,"IL-1 beta, TNF-R2, CCL20, alpha-4/beta-1 integrin, ICAM1, CD44, GITRL, Collagen IV, Fibronectin, MMP-9, MDR1, TNF-alpha",
119,Development_WNT and Notch signaling in early cardiac myogenesis,35,3.437E-05,4.064E-04,3.437E-05,4.064E-04,12,"TBX5, WNT, WNT 8A, WNT11, MEF2C, Jagged1, FZD7, SFRP5, TCF7 (TCF1), BMP2, Frizzled, WNT1",
120,Colorectal cancer (general schema),30,3.565E-05,4.165E-04,3.565E-05,4.165E-04,11,"HGF, PTCH1, IL-8, WNT, TGF-beta receptor type II, EGFR, IL-6, HGF receptor (Met), Ephrin-B receptors, Frizzled, TNF-alpha",
121,Dual function of Treg cells in cancer development,46,3.582E-05,4.165E-04,3.582E-05,4.165E-04,14,"COX-2 (PTGS2), ETS1, WNT, Neuropilin-1, IL-6, STAT5, PD-1, CTLA-4, 5'-NTD, OX40(TNFRSF4), FasL(TNFSF6), ICOS, IL-2R alpha chain, Perforin",
122,Immune response_Lysophosphatidic acid signaling via NF-kB,52,3.843E-05,4.422E-04,3.843E-05,4.422E-04,15,"COX-2 (PTGS2), PKD, CCL20, VCAM1, PKC, ICAM1, CCL2, IL-8, MMP-2, IL-6, TSLP, c-Src, GRO-3, A20, MMP-9",
123,CHDI_Correlations from Replication data_Cytoskeleton and adhesion module,64,3.874E-05,4.422E-04,3.874E-05,4.422E-04,17,"MHC class II, ITGB2, ICAM1, ZAP70, CD3, MRLC, PLAUR (uPAR), Actin cytoskeletal, Fyn, AKT(PKB), Collagen IV, MELC, Fibronectin, MyHC, PI3K reg class IB (p101), Ephrin-B receptors, PLAU (UPA)",
124,Role of integrins in eosinophil degranulation in asthma,58,3.928E-05,4.422E-04,3.928E-05,4.422E-04,16,"PI3K cat class IA, VCAM1, PKC, Eotaxin-2, alpha-4/beta-1 integrin, ICAM1, C3b, G-protein alpha-i family, GM-CSF, Eotaxin-3, Eotaxin, Fc gamma RII alpha, Fibronectin, ECP (RNase 3), CCL7, TNF-alpha",
125,TGF-beta signaling via kinase cascades in breast cancer,58,3.928E-05,4.422E-04,3.928E-05,4.422E-04,16,"COX-2 (PTGS2), TGF-beta 2, ITGB1, MMP-13, ADAM12, ITGB3, IL-8, TGF-beta receptor type II, EGFR, MMP-2, TGF-alpha, TWIST1, AKT(PKB), c-Src, MMP-9, TNF-alpha",
126,Pro-tumoral TNF-alpha signaling in melanoma,41,4.192E-05,4.681E-04,4.192E-05,4.681E-04,13,"ITGB1, TNF-R2, PI3K cat class IA, VCAM1, ITGA4, alpha-4/beta-1 integrin, IL-8, MMP-2, alpha-5/beta-1 integrin, AKT(PKB), Fibronectin, MMP-9, TNF-alpha",
127,Development_Role of HGF in hematopoietic stem cell mobilization,21,4.374E-05,4.846E-04,4.374E-05,4.846E-04,9,"HGF, PI3K cat class IA, RECK, MMP-14, MMP-2, SGK1, AKT(PKB), HGF receptor (Met), MMP-9",
128,Inhibition of neutrophil migration by proresolving lipid mediators in COPD,71,4.564E-05,5.017E-04,4.564E-05,5.017E-04,18,"FPRL1, IL-1 beta, TNF-R2, cPKC (conventional), PKC, ITGB2, ICAM1, MSN (moesin), IL-8, G-protein alpha-i family, TLR4, Actin cytoskeletal, Rac2, ICAM2, PI3K reg class IB (p101), FPR, TLR2, TNF-alpha",
129,Immune response_Histamine H1 receptor signaling in immune response,47,4.679E-05,5.104E-04,4.679E-05,5.104E-04,14,"Histamine H1 receptor, VCAM1, MMP-13, iNOS, ICAM1, PKC-alpha, IL-8, cPLA2, GM-CSF, IL-6, G-protein alpha-q/11, Tissue factor, MMP-9, TNF-alpha",
130,Cigarette smoke-induced inflammatory signaling in airway epithelial cells,36,4.733E-05,5.123E-04,4.733E-05,5.123E-04,12,"COX-2 (PTGS2), IL-1 beta, ICAM1, PKC-alpha, IL-8, EGFR, GM-CSF, sICAM1, IL-6, TGF-alpha, c-Src, TNF-alpha",
131,Transcription_Role of VDR in regulation of genes involved in osteoporosis,59,4.941E-05,5.307E-04,4.941E-05,5.307E-04,16,"IL-1 beta, Osteopontin, IL-1 alpha, TRPC3, RUNX2, Fra-1, RANKL(TNFSF11), CDX2, CYP24A1, IL-6, FasL(TNFSF6), Osteoprotegerin, Carbonic anhydrase II, RANK(TNFRSF11A), CALB1, TNF-alpha",
132,Hypoxia-induced EMT in cancer and fibrosis,13,5.262E-05,5.608E-04,5.262E-05,5.608E-04,7,"Lysyl oxidase, ETS1, SLUG, LOXL2, SIP1 (ZFHX1B), TWIST1, TCF8",
133,Common mechanisms of Th17 cell migration,48,6.060E-05,6.316E-04,6.060E-05,6.316E-04,14,"MCAM, CCL20, VCAM1, IP10, alpha-4/beta-1 integrin, CD43, ICAM1, CCL2, I-TAC, G-protein alpha-i family, CCL25, PI3K reg class IB (p101), P-selectin, CCL7",
134,Main genetic and epigenetic alterations in lung cancer,48,6.060E-05,6.316E-04,6.060E-05,6.316E-04,14,"GSTP1, HGF, Neuropilin-2, p14ARF, RECK, TGF-beta receptor type II, EGFR, Neuropilin-1, MMP-2, TGF-alpha, HGF receptor (Met), p16INK4, IBP, IBP3",
135,Cell adhesion_Integrin-mediated cell adhesion and migration,48,6.060E-05,6.316E-04,6.060E-05,6.316E-04,14,"alpha-11/beta-1 integrin, MRLC, alpha-5/beta-1 integrin, Actin cytoskeletal, alpha-1/beta-1 integrin, RASGRF1, Collagen IV, MELC, Fibronectin, MyHC, MYLK1, c-Src, MLCK, Cofilin",
136,Signal transduction_MIF signaling pathway,60,6.177E-05,6.391E-04,6.177E-05,6.391E-04,16,"Syk, COX-2 (PTGS2), PI3K cat class IA, VCAM1, ICAM1, CD44, ZAP70, IL-8, cPLA2, Lyn, G-protein alpha-i family, TLR4, AKT(PKB), SFK, PI3K reg class IB (p101), c-Src",
137,Gamma-secretase regulation of osteogenesis,37,6.431E-05,6.605E-04,6.431E-05,6.605E-04,12,"HEY1, RUNX2, CD44, RANKL(TNFSF11), CD44 soluble, CD44 (EXT), ALPL, CD44 (ICD), Osteoprotegerin, CSF1, Jagged1, RANK(TNFRSF11A)",
138,Origin of Langerhans cells in the steady-state and under inflammatory conditions,22,6.808E-05,6.941E-04,6.808E-05,6.941E-04,9,"IL-1 beta, CCL20, RUNX3, CCL2, IL-34, TGF-beta receptor type II, CSF1, P-selectin, TNF-alpha",
139,Interleukins-induced inflammatory signaling in normal and asthmatic airway epithelium,32,7.103E-05,7.190E-04,7.103E-05,7.190E-04,11,"IL-1 beta, IL-1 alpha, IP10, IFN-alpha, IL-8, GM-CSF, IL-33, IL-6, Eotaxin, TSLP, Fibronectin",
140,ErbB2-induced breast cancer cell invasion,67,7.291E-05,7.261E-04,7.291E-05,7.261E-04,17,"PI3K cat class IA, MMP-13, ITGA4, PKC-alpha, ETS1, NGAL, EGFR, MMP-14, MMP-2, PLAUR (uPAR), Actin cytoskeletal, AKT(PKB), ER81, c-Src, MMP-9, PLAU (UPA), Cofilin",
141,Development_Growth factors in regulation of oligodendrocyte progenitor cell proliferation,67,7.291E-05,7.261E-04,7.291E-05,7.261E-04,17,"HGF, NGF, Myelin basic protein, TrkA, PI3K cat class IA, FGF18, PKC, Tenascin-C, Lyn, EGFR, Fyn, FGF2, PDGF-R-alpha, AKT(PKB), FGF8, HGF receptor (Met), Fibronectin",
142,"NF-kB-, AP-1- and MAPKs-mediated proinflammatory cytokine production by eosinophils in asthma",43,7.328E-05,7.261E-04,7.328E-05,7.261E-04,13,"IL-1 beta, GRO-1, CCL2, IL-8, IL-17F, GM-CSF, IL-33, ENA-78, IL-6, Eotaxin, TSLP, TNF-alpha, TSLPR",
143,Activation of TNF-alpha-dependent pro-tumoral effect in colorectal cancer,49,7.783E-05,7.658E-04,7.783E-05,7.658E-04,14,"COX-2 (PTGS2), PGE2R2, c-IAP2, VCAM1, GRO-1, IP10, alpha-4/beta-1 integrin, ICAM1, CCL2, IL-8, ALDR, IL-6, Axin, TNF-alpha",
144,Immune response_Immunological synapse formation,55,7.869E-05,7.689E-04,7.869E-05,7.689E-04,15,"ITGB1, MHC class II, PI3K cat class IA, VCAM1, PKC-theta, ITGB2, alpha-4/beta-1 integrin, ICAM1, PKC-alpha, ZAP70, CD3, Fyn, FYB1, LAT, GRAP2",
145,Release of pro-inflammatory factors and proteases by alveolar macrophages in asthma,44,9.546E-05,9.120E-04,9.546E-05,9.120E-04,13,"GRO-2, IL-1 beta, GRO-1, iNOS, IP10, CCL2, IL-8, TLR4, GM-CSF, IL-6, MMP-9, TLR2, TNF-alpha",
146,Transcription_HIF-1 targets,95,9.756E-05,9.120E-04,9.756E-05,9.120E-04,21,"TGF-beta 2, Ceruloplasmin, iNOS, Lysyl oxidase, Transferrin, PLGF, Oct-3/4, LOXL2, MMP-2, Galectin-1, PLAUR (uPAR), 5'-NTD, FGF2, CTGF, Alpha-1B adrenergic receptor, IBP1, HGF receptor (Met), MMP-9, Carbonic anhydrase IX, MDR1, IBP3",
147,Role of metalloproteases and heparanase in progression of pancreatic cancer,33,9.787E-05,9.120E-04,9.787E-05,9.120E-04,11,"Heparanase 1, CD44, EGFR, CD44 soluble, MMP-14, MMP-2, CD44 (EXT), Matrilysin (MMP-7), FasL(TNFSF6), Collagen IV, MMP-9",
148,The innate immune response to contact allergens,33,9.787E-05,9.120E-04,9.787E-05,9.120E-04,11,"IL-1 beta, Biglycan, IL-1 alpha, IL-18, CCL2, IL-8, TLR4, IL-6, Caspase-1, TLR2, TNF-alpha",
149,Influence of multiple myeloma cells on bone marrow stromal cells,33,9.787E-05,9.120E-04,9.787E-05,9.120E-04,11,"COX-2 (PTGS2), IL-1 beta, VCAM1, ITGA4, ICAM1, RANKL(TNFSF11), IL-6, FGF2, Osteoprotegerin, RANK(TNFRSF11A), TNF-alpha",
150,SHH signaling in melanoma,33,9.787E-05,9.120E-04,9.787E-05,9.120E-04,11,"N-cadherin, Osteopontin, B-Raf, PTCH1, SLUG, MMP-2, GLI-1, PDGF-R-alpha, Vimentin, MMP-9, GLI-2",
151,Impaired inhibitory action of lipoxins on neutrophil migration in CF,56,9.858E-05,9.120E-04,9.858E-05,9.120E-04,15,"FPRL1, ITGB2, ICAM1, IL-8, G-protein alpha-i family, MRLC, Myosin II, Actin cytoskeletal, Rac2, AKT(PKB), MELC, MYLK1, PI3K reg class IB (p101), MLCK, Cofilin",
152,Immune response_Lectin induced complement pathway,50,9.917E-05,9.120E-04,9.917E-05,9.120E-04,14,"C4a, C1 inhibitor, C6, C3, Factor I, C3b, C3c, C4b, C7, iC3b, C3dg, CD21, C3a, C4",
153,VEGF signaling in multiple myeloma,50,9.917E-05,9.120E-04,9.917E-05,9.120E-04,14,"ITGB1, PI3K cat class IA, VCAM1, alpha-4/beta-1 integrin, ICAM1, PKC-alpha, Semaphorin 3A, Neuropilin-1, IL-6, alpha-5/beta-1 integrin, Caveolin-1, Fibronectin, c-Src, MDR1",
154,Development_NODAL signaling in early mesendoderm formation,23,1.029E-04,9.399E-04,1.029E-04,9.399E-04,9,"Cerberus, Lefty-1, BMP4, CRIPTO, Mixl1, WNT3, CFC1, Lefty-2, HNF3-beta",
155,Role of Th17 cells in asthma,28,1.049E-04,9.525E-04,1.049E-04,9.525E-04,10,"GRO-2, VCAM1, GRO-1, ICAM1, IL-8, IL-17F, EGFR, MRLC, Myosin II, GRO-3",
156,HGF signaling in melanoma,39,1.145E-04,1.019E-03,1.145E-04,1.019E-03,12,"HGF, N-cadherin, PI3K cat class IA, B-Raf, Desmoglein 1, CD44, PKC-alpha, SLUG, TWIST1, AKT(PKB), HGF receptor (Met), Fibronectin",
157,Immune response_TSLP signalling,39,1.145E-04,1.019E-03,1.145E-04,1.019E-03,12,"PI3K cat class IA, IL7RA, STAT4, CCL2, IL-8, IL-6, STAT5, CRLF2, Eotaxin, AKT(PKB), TSLP, TSLPR",
158,FGF2 signaling in melanoma,39,1.145E-04,1.019E-03,1.145E-04,1.019E-03,12,"PI3K cat class IA, B-Raf, Heparanase 1, Fra-1, MMP-2, FGF2, Caveolin-1, Collagen IV, SPRY2, Fibronectin, c-Src, Syndecan-2",
159,Development_Negative regulation of WNT/Beta-catenin signaling at the receptor level,45,1.232E-04,1.090E-03,1.232E-04,1.090E-03,13,"DKK4, Sclerostin, NOTUM, LRP4, Tcf(Lef), WNT, Syndecans, TIKI, SFRP, c-Src, APCDD1, Axin, Frizzled",
160,Development_Endothelial differentiation during embryonic development,51,1.254E-04,1.096E-03,1.254E-04,1.096E-03,14,"HEY1, PROX1, PI3K cat class IA, PKC, ETS1, WNT, BMP4, SOX18, Neuropilin-1, Angiopoietin 1, FOXC2, AKT(PKB), FOXC1, GLI-2",
161,Regulation of angiogenesis in prostate cancer,51,1.254E-04,1.096E-03,1.254E-04,1.096E-03,14,"COX-2 (PTGS2), PI3K cat class IA, IL-1 alpha, CCL2, IL-8, TGF-beta receptor type II, EGFR, Angiopoietin 1, AKT(PKB), Collagen IV, Angiotensin II, MMP-9, PLAU (UPA), TNF-alpha",
162,Signal transduction_PDGF signaling via PI3K/AKT and NFkB pathways,70,1.312E-04,1.140E-03,1.312E-04,1.140E-03,17,"Myocardin, CCL2, Tenascin-C, ETS1, MMP-2, PDGF-C, Transgelin, ACTA2, SGK1, PDGFR-ab, PDGF-R-alpha, AKT(PKB), PDGF receptor, c-Src, MMP-9, Phox1 (PRRX1), PDGF-R-beta",
163,Development_Epigenetic and transcriptional regulation of oligodendrocyte precursor cell differentiation and myelination,34,1.329E-04,1.147E-03,1.329E-04,1.147E-03,11,"UGT8, SOX10, Myelin basic protein, HES5, SOX8, SOX17, OLIG2, C11orf9, ID4, Jagged1, Frizzled",
164,DKK1 signaling in multiple myeloma,19,1.372E-04,1.177E-03,1.372E-04,1.177E-03,8,"RANKL(TNFSF11), Tcf(Lef), ALPL, IL-6, Osteoprotegerin, Axin, BMP2, Frizzled",
165,Immune response _CCR3 signaling in eosinophils,77,1.423E-04,1.206E-03,1.423E-04,1.206E-03,18,"iNOS, Eotaxin-2, PKC-alpha, cPLA2, G-protein alpha-i family, MRLC, Eotaxin-3, Myosin II, Actin cytoskeletal, Rac2, Eotaxin, MELC, MyHC, PI3K reg class IB (p101), c-Src, MLCK, Cofilin, CCL7",
166,Immune response_IFN-alpha/beta signaling via MAPKs,77,1.423E-04,1.206E-03,1.423E-04,1.206E-03,18,"TAP1 (PSF1), PKC-theta, IP10, ISG15, ZAP70, SP5, IFN-alpha, ISG54, FasR(CD95), RIG-G, Axin2, Matrilysin (MMP-7), RSAD2, Apo-2L(TNFSF10), AKT(PKB), FZD7, IFN-beta, PL scramblase 1",
167,Development_Auditory hair cell differentiation in embryogenesis,29,1.472E-04,1.226E-03,1.472E-04,1.226E-03,10,"NGFR(TNFRSF16), PROX1, HES5, p57, FGF20, BMP4, BARHL1, FGF8, Jagged1, GFI-1",
168,Cigarette smoke-mediated attenuation of antibacterial and antivirus immune response,29,1.472E-04,1.226E-03,1.472E-04,1.226E-03,10,"IL-1 beta, IP10, ICAM1, IL-8, TLR4, GM-CSF, sICAM1, IL-6, IFN-beta, TNF-alpha",
169,Prostate Cancer: candidate susceptibility genes in inflammatory pathways,29,1.472E-04,1.226E-03,1.472E-04,1.226E-03,10,"IL-1 beta, TLR1, TNF-R2, IL-1 alpha, TLR10, IL-8, TLR6, TLR4, IL-6, TNF-alpha",
170,IFN-gamma and Th2 cytokines-induced inflammatory signaling in normal and asthmatic airway epithelium,40,1.501E-04,1.231E-03,1.501E-04,1.231E-03,12,"IP10, ICAM1, CCL2, I-TAC, IFN-alpha, IL-8, IL-6, Eotaxin-3, Eotaxin, TSLP, Fibronectin, TSLPR",
171,Development_WNT/Beta-catenin and NOTCH in induction of osteogenesis,40,1.501E-04,1.231E-03,1.501E-04,1.231E-03,12,"HEY1, Osteopontin, RUNX2, RANKL(TNFSF11), WNT, ALPL, Osteoprotegerin, Jagged1, Axin, TCF7 (TCF1), Frizzled, WNT1",
172,Retinoic acid regulation of oligodendrocyte differentiation in multiple sclerosis,24,1.514E-04,1.231E-03,1.514E-04,1.231E-03,9,"UGT8, Myelin basic protein, DHA2, RBP4, BMP4, STRA6, PDGF-R-alpha, BMP2, TNF-alpha",
173,Development_Schema: SMAD-dependent TGF-beta family signaling in embryonic stem cells,24,1.514E-04,1.231E-03,1.514E-04,1.231E-03,9,"Activin A, Oct-3/4, Gremlin, BMP4, SOX17, SMAD9 (SMAD8), Lefty-2, FGF2, BMP2",
174,"Development_TGF-beta-dependent induction of EMT via RhoA,  PI3K and ILK",46,1.576E-04,1.275E-03,1.576E-04,1.275E-03,13,"TGF-beta 2, PI3K cat class IA, TGF-beta receptor type II, SLUG, Caldesmon, ACTA2, AKT(PKB), HIC5, Fibronectin, Vimentin, Claudin-1, Actin, Cofilin",
175,Signal transduction_PDGF signaling via MAPK cascades,65,1.734E-04,1.386E-03,1.734E-04,1.386E-03,16,"COX-2 (PTGS2), Osteopontin, MMP-13, Fra-1, MMP-2, PDGF-C, IL-6, PDGFR-ab, TRPC6, PDGF-R-alpha, PDGF receptor, Tissue factor, c-Src, MMP-9, Phox1 (PRRX1), PDGF-R-beta",
176,NF-AT signaling in cardiac hypertrophy,65,1.734E-04,1.386E-03,1.734E-04,1.386E-03,16,"HDAC9, PI3K cat class IA, PKC-alpha, NCX1, G-protein alpha-i family, MEF2C, LIF, HAND1, IL-6, ACTC, AKT(PKB), G-protein alpha-q/11, beta-MHC, Angiotensin II, HAND2, c-Src",
177,Mechanisms of CAM-DR in multiple myeloma,35,1.781E-04,1.408E-03,1.781E-04,1.408E-03,11,"ITGB1, c-IAP2, VCAM1, alpha-4/beta-1 integrin, ICAM1, Cyclin E, WNT3, Cyclin A, alpha-5/beta-1 integrin, Fibronectin, Frizzled",
178,Development_Schema: Adult neuron differentiation in the Subventricular and Subgranular Zones,35,1.781E-04,1.408E-03,1.781E-04,1.408E-03,11,"PROX1, NCAM1, GAD2, Chordin-like 1, MAP2, Nestin, DLX2, GAD1, Vimentin, SLC17A6, NT-3",
179,Role of Bregs in attenuation of T and NK cells mediated anti-tumor immune responses,41,1.949E-04,1.518E-03,1.949E-04,1.518E-03,12,"IP10, CD3, CD1d, TGF-beta receptor type II, CD3 zeta, FasR(CD95), PD-1, CTLA-4, 5'-NTD, FasL(TNFSF6), IL-2R alpha chain, PD-L1",
180,Fibroblast/ myofibroblast proliferation in asthmatic airways,41,1.949E-04,1.518E-03,1.949E-04,1.518E-03,12,"Histamine H1 receptor, IL-1 beta, PI3K cat class IA, PKC, ITGB3, TGF-beta receptor type II, PAR1, CTGF, PDGF-R-alpha, Tissue factor, ECP (RNase 3), EDNRA",
181,Immune response_Alternative complement pathway,53,1.963E-04,1.518E-03,1.963E-04,1.518E-03,14,"PTX3, FHR-1, C6, CRP, C3, Factor I, C3b, C3c, C7, Factor H, iC3b, C3dg, CD21, C3a",
182,Immune response_Induction of the antigen presentation machinery by IFN-gamma,53,1.963E-04,1.518E-03,1.963E-04,1.518E-03,14,"TAP1 (PSF1), HLA-DRB1, MHC class II, PSMB8(LMP7), HLA-B, NLRC5, HLA-A, TAP2 (PSF2), PSMB9, HLA-F, HLA-DRA1, HLA-DQA1, HLA-DMB, Cathepsin S",
183,Immune response_Induction of apoptosis and inhibition of proliferation mediated by IFN-gamma,47,2.000E-04,1.522E-03,2.000E-04,1.522E-03,13,"IL-15, IFI17, IDO1, GBP1, Caspase-12, IFN-alpha, Cyclin E, FasR(CD95), FasL(TNFSF6), Apo-2L(TNFSF10), CTGF, Caspase-1, IFN-beta",
184,Immune response_Role of DPP4 (CD26) in immune regulation,47,2.000E-04,1.522E-03,2.000E-04,1.522E-03,13,"MHC class II, ZAP70, CD3, CD3 zeta, ADA, IL-6, Fyn, DPP4, FasL(TNFSF6), Caveolin-1, c-Src, CARD11, TNF-alpha",
185,Chemotaxis_SDF-1/ CXCR4-induced chemotaxis of immune cells,79,2.012E-04,1.522E-03,2.012E-04,1.522E-03,18,"ITGB1, PI3K cat class IA, VCAM1, PAK, ITGB2, alpha-4/beta-1 integrin, ICAM1, ZAP70, CD3, CD3 zeta, G-protein alpha-i family, F-Actin cytoskeleton, Fyn, AKT(PKB), SFK, PI3K reg class IB (p101), TSAD, Cofilin",
186,CHDI_Correlations from Replication data_Causal network (positive correlations),79,2.012E-04,1.522E-03,2.012E-04,1.522E-03,18,"MHC class II, PI3K cat class IA, IL-1 alpha, PKC-theta, ICAM1, CD44, PKC-alpha, ZAP70, CD3, NR2, IRAK1/2, CD83, MEF2, AKT(PKB), LAT, PI3K reg class IB (p101), NR2A, TLR2",
187,"Development_ROBO2, ROBO3 and ROBO4 signaling pathways",25,2.176E-04,1.638E-03,2.176E-04,1.638E-03,9,"ROBO3, P-cadherin, ROBO2, SLIT2, MYRL2, SLIT3, Myosin II, alpha-5/beta-1 integrin, HIC5",
188,Th17 cytokines in COPD,36,2.356E-04,1.754E-03,2.356E-04,1.754E-03,11,"IL-1 beta, MHC class II, CCL20, GRO-1, IP10, CCL2, IL-8, IL-17F, GM-CSF, IL-6, MMP-9",
189,Role of IL-8 in melanoma,36,2.356E-04,1.754E-03,2.356E-04,1.754E-03,11,"IL-1 beta, B-Raf, ITGB2, ICAM1, IL-8, G-protein alpha-i family, MMP-2, IL-6, Beta-2 adrenergic receptor, AKT(PKB), TNF-alpha",
190,Neuroendocrine transdifferentiation in Prostate Cancer,48,2.518E-04,1.865E-03,2.518E-04,1.865E-03,13,"BMX, Secretogranin 1, GRP(1-27), Oct-3/4, Tcf(Lef), IL-8, EGFR, NT, IL-6, PTHrP, NeuroD1, AKT(PKB), c-Src",
191,SHH signaling in colorectal cancer,31,2.755E-04,2.019E-03,2.755E-04,2.019E-03,10,"B-Raf, PTCH1, WNT, SIP1 (ZFHX1B), FOXC2, GLI-1, PDGF-R-alpha, Vimentin, Frizzled, GLI-2",
192,Fibroblast differentiation to myofibroblasts in asthmatic airways,31,2.755E-04,2.019E-03,2.755E-04,2.019E-03,10,"ITGB1, PI3K cat class IA, TGF-beta receptor type II, ACTA2, alpha-5/beta-1 integrin, AKT(PKB), ITGA5, Fibronectin, ECP (RNase 3), EDNRA",
193,Immune response_T regulatory cell-mediated modulation of effector T cell and NK cell functions,55,2.994E-04,2.181E-03,2.994E-04,2.181E-03,14,"COX-2 (PTGS2), PGE2R2, STAT4, TGF-beta receptor type II, T-bet, Galectin-1, 5'-NTD, FasL(TNFSF6), KLRK1 (NKG2D), Jagged1, Granzyme A, IL-2R alpha chain, Perforin, Adenylate cyclase type VII",
194,Role of fibroblasts and keratinocytes in the elicitation phase of allergic contact dermatitis,26,3.063E-04,2.181E-03,3.063E-04,2.181E-03,9,"GRO-2, IL-1 beta, CCL20, IL-1 alpha, GRO-1, IP10, CCL2, IL-8, TNF-alpha",
195,CD8+ Tc1 cells in allergic contact dermatitis,26,3.063E-04,2.181E-03,3.063E-04,2.181E-03,9,"IL-1 beta, TNF-R2, MHC class II, IL-18, FasR(CD95), FasL(TNFSF6), Caspase-1, Perforin, TNF-alpha",
196,Attenuation of IFN type I signaling in melanoma cells,37,3.081E-04,2.181E-03,3.081E-04,2.181E-03,11,"TAP1 (PSF1), PSMB8(LMP7), IP10, HLA-A, I-TAC, IFN-alpha, TAP2 (PSF2), PSMB9, Apo-2L(TNFSF10), TAP, IFN-beta",
197,Role of red blood cell adhesion to endothelium in vaso-occlusion in Sickle cell disease,37,3.081E-04,2.181E-03,3.081E-04,2.181E-03,11,"VCAM1, ITGA4, alpha-4/beta-1 integrin, CD44, IL-8, G-protein alpha-i family, Beta-2 adrenergic receptor, DARC, Fibronectin, c-Src, P-selectin",
198,Putative pathways of MHC class I-dependent postsynaptic long-term depression in major depressive disorder,21,3.132E-04,2.181E-03,3.132E-04,2.181E-03,8,"MHC Class I alpha chain, TAP1 (PSF1), HLA-B, HLA-A, CD3 zeta, TAP2 (PSF2), TAP, TNF-alpha",
199,Development_Schema: Osteogenic and adipogenic differentiation of mesenchymal stem cells,21,3.132E-04,2.181E-03,3.132E-04,2.181E-03,8,"IL-1 alpha, RUNX2, BMP6, BMP4, Beta-adrenergic receptor, BMP2, WNT1, TNF-alpha",
200,Glucocorticoids-mediated inhibition of pro-constrictory and pro-inflammatory signaling in airway smooth muscle cells,49,3.146E-04,2.181E-03,3.146E-04,2.181E-03,13,"COX-2 (PTGS2), IL-1 beta, GRO-1, CD38, MRLC, IL-6, Myosin II, PA24A, Beta-2 adrenergic receptor, CPI-17, Eotaxin, PLA2, TNF-alpha",
201,Th17 cells in CF (mouse model),49,3.146E-04,2.181E-03,3.146E-04,2.181E-03,13,"IL-1 beta, MHC class II, GRO-1, GCP2, ICAM1, LBP, IL23A, IL-17F, TGF-beta receptor type II, TLR4, GM-CSF, MD-2, IL-6",
202,Neutrophil-derived granule proteins and cytokines in asthma,49,3.146E-04,2.181E-03,3.146E-04,2.181E-03,13,"CHI3L1, Syk, TGF-beta 2, PKC, IP10, IL-8, GM-CSF, Rac2, MMP-8, TSLP, Alpha-defensin, MMP-9, TNF-alpha",
203,PDE4 regulation of cyto/chemokine expression in arthritis,49,3.146E-04,2.181E-03,3.146E-04,2.181E-03,13,"PGE2R2, IL-1 beta, PI3K cat class IA, IL-1 alpha, IP10, CCL2, IL-8, GM-CSF, ENA-78, IL-6, AKT(PKB), PDE4, TNF-alpha",
204,Development_Schema: Embryonal myogenesis,12,3.168E-04,2.185E-03,3.168E-04,2.185E-03,6,"HGF, WNT7A, BMP4, FGF8, HGF receptor (Met), WNT1",
205,"Immune response_IL-4-induced regulators of cell growth, survival, differentiation and metabolism",62,3.362E-04,2.307E-03,3.362E-04,2.307E-03,15,"EGR2 (Krox20), MMP-13, ATP6V0D2, DHA2, Cyclin E, STAT5, Cyclin A, FasL(TNFSF6), Osteoprotegerin, AKT(PKB), Cathepsin V, ACADL, LPL, GFI-1, CDK6",
206,Calcium-dependent regulation of normal and asthmatic smooth muscle contraction,69,3.621E-04,2.473E-03,3.621E-04,2.473E-03,16,"Histamine H1 receptor, TRPC3, HTR2C (HTR1C), CD38, NCX1, G-protein alpha-i family, MRLC, Myosin II, PAR1, TRPC6, Endothelin-3, TrkB, MYLK1, MLCK, EDNRA, ACM3",
207,Upregulation of IL-8 expression in colorectal cancer,32,3.684E-04,2.504E-03,3.684E-04,2.504E-03,10,"IL-1 beta, IL-8, WNT, TGF-beta receptor type II, NT, WNT2, Frizzled, WNT1, TNF-alpha, WNT6",
208,G protein-coupled receptors signaling in lung cancer,76,3.781E-04,2.546E-03,3.781E-04,2.546E-03,17,"CD44, GRP(1-27), IL-8, EGFR, NT, G-protein alpha-i family, MMP-2, Galpha(i)-specific peptide GPCRs, VIP, TGF-alpha, Galanin, Galpha(q)-specific peptide GPCRs, AKT(PKB), G-protein alpha-q/11, c-Src, SSTR5, EDNRA",
209,"Signal transduction_Angiotensin II/AGTR1 signaling via Notch, Beta-catenin and NF-kB pathways",76,3.781E-04,2.546E-03,3.781E-04,2.546E-03,17,"HEY1, PKC, HES5, CCL2, WISP1, IL-8, MMP-2, Axin2, IL-6, ACTA2, Angiotensinogen, TRPC6, CTGF, AKT(PKB), Angiotensin II, Fibronectin, MMP-9",
210,Immune response_IFN-gamma in macrophages activation,50,3.903E-04,2.603E-03,3.903E-04,2.603E-03,13,"COX-2 (PTGS2), iNOS, IP10, IL-18, CCL2, TLR4, IL-6, PAI2, Caspase-1, CLIC5, Pleiotrophin (OSF1), RANK(TNFRSF11A), TNF-alpha",
211,PDE4 regulation of cyto/chemokine expression in inflammatory skin diseases,50,3.903E-04,2.603E-03,3.903E-04,2.603E-03,13,"IL-1 beta, G-protein alpha-i1, MxA, iNOS, IP10, CCL2, IL23A, IL-8, G-protein alpha-i family, Adenylate cyclase, IL-6, PDE4, TNF-alpha",
212,Eosinophil-derived cytokines in airway remodeling in asthma,38,3.984E-04,2.644E-03,3.984E-04,2.644E-03,11,"NGF, TGF-beta 2, Osteopontin, CD44, PKC-alpha, IL-17F, GM-CSF, FGF2, TGF-alpha, MMP-9, TNF-alpha",
213,Regulatory T cells in murine model of contact hypersensitivity,27,4.227E-04,2.792E-03,4.227E-04,2.792E-03,9,"TNF-R2, MHC class II, ICAM1, FasR(CD95), CTLA-4, 5'-NTD, FasL(TNFSF6), P-selectin, TNF-alpha",
214,TLR and EGFR-induced inflammatory signaling in normal and asthmatic airway epithelium,22,4.532E-04,2.980E-03,4.532E-04,2.980E-03,8,"IL-8, TLR6, EGFR, TGF-alpha, TSLP, TLR3, MMP-9, TLR2",
215,PI3K signaling in gastric cancer,51,4.809E-04,3.123E-03,4.809E-04,3.123E-03,13,"HGF, Osteopontin, PI3K cat class IA, IL-8, EGFR, Cyr61, PRNP, AKT(PKB), G-protein alpha-q/11, HGF receptor (Met), c-Src, BMP2, MDR1",
216,MAPK-independent proliferation of normal and asthmatic smooth muscle cells,64,4.850E-04,3.123E-03,4.850E-04,3.123E-03,15,"Histamine H1 receptor, PI3K cat class IA, PLAT (TPA), EGFR, G-protein alpha-i family, PDGF-C, FGF2, PDGF-R-alpha, AKT(PKB), G-protein alpha-q/11, PDGF receptor, c-Src, EDNRA, PDGF-R-beta, IBP3",
217,Interaction of deficient alpha-MSH signaling with TNF-alpha in melanoma,33,4.861E-04,3.123E-03,4.861E-04,3.123E-03,10,"COX-2 (PTGS2), N-cadherin, ITGB1, ICAM1, SLUG, SIP1 (ZFHX1B), Fibronectin, Vimentin, MMP-9, TNF-alpha",
218,Development_EGF-induced proliferation of Type C cells in SVZ of adult brain,33,4.861E-04,3.123E-03,4.861E-04,3.123E-03,10,"PI3K cat class IA, PTCH1, EGFR, Fyn, TGF-alpha, DLX2, GLI-1, AKT(PKB), Prolactin, GLI-2",
219,Development_Self-renewal and pluripotency maintenance of human embryonic stem cells,33,4.861E-04,3.123E-03,4.861E-04,3.123E-03,10,"p14ARF, Oct-3/4, CGB3, CDX2, BMP4, CRIPTO, Lefty-2, FGF2, PAX6, WNT1",
220,LKB1 signaling pathway in lung cancer cells,45,5.049E-04,3.203E-03,5.049E-04,3.203E-03,12,"COX-2 (PTGS2), p63, N-cadherin, TGF-beta 2, ITGB1, Lysyl oxidase, Collagen IV, p16INK4, Fibronectin, Vimentin, c-Src, TCF8",
221,Role of free fatty acids in obesity and type 2 diabetes,45,5.049E-04,3.203E-03,5.049E-04,3.203E-03,12,"COX-2 (PTGS2), IL-1 beta, PI3K cat class IA, PKC-theta, iNOS, CCL2, TLR4, IL-6, AKT(PKB), IFN-beta, TLR2, TNF-alpha",
222,Complement pathway disruption in thrombotic microangiopathy,39,5.099E-04,3.203E-03,5.099E-04,3.203E-03,11,"IL-1 beta, cPKC (conventional), PKC, C3, IL-8, Factor I, C3b, Factor H, MYLK1, C3a, P-selectin",
223,Role of tumor microenvironment in plexiform neurofibroma formation in neurofibromatosis type 1,39,5.099E-04,3.203E-03,5.099E-04,3.203E-03,11,"NGF, TrkA, PI3K cat class IA, VCAM1, alpha-4/beta-1 integrin, MMP-2, FGF2, Rac2, AKT(PKB), Fibronectin, PDGF-R-beta",
224,Cell adhesion_PLAU signaling,39,5.099E-04,3.203E-03,5.099E-04,3.203E-03,11,"HGF, PI3K cat class IA, SERPINE2, PLAT (TPA), EGFR, PAI2, PLAUR (uPAR), AKT(PKB), HGF receptor (Met), c-Src, PLAU (UPA)",
225,SHH signaling in oligodendrocyte precursor cells differentiation in multiple sclerosis,13,5.432E-04,3.397E-03,5.432E-04,3.397E-03,6,"SOX10, Myelin basic protein, PTCH1, OLIG2, GLI-1, GLI-2",
226,Rho-dependent regulation of normal and asthmatic smooth muscle contraction,28,5.732E-04,3.522E-03,5.732E-04,3.522E-03,9,"Histamine H1 receptor, PKC, G-protein alpha-i family, MRLC, Myosin II, CPI-17, G-protein alpha-q/11, EDNRA, ACM3",
227,Development_Astrocyte differentiation (general schema),28,5.732E-04,3.522E-03,5.732E-04,3.522E-03,9,"SOX1, CD44, BMP4, LIF, Nestin, MCT1 (SLC16A1), Vimentin, GLAST1/EAAT1, BMP2",
228,Glucocorticoid- and LABA-mediated inhibition of pro-inflammatory signaling in airway fibroblasts/myofibroblasts,28,5.732E-04,3.522E-03,5.732E-04,3.522E-03,9,"IL-1 beta, IL-1 alpha, VCAM1, ICAM1, IL-8, GM-CSF, IL-6, Beta-2 adrenergic receptor, TNF-alpha",
229,IL-17 and IL-17F-induced inflammatory signaling in normal and asthmatic airway epithelium,28,5.732E-04,3.522E-03,5.732E-04,3.522E-03,9,"GRO-1, IP10, GCP2, ICAM1, IL-8, IL-17F, GM-CSF, ENA-78, IL-6",
230,Ovarian cancer (main signaling cascades),65,5.785E-04,3.539E-03,5.785E-04,3.539E-03,15,"HGF, PI3K cat class IA, B-Raf, Tcf(Lef), EGFR, G-protein alpha-i family, MMP-2, IL-6, AKT(PKB), HGF receptor (Met), PI3K reg class IB (p101), c-Src, MMP-9, PLAU (UPA), EDNRA",
231,Development_BMP signaling in cardiac myogenesis,34,6.332E-04,3.857E-03,6.332E-04,3.857E-03,10,"ACTA1, BMP5, MLC2, BMP6, p57, BMP4, MEF2C, ACTC, beta-MHC, BMP2",
232,Role of IL-17-producing T cells in allergic contact dermatitis,23,6.401E-04,3.882E-03,6.401E-04,3.882E-03,8,"MHC class II, GRO-1, ICAM1, IL-8, GM-CSF, FasR(CD95), IL-6, FasL(TNFSF6)",
233,Development_H3K27 demethylases in differentiation of stem cells,40,6.464E-04,3.901E-03,6.464E-04,3.901E-03,11,"HOXA13, SOX1, BMP4, Nestin, HOXA1, HOXA7, HOXA3, DLX5, HOXA11, BMP2, PAX6",
234,Development_Regulation of cytoskeleton proteins in oligodendrocyte differentiation and myelination,59,6.488E-04,3.901E-03,6.488E-04,3.901E-03,14,"Tubulin beta, Myelin basic protein, MAP-1B, NCAM1, MAP2, MRLC, Tubulin beta 4, Myosin II, Actin cytoskeletal, Fyn, PDGF-R-alpha, PDGF receptor, MELC, Cofilin",
235,Immune response_IFN-alpha/beta signaling via PI3K and NF-kB pathways,94,6.833E-04,4.091E-03,6.833E-04,4.091E-03,19,"IFI17, GBP1, PI3K cat class IA, IFIT1, ISG15, IRS-2, PKC-alpha, I-TAC, IFN-alpha, Cyclin E, ISG54, NMI, p15, Cyclin A, RSAD2, Apo-2L(TNFSF10), AKT(PKB), p16INK4, IFN-beta",
236,Role of neuropeptides in pathogenesis of SCLC,67,8.121E-04,4.780E-03,8.121E-04,4.780E-03,15,"cPKC (conventional), PKC, Neprilysin, CCKAR, GRP(1-27), PKC-alpha, V1a receptor, EGFR, NT, GRP precursor, Fyn, Galanin, AKT(PKB), G-protein alpha-q/11, Neuromedin B",
237,Role of growth factor receptors transactivation by Hyaluronic acid / CD44 signaling in tumor progression,35,8.153E-04,4.780E-03,8.153E-04,4.780E-03,10,"HGF, PI3K cat class IA, CD44, PKC-alpha, EGFR, MMP-2, PTHrP, HGF receptor (Met), MMP-9, MDR1",
238,Cell adhesion_Alpha-4 integrins in cell migration and adhesion,35,8.153E-04,4.780E-03,8.153E-04,4.780E-03,10,"ITGB1, PI3K cat class IA, VCAM1, ITGA4, alpha-4/beta-1 integrin, F-Actin cytoskeleton, Actin cytoskeletal, Fibronectin, c-Src, Cofilin",
239,NALP3 inflammasome activation in age-related macular degeneration (AMD),35,8.153E-04,4.780E-03,8.153E-04,4.780E-03,10,"IL-1 beta, IL-18R1, CCL20, IL-1 alpha, IL-18, IL-6, FasL(TNFSF6), Caspase-1, TLR2, TNF-alpha",
240,Extracellular matrix-regulated proliferation of airway smooth muscle cells in asthma,35,8.153E-04,4.780E-03,8.153E-04,4.780E-03,10,"PI3K cat class IA, Decorin, alpha-4/beta-1 integrin, TGF-beta receptor type II, EGFR, alpha-5/beta-1 integrin, CTGF, Collagen IV, Fibronectin, Collagen III",
241,Immune response_HSP60 and HSP70/ TLR signaling pathway,54,8.663E-04,5.037E-03,8.663E-04,5.037E-03,13,"CD69, IL-1 beta, MHC class II, iNOS, ICAM1, IL-8, TLR4, MD-2, IL-6, IRAK1/2, CD83, TLR2, TNF-alpha",
242,"Disruption of apoptosis, proliferation and shedding of epithelial cells in asthma",54,8.663E-04,5.037E-03,8.663E-04,5.037E-03,13,"IL-1 beta, TGF-beta 2, TNF-R2, IL-1 alpha, Desmocollin 3, ICAM1, EGFR, p15, TGF-alpha, TSLP, MMP-9, TNF-alpha, TSLPR",
243,Immune response_C3a signaling,48,9.482E-04,5.447E-03,9.482E-04,5.447E-03,12,"IL-1 beta, NGF, MHC class II, CCL2, IL-8, G-protein alpha-i family, Adenylate cyclase, IL-6, AKT(PKB), C3a, PI3K reg class IB (p101), TNF-alpha",
244,Development_Schema: Adult neurogenesis in the Subventricular Zone,19,9.485E-04,5.447E-03,9.485E-04,5.447E-03,7,"NCAM1, MAP2, OLIG2, Nestin, DLX2, Vimentin, GLAST1/EAAT1",
245,Schema: Initiation of T cell recruitment in allergic contact dermatitis,19,9.485E-04,5.447E-03,9.485E-04,5.447E-03,7,"VCAM1, IP10, alpha-4/beta-1 integrin, ICAM1, CD1d, CD5, TNF-alpha",
246,Inhibition of Ephrin receptors in colorectal cancer,30,1.006E-03,5.714E-03,1.006E-03,5.714E-03,9,"WNT, Ephrin-B receptor 2, Ephrin-A receptor 3, Ephrin-A receptors, Ephrin-B receptor 1, Ephrin-A, Ephrin-B receptors, Ephrin-A receptor 2, Frizzled",
247,Role of adipose tissue hypoxia in obesity and type 2 diabetes,30,1.006E-03,5.714E-03,1.006E-03,5.714E-03,9,"IL-1 beta, Lysyl oxidase, CCL2, Angiopoietin 1, IL-6, MCT1 (SLC16A1), MMP-9, IBP3, TNF-alpha",
248,Apoptosis and survival_Apoptotic TNF-family pathways,42,1.011E-03,5.714E-03,1.011E-03,5.714E-03,11,"NGF, TNF-R2, NGFR(TNFRSF16), Caspase-10, CD70(TNFSF7), GITRL, FasR(CD95), FasL(TNFSF6), Apo-2L(TNFSF10), LIGHT(TNFSF14), TNF-alpha",
249,Development_NOTCH in inhibition of WNT/Beta-catenin-induced osteogenesis,42,1.011E-03,5.714E-03,1.011E-03,5.714E-03,11,"HEY1, STAT5A, RUNX2, RANKL(TNFSF11), WNT, ALPL, Jagged1, Axin, TCF7 (TCF1), Frizzled, WNT1",
250,Cytoskeleton remodeling_Keratin filaments,36,1.038E-03,5.816E-03,1.038E-03,5.816E-03,10,"Tubulin beta, Keratin 17, Keratin 5/14, Keratin 14, Keratin 5, Keratin 16, Keratin 6C, Actin cytoskeletal, Keratin 6A, Vimentin",
251,Development_Hedgehog and PTH signaling pathways in bone and cartilage development,36,1.038E-03,5.816E-03,1.038E-03,5.816E-03,10,"Osteopontin, MMP-13, RUNX2, PTCH1, RANKL(TNFSF11), PTHrP, COL1A2, GLI-1, G-protein alpha-q/11, GLI-2",
252,Immune response_Role of DAP12 receptors in NK cells,55,1.042E-03,5.816E-03,1.042E-03,5.816E-03,13,"Syk, PI3K cat class IA, KLRC3, PKC-theta, HLA-B, ZAP70, NKG2C, Actin cytoskeletal, Fyn, CD94, HLA-G, LAT, KIR2DL1",
253,Sitagliptin in treatment of type 2 diabetes and metabolic syndrome X,10,1.047E-03,5.821E-03,1.047E-03,5.821E-03,5,"Glucagon, GLP-1 (7-36) amide, GLP-1 (7-37), GLP-1 receptor, DPP4",
254,Immune response_Bacterial infections in normal airways,49,1.154E-03,6.366E-03,1.154E-03,6.366E-03,12,"IL-1 beta, TLR1, iNOS, LBP, IL-8, TLR4, FasR(CD95), MD-2, IL-6, IRAK1/2, FasL(TNFSF6), TLR2",
255,Signal transduction_Soluble CXCL16 signaling,49,1.154E-03,6.366E-03,1.154E-03,6.366E-03,12,"Osteopontin, CD44, RANKL(TNFSF11), IL-8, G-protein alpha-i family, F-Actin cytoskeleton, MMP-2, AKT(PKB), P-selectin, MMP-9, Cofilin, TNF-alpha",
256,Immune response_LPS-induced platelet activation,25,1.198E-03,6.560E-03,1.198E-03,6.560E-03,8,"COX-2 (PTGS2), IL-1 beta, LBP, TLR4, MD-2, PAR1, P-selectin, TLR2",
257,Inhibition of oligodendrocyte precursor cells differentiation by Wnt signaling in multiple sclerosis,25,1.198E-03,6.560E-03,1.198E-03,6.560E-03,8,"WNT, OLIG2, GLI-1, FZD7, Axin, Frizzled, GLI-2, WNT1",
258,Role of FSH and Lutropin in ovarian cancer,56,1.246E-03,6.785E-03,1.246E-03,6.785E-03,13,"COX-2 (PTGS2), B-Raf, TRPC3, CD44, PKC-alpha, Cyclin E, EGFR, Adenylate cyclase, SLIT2, MMP-2, IL-6, AKT(PKB), MMP-9",
259,Environmental factors-induced inflammatory signaling in normal and asthmatic airway epithelium,43,1.249E-03,6.785E-03,1.249E-03,6.785E-03,11,"IL-1 beta, iNOS, PKC, ICAM1, IL-8, GM-CSF, sICAM1, IL-6, Eotaxin, TSLP, TNF-alpha",
260,Deregulation of canonical WNT signaling in major depressive disorder,31,1.304E-03,6.927E-03,1.304E-03,6.927E-03,9,"MAP-1B, Tcf(Lef), WNT7A, WNT, NeuroD1, FZD9, Axin, TCF7 (TCF1), Frizzled",
261,Arachidonic acid metabolites production in alveolar macrophages in asthma,31,1.304E-03,6.927E-03,1.304E-03,6.927E-03,9,"COX-2 (PTGS2), IL-1 beta, CCL2, IL-8, cPLA2, TLR4, GM-CSF, TLR2, TNF-alpha",
262,Role of IL-2 in the enhancement of NK cell cytotoxicity in multiple sclerosis,31,1.304E-03,6.927E-03,1.304E-03,6.927E-03,9,"PI3K cat class IA, STAT5, FasL(TNFSF6), Apo-2L(TNFSF10), KLRK1 (NKG2D), Granzyme A, Perforin, CARD11, TNF-alpha",
263,Autocrine production of eosinophil pro-survival cytokines in asthma,31,1.304E-03,6.927E-03,1.304E-03,6.927E-03,9,"IL-15, PI3K cat class IA, VCAM1, alpha-4/beta-1 integrin, ICAM1, CD44, GM-CSF, Fibronectin, TNF-alpha",
264,Development_Negative feedback regulation of WNT/Beta-catenin signaling,37,1.309E-03,6.927E-03,1.309E-03,6.927E-03,10,"NOTUM, NKD1, Tcf(Lef), WNT, G-protein alpha-i family, Axin2, c-Src, NKD2, Axin, Frizzled",
265,Development_Retinoic acid and retinoic acid receptors in regulation of oligodendrocyte differentiation,37,1.309E-03,6.927E-03,1.309E-03,6.927E-03,10,"UGT8, Myelin basic protein, p14ARF, DHA2, RBP4, BMP4, p15, STRA6, PDGF-R-alpha, BMP2",
266,Hypertrophy of  asthmatic airway smooth muscle cells ,70,1.310E-03,6.927E-03,1.310E-03,6.927E-03,15,"Smooth muscle myosin, IL-1 beta, TGF-beta 2, TGF-beta receptor type II, EGFR, Transgelin, ACTA2, PDGF-R-alpha, AKT(PKB), IFN-beta, MLCK, EDNRA, Actin muscle, PDGF-R-beta, TNF-alpha",
267,Role of GITR in skin sensitization,15,1.351E-03,7.094E-03,1.351E-03,7.094E-03,6,"IL-1 beta, TNF-R2, IL-1 alpha, IP10, GITRL, TNF-alpha",
268,Immune response_Regulatory role of C1q in platelet activation,15,1.351E-03,7.094E-03,1.351E-03,7.094E-03,6,"PKC, CRP, C3b, Fc gamma RII alpha, P-selectin, Collagen III",
269,Modulation of tumor response to cytotoxic T cells by hypoxia in tumors,50,1.395E-03,7.242E-03,1.395E-03,7.242E-03,12,"FasR(CD95), PD-1, CTLA-4, 5'-NTD, CD137 ligand(TNFSF9), HOXA1, FasL(TNFSF6), AKT(PKB), CD137(TNFRSF9), c-Src, Perforin, PD-L1",
270,Angiogenesis in HCC,50,1.395E-03,7.242E-03,1.395E-03,7.242E-03,12,"COX-2 (PTGS2), Heparanase 1, CCL2, IL-8, TGF-beta receptor type II, EGFR, MMP-2, Angiopoietin 1, STAT5, FGF2, Ephrin-B receptors, MMP-9",
271,IgE- and MGF-induced Lyn-mediated production of cytokines and arachidonic acid metabolites in lung mast cells in asthma,50,1.395E-03,7.242E-03,1.395E-03,7.242E-03,12,"Syk, CCL2, PKC-alpha, IL-8, cPLA2, Lyn, GM-CSF, Fyn, AKT(PKB), LAT, GRAP2, TNF-alpha",
272,HGF signaling in colorectal cancer,64,1.522E-03,7.833E-03,1.522E-03,7.833E-03,14,"HGF, COX-2 (PTGS2), PI3K cat class IA, LAMC2, CD44, EGFR, MMP-2, PLAUR (uPAR), Actin cytoskeletal, AKT(PKB), LAMB3, HGF receptor (Met), c-Src, MMP-9",
273,Immune response_IL-6 signaling pathway via JAK/STAT,71,1.524E-03,7.833E-03,1.524E-03,7.833E-03,15,"COX-2 (PTGS2), iNOS, RUNX2, ICAM1, CCL2, RANKL(TNFSF11), Mucin 13, ALPL, IL-6, Mucin 4, STAT5, Rac2, AKT(PKB), ICOS, CDK6",
274,Transition of HCC cells to invasive and migratory phenotype,44,1.531E-03,7.833E-03,1.531E-03,7.833E-03,11,"N-cadherin, PI3K cat class IA, SIP1 (ZFHX1B), MMP-14, MMP-2, Matrilysin (MMP-7), TWIST1, AKT(PKB), Vimentin, c-Src, MMP-9",
275,Arachidonic acid metabolites production in eosinophils in asthma,44,1.531E-03,7.833E-03,1.531E-03,7.833E-03,11,"COX-2 (PTGS2), PKC, alpha-4/beta-1 integrin, ICAM1, PGD2R, cPLA2, G-protein alpha-i family, GM-CSF, PA24A, Eotaxin, Fibronectin",
276,"Immune response_IL-3 signaling via JAK/STAT, p38, JNK and NF-kB",93,1.578E-03,8.044E-03,1.578E-03,8.044E-03,18,"CD69, ITGB1, STAT5A, MHC class II, PI3K cat class IA, DHA2, ICAM1, Lyn, IL-6, NOTCH4, STAT5, AKT(PKB), Fibronectin, c-Src, P-selectin, IL-2R alpha chain, Pim-1, BMP2",
277,Hypothetical role of microRNAs in fibrosis development after myocardial infarction,26,1.595E-03,8.071E-03,1.595E-03,8.071E-03,8,"Fibrillin 1, PI3K cat class IA, TGF-beta receptor type II, MMP-2, COL1A2, CTGF, AKT(PKB), Collagen III",
278,Muscle contraction_Delta-type opioid receptor in smooth muscle contraction,26,1.595E-03,8.071E-03,1.595E-03,8.071E-03,8,"Metenkefalin, G-protein alpha-i family, MRLC, MYRL2, Myosin II, CPI-17, Leu-enkephalin, PI3K reg class IB (p101)",
279,Role of type 2 innate lymphoid cells in airway allergic inflammation and tissue repair,38,1.634E-03,8.152E-03,1.634E-03,8.152E-03,10,"IL7RA, ETS1, EGFR, IL-33, STAT5, CRLF2, TSLP, IL-2R alpha chain, PI3K cat class IA (p110-delta), TSLPR",
280,TNF-alpha-induced inflammatory signaling in normal and asthmatic airway epithelium,38,1.634E-03,8.152E-03,1.634E-03,8.152E-03,10,"GRO-1, IP10, ICAM1, CCL2, IL-8, GM-CSF, IL-6, Eotaxin, TSLP, TNF-alpha",
281,Development_Oligodendrocyte differentiation (general schema),38,1.634E-03,8.152E-03,1.634E-03,8.152E-03,10,"SOX10, Myelin basic protein, BMP4, EGFR, OLIG2, FGF2, TGF-alpha, PDGF-R-alpha, BMP2, EDNRA",
282,Role of type 2 innate lymphoid cells in asthma,38,1.634E-03,8.152E-03,1.634E-03,8.152E-03,10,"FPRL1, IL7RA, ETS1, IL-33, STAT5, CRLF2, TSLP, IL-2R alpha chain, PI3K cat class IA (p110-delta), TSLPR",
283,Cytoskeleton remodeling_Fibronectin-binding integrins in cell motility,32,1.671E-03,8.274E-03,1.671E-03,8.274E-03,9,"PI3K cat class IA, alpha-5/beta-1 integrin, Actin cytoskeletal, Fyn, Caveolin-1, ITGA5, Fibronectin, c-Src, Cofilin",
284,"Development_Role of Ceramide 1-phosphate, Sphingosine 1-phosphate and Complement cascade in hematopoietic stem cell homing",32,1.671E-03,8.274E-03,1.671E-03,8.274E-03,9,"COX-2 (PTGS2), PGE2R2, S1P1 receptor, VCAM1, alpha-4/beta-1 integrin, iC3b, AKT(PKB), C3a, MMP-9",
285,Development_Signaling pathways in embryonic hepatocyte maturation,51,1.676E-03,8.274E-03,1.676E-03,8.274E-03,12,"HGF, PI3K cat class IA, APOA2, Transferrin, RBP4, FasR(CD95), APOC2, OSMR, AKT(PKB), HGF receptor (Met), HNF4-alpha, HNF3-beta",
286,Blood coagulation_Platelet microparticle generation,72,1.767E-03,8.691E-03,1.767E-03,8.691E-03,15,"IL-1 beta, ITGB1, cPKC (conventional), PKC, MSN (moesin), cPLA2, Actin cytoskeletal, PAR1, PLA2G7, TRPC6, Tissue factor, Fibronectin, MyHC, MYLK1, P-selectin",
287,Neurophysiological process_Constitutive and regulated NMDA receptor trafficking,65,1.781E-03,8.701E-03,1.781E-03,8.701E-03,14,"Neuroligin 1, PACAP receptor 1, cPKC (conventional), PKC, NR2, PACAP, G-protein alpha-i family, Adenylate cyclase, Fyn, KIF17, DARPP-32, STEP, c-Src, NR2A",
288,Dysregulation of germinal center response in SLE,65,1.781E-03,8.701E-03,1.781E-03,8.701E-03,14,"IL-15, MFGE8, IL-15RA, VCAM1, alpha-4/beta-1 integrin, ICAM1, IFN-alpha, BOB1, FasR(CD95), TLR7, FasL(TNFSF6), C3dg, CD21, PI3K cat class IA (p110-delta)",
289,Cell adhesion_Histamine H1 receptor signaling in the interruption of cell barrier integrity,45,1.863E-03,9.008E-03,1.863E-03,9.008E-03,11,"Histamine H1 receptor, PKC-alpha, MRLC, Myosin II, Actin cytoskeletal, CPI-17, G-protein alpha-q/11, MELC, c-Src, MLCK, Cofilin",
290,Role of cell adhesion molecules in progression of pancreatic cancer,45,1.863E-03,9.008E-03,1.863E-03,9.008E-03,11,"IL-1 beta, ITGB1, iNOS, NCAM1, Tcf(Lef), alpha-5/beta-1 integrin, Collagen IV, ITGA5, Fibronectin, c-Src, SIAT8B",
291,Role of DNA methylation in progression of multiple myeloma,45,1.863E-03,9.008E-03,1.863E-03,9.008E-03,11,"p14ARF, DKK3, SFRP2, WNT, p15, IL-6, SFRP1, p16INK4, SFRP5, Frizzled, CDK6",
292,Androgen receptor activation and downstream signaling in Prostate cancer,110,1.977E-03,9.526E-03,1.977E-03,9.526E-03,20,"N-cadherin, B-Raf, STEAP1, IL-8, EGFR, FGF1, Versican, IL-6, Matrilysin (MMP-7), SGK1, FGF2, PAR1, AKT(PKB), Caveolin-1, FGF8, SPRY2, ER81, c-Src, TLR2, IBP3",
293,IGF signaling in HCC,52,2.002E-03,9.614E-03,2.002E-03,9.614E-03,12,"HGF, PI3K cat class IA, PKC, IRS-2, EGFR, MMP-2, TGF-alpha, AKT(PKB), HGF receptor (Met), Jagged1, MMP-9, IBP3",
294,Development_BMP7 in brown adipocyte differentiation,39,2.021E-03,9.641E-03,2.021E-03,9.641E-03,10,"CIDE-A, OTOP1, WNT10A, PPARGC1 (PGC1-alpha), Angiotensinogen, COL5A1, Annexin I, PSAT, EDNRA, Necdin",
295,Role of iNKT and B cells in T cell recruitment in allergic contact dermatitis,39,2.021E-03,9.641E-03,2.021E-03,9.641E-03,10,"VCAM1, IP10, alpha-4/beta-1 integrin, ICAM1, CD3, CD1d, T-bet, CD5, CD21, TNF-alpha",
296,Mast cell migration in asthma,73,2.041E-03,9.701E-03,2.041E-03,9.701E-03,15,"TGF-beta 2, IP10, CD44, CCL2, I-TAC, IL-8, TGF-beta receptor type II, G-protein alpha-i family, alpha-5/beta-1 integrin, FGF2, Eotaxin, PDGF receptor, Fibronectin, C3a, PI3K reg class IB (p101)",
297,Reactive oxygen and nitrogen species production in eosinophils in asthma,59,2.067E-03,9.794E-03,2.067E-03,9.794E-03,13,"Histamine H1 receptor, ITGB1, PI3K cat class IA, VCAM1, iNOS, Eotaxin-2, ITGA4, ITGB2, ICAM1, GM-CSF, IL-33, Eotaxin, C3a",
298,"IGF family, invasion and metastasis in colorectal cancer",33,2.115E-03,9.952E-03,2.115E-03,9.952E-03,9,"ITGB1, PI3K cat class IA, PLAT (TPA), PLAUR (uPAR), alpha-1/beta-1 integrin, Collagen IV, IBP6, Fibronectin, PLAU (UPA)",
299,Role of GSK3 beta in cardioprotection against myocardial infarction,33,2.115E-03,9.952E-03,2.115E-03,9.952E-03,9,"PI3K cat class IA, CRLR, Metenkefalin, RAMP2, EGFR, Enkephalin A, MMP-8, AKT(PKB), Plasma kallikrein",
300,Regulation of GSK3 beta in bipolar disorder,46,2.251E-03,1.052E-02,2.251E-03,1.052E-02,11,"IL-1 beta, NGF, TrkA, WNT, FGF2, AKT(PKB), TrkB, Nucleoredoxin, Axin, Frizzled, NT-3",
301,High shear stress-induced platelet activation,46,2.251E-03,1.052E-02,2.251E-03,1.052E-02,11,"UFO, ITGB3, G-protein alpha-i family, Actin cytoskeletal, PAR1, Ephrin-B receptor 1, AKT(PKB), Fibronectin, Collagen VI, P-selectin, Collagen III",
302,Immune response_M-CSF-receptor signaling pathway,81,2.259E-03,1.053E-02,2.259E-03,1.053E-02,16,"Syk, STAT5A, PI3K cat class IA, PKC, Tcf(Lef), ETS1, IL-34, Fyn, Rac2, AKT(PKB), CSF1, GRAP2, GAB3, c-Src, TSAD, PLAU (UPA)",
303,IL-6 signaling in breast cancer cells,53,2.378E-03,1.101E-02,2.378E-03,1.101E-02,12,"N-cadherin, PI3K cat class IA, IP10, Fascin, IL-6, S100A7, TWIST1, AKT(PKB), Jagged1, Vimentin, Carbonic anhydrase IX, MDR1",
304,EGFR signaling pathway in lung cancer,53,2.378E-03,1.101E-02,2.378E-03,1.101E-02,12,"HGF, COX-2 (PTGS2), PI3K cat class IA, EGFR, IL-6, STAT5, TGF-alpha, AKT(PKB), HGF receptor (Met), c-Src, MMP-9, Carbonic anhydrase IX",
305,Pro-oncogenic action of Estradiol/ Estrogen receptors in ovarian cancer,60,2.424E-03,1.118E-02,2.424E-03,1.118E-02,13,"BETA-IG-H3, MALL, PI3K cat class IA, CD44, Fra-1, Cyclin E, EGFR, AKT(PKB), Fibronectin, c-Src, MMP-9, PLAU (UPA), IBP3",
306,CAR-mediated direct regulation of xenobiotic metabolizing enzymes / Rodent version,40,2.480E-03,1.118E-02,2.480E-03,1.118E-02,10,"GSTP1, PPCKC, UGT1A1, CYP3A7, ADHG, CYP24A1, AL1A1, CYP7A1, MDR1, UGT1A6",
307,Apoptosis and survival_NGF activation of NF-kB,40,2.480E-03,1.118E-02,2.480E-03,1.118E-02,10,"GSTP1, NGF, NGFR(TNFRSF16), TrkA, PI3K cat class IA, iNOS, HES5, Synapsin II, AKT(PKB), c-Src",
308,CAR-mediated direct regulation of xenobiotic metabolizing enzymes / Human version,40,2.480E-03,1.118E-02,2.480E-03,1.118E-02,10,"GSTP1, PPCKC, UGT1A1, CYP3A7, ADHG, CYP24A1, AL1A1, CYP7A1, MDR1, UGT1A6",
309,CHDI_Correlations from Replication data_Causal network (negative correlations),40,2.480E-03,1.118E-02,2.480E-03,1.118E-02,10,"PKC, WNT, PLAUR (uPAR), AKT(PKB), Collagen IV, Fibronectin, Axin, PLAU (UPA), Frizzled, ACM3",
310,Stem cells_Pancreatic cancer stem cells in tumor metastasis,40,2.480E-03,1.118E-02,2.480E-03,1.118E-02,10,"G-protein alpha-i family, F-Actin cytoskeleton, MRLC, Myosin II, Fyn, MELC, MyHC, PI3K reg class IB (p101), c-Src, MLCK",
311,Development_Astrocyte differentiation from adult stem cells,40,2.480E-03,1.118E-02,2.480E-03,1.118E-02,10,"SOX1, CD44, BMP4, LIF, OLIG2, SMAD9 (SMAD8), Nestin, ID4, Vimentin, BMP2",
312,Cell adhesion_IL-8 family-dependent cell migration and adhesion,40,2.480E-03,1.118E-02,2.480E-03,1.118E-02,10,"GRO-2, GRO-1, GCP2, ITGB2, ICAM1, IL-8, G-protein alpha-i family, ENA-78, PI3K reg class IB (p101), GRO-3",
313,Transition of Monoclonal gammopathy of undetermined significance to active multiple myeloma (schema),22,2.520E-03,1.129E-02,2.520E-03,1.129E-02,7,"NCAM1, RANKL(TNFSF11), MMP-2, p15, Osteoprotegerin, p16INK4, MMP-9",
314,Development_Generation of pancreatic beta-cells from embryonic stem cells (late stages),22,2.520E-03,1.129E-02,2.520E-03,1.129E-02,7,"HGF, BMP4, PAX4, FGF2, NeuroD1, HNF3-beta, PAX6",
315,Development_Negative regulation of WNT/Beta-catenin signaling in the cytoplasm,82,2.576E-03,1.151E-02,2.576E-03,1.151E-02,16,"Prickle-1, PKC-alpha, NKD1, Tcf(Lef), WNT, RIPK4, TAZ, Nucleoredoxin, NKD2, A20, DACT3, Axin, Frizzled, YAP1/TAZ, DACT1, CDK6",
316,Nicotine / Beta-adrenergic signaling in lung cancer,34,2.648E-03,1.168E-02,2.648E-03,1.168E-02,9,"Beta-3 adrenergic receptor, PKC-alpha, G-protein alpha-i family, Adenylate cyclase, Beta-2 adrenergic receptor, AKT(PKB), Beta-adrenergic receptor, PI3K reg class IB (p101), c-Src",
317,Th2 cell migration in asthma,34,2.648E-03,1.168E-02,2.648E-03,1.168E-02,9,"VCAM1, alpha-4/beta-1 integrin, ICAM1, CD44, G-protein alpha-i family, Beta-2 adrenergic receptor, Eotaxin, PI3K reg class IB (p101), c-Src",
318,Proinflammatory cytokine release from eosinophils in asthma,34,2.648E-03,1.168E-02,2.648E-03,1.168E-02,9,"IL-1 beta, NGF, TrkA, IL-8, GM-CSF, LIF, IL-6, Eotaxin, TNF-alpha",
319,Role of IFN-beta in inhibition of Th1 cell differentiation in multiple sclerosis,34,2.648E-03,1.168E-02,2.648E-03,1.168E-02,9,"IL-18R1, MHC class II, PI3K cat class IA, IL-18, TLR4, PD-1, AKT(PKB), IFN-beta, PD-L1",
320,HGF signaling in pancreatic cancer,28,2.694E-03,1.185E-02,2.694E-03,1.185E-02,8,"HGF, PI3K cat class IA, Neuropilin-1, MMP-2, HGF receptor (Met), c-Src, MMP-9, PLAU (UPA)",
321,Th9 cells in asthma,47,2.703E-03,1.185E-02,2.703E-03,1.185E-02,11,"MHC class II, CRLR, Activin A, IL-33, STAT5, TGF-beta, OX40(TNFRSF4), Eotaxin, TSLP, CCL7, TSLPR",
322,T follicular helper cell dysfunction in SLE,90,2.756E-03,1.204E-02,2.756E-03,1.204E-02,17,"MHC class II, Osteopontin, PI3K cat class IA, PKC-theta, IFN-alpha, IL-6, PD-1, CTLA-4, Fyn, OX40(TNFRSF4), TLR7, AKT(PKB), ICOS, A20, IFN-beta, BLIMP1 (PRDI-BF1), CARD11",
323,Role of IL-23/ T17 pathogenic axis in psoriasis,54,2.811E-03,1.224E-02,2.811E-03,1.224E-02,12,"IL-15, IL-1 beta, MHC class II, IL-15RA, CCL20, IL23A, IL-8, IL-17F, IL-6, sIL-15RA, AKT(PKB), IL22RA1",
324,Role of tumor-infiltrating B cells in anti-tumor immunity,91,3.109E-03,1.350E-02,3.109E-03,1.350E-02,17,"IL-18R1, MHC class II, ADAM-TS9, IP10, IL-18, MAGEC1, CXorf61, CD38, I-TAC, IFN-alpha, T-bet, G-protein alpha-i family, FasR(CD95), FasL(TNFSF6), Apo-2L(TNFSF10), Perforin, BLIMP1 (PRDI-BF1)",
325,Neurophysiological process_ACM regulation of nerve impulse,48,3.224E-03,1.387E-02,3.224E-03,1.387E-02,11,"TRPC5, cPKC (conventional), TRPC3, PKC, PKC-alpha, P/Q-type calcium channel alpha-1A subunit, G-protein alpha-i family, ACM4, TRPC6, G-protein alpha-q/11, ACM3",
326,K-RAS signaling in lung cancer,48,3.224E-03,1.387E-02,3.224E-03,1.387E-02,11,"COX-2 (PTGS2), GRO-2, GRO-1, CCL2, EGFR, ENA-78, PA24A, FasL(TNFSF6), AKT(PKB), SPRY2, MMP-9",
327,Immune response_IL-12 signaling pathway,48,3.224E-03,1.387E-02,3.224E-03,1.387E-02,11,"STAT5A, PI3K cat class IA, iNOS, RUNX3, IL-18, STAT4, T-bet, STAT5, AKT(PKB), IL-12RB2, ERM",
328,Development_Transcriptional regulation of megakaryopoiesis,35,3.283E-03,1.400E-02,3.283E-03,1.400E-02,9,"NF-E2 (45 kDa), CD38, ETS, ETS1, LMO2, Fc gamma RII alpha, FLI1, Jagged1, PF4",
329,Immune response_Differentiation of natural regulatory T cells,35,3.283E-03,1.400E-02,3.283E-03,1.400E-02,9,"MHC class II, TGF-beta receptor type II, GITRL, STAT5, CTLA-4, OX40(TNFRSF4), TSLP, IL-2R alpha chain, TSLPR",
330,Immune response_TLR ligands,35,3.283E-03,1.400E-02,3.283E-03,1.400E-02,9,"TLR1, LBP, TLR10, TLR6, TLR4, MD-2, TLR7, Fibronectin, TLR2",
331,Role of alpha-V/ beta-6 integrin in colorectal cancer,23,3.342E-03,1.421E-02,3.342E-03,1.421E-02,7,"PKC, ETS1, MMP-2, Collagen IV, Fibronectin, MMP-9, PLAU (UPA)",
332,Role of Neuregulin 1 and Thymosin beta-4 in myocardium regeneration after infarction,29,3.429E-03,1.449E-02,3.429E-03,1.449E-02,8,"ITGB1, ACTA1, PI3K cat class IA, Angiopoietin 1, alpha-5/beta-1 integrin, AKT(PKB), ITGA5, Fibronectin",
333,Role of IFN-beta in activation of T cell apoptosis in multiple sclerosis,29,3.429E-03,1.449E-02,3.429E-03,1.449E-02,8,"c-IAP2, FasR(CD95), CTLA-4, 5'-NTD, FasL(TNFSF6), Apo-2L(TNFSF10), AKT(PKB), IFN-beta",
334,Inhibition of apoptosis in gastric cancer,42,3.645E-03,1.526E-02,3.645E-03,1.526E-02,10,"HGF, c-IAP2, Caspase-10, Gasdermin, RUNX3, TGF-beta receptor type II, Apo-2L(TNFSF10), AKT(PKB), HGF receptor (Met), XAF1",
335,Transcription targets of Androgen receptor involved in Prostate Cancer,42,3.645E-03,1.526E-02,3.645E-03,1.526E-02,10,"N-cadherin, IL-8, Versican, IL-6, Matrilysin (MMP-7), PAR1, FGF8, ER81, TLR2, IBP3",
336,"TNF-alpha, IL-1 beta induce dyslipidemia and inflammation in obesity and type 2 diabetes in adipocytes ",42,3.645E-03,1.526E-02,3.645E-03,1.526E-02,10,"COX-2 (PTGS2), IL-1 beta, PTX3, TNF-R2, iNOS, CCL2, CIDE-A, IL-6, HSD11B1, TNF-alpha",
337,Transport_Macropinocytosis regulation by growth factors,63,3.809E-03,1.582E-02,3.809E-03,1.582E-02,13,"HGF, NGF, TrkA, IRS-2, EGFR, Actin cytoskeletal, PDGF-R-alpha, AKT(PKB), CSF1, PDGF receptor, HGF receptor (Met), Cofilin, PDGF-R-beta",
338,Bacterial infections in CF airways,49,3.824E-03,1.582E-02,3.824E-03,1.582E-02,11,"TLR1, iNOS, IL-8, TLR4, GM-CSF, FasR(CD95), MD-2, Cathepsin S, IFN-beta, TLR2, TNF-alpha",
339,Role and regulation of Prostaglandin E2 in gastric cancer,49,3.824E-03,1.582E-02,3.824E-03,1.582E-02,11,"COX-2 (PTGS2), PGE2R2, IL-1 beta, CCL2, IL-8, EGFR, Adenylate cyclase, PLAUR (uPAR), Jagged1, PLAU (UPA), TLR2",
340,Signal transduction_IP3 signaling,49,3.824E-03,1.582E-02,3.824E-03,1.582E-02,11,"Syk, Galpha(q)-specific nucleotide-like GPCRs, PI3K cat class IA, ZAP70, CD3, MEF2, AKT(PKB), G-protein alpha-q/11, PDGF receptor, LAT, HGF receptor (Met)",
341,Immune response_IFN-gamma signaling via PI3K and NF-kB,56,3.865E-03,1.595E-02,3.865E-03,1.595E-02,12,"PI3K cat class IA, Alpha1-globin, iNOS, IP10, RUNX3, STAT5, Fyn, AKT(PKB), TLR3, HLA-B7, LPL, PD-L1",
342,Populations of skin dendritic cells involved in contact hypersensitivity,18,3.953E-03,1.626E-02,3.953E-03,1.626E-02,6,"MHC class II, Langerin, CD1d, LY75, CD83, EMR1",
343,Immune response_IL-6-induced acute-phase response in hepatocytes,36,4.031E-03,1.644E-02,4.031E-03,1.644E-02,9,"GRO-1, SAA1, SAA2, A2M, CRP, C3, IL-6, Angiotensinogen, IBP1",
344,Immune response_HMGB1/TLR signaling pathway,36,4.031E-03,1.644E-02,4.031E-03,1.644E-02,9,"IL-1 beta, IFN-alpha, IL-8, TLR4, IL-6, IRAK1/2, IFN-beta, TLR2, TNF-alpha",
345,CHDI_Correlations from Discovery data_Causal network (positive),36,4.031E-03,1.644E-02,4.031E-03,1.644E-02,9,"GABA-A receptor, IFN-alpha, MMP-2, alpha-5/beta-1 integrin, Actin cytoskeletal, Collagen IV, Actin, Ephrin-B receptors, Collagen III",
346,Development_Role of BMP signaling in embryonic stem cell neural differentiation,30,4.310E-03,1.743E-02,4.310E-03,1.743E-02,8,"NCAM1, IRX1, BMP4, MSX1, SMAD9 (SMAD8), Tubulin beta 2B, NeuroD1, BMP2",
347,Development_Transcription factors in segregation of hepatocytic lineage,30,4.310E-03,1.743E-02,4.310E-03,1.743E-02,8,"p14ARF, Activin A, A2M, TGF-beta receptor type II, Activin, HGF receptor (Met), p16INK4, HNF4-alpha",
348,Putative role of Tregs in COPD,30,4.310E-03,1.743E-02,4.310E-03,1.743E-02,8,"IL7RA, ZAP70, CD3, CD3 zeta, STAT5, CTLA-4, LAT, IL-2R alpha chain",
349,"Chemotaxis_CCL16-, CCL20-, CXCL16- and CCL25-mediated cell migration",43,4.370E-03,1.747E-02,4.370E-03,1.747E-02,10,"CCL20, MMP-13, G-protein alpha-i family, CCL25, MMP-2, MMP-8, AKT(PKB), PI3K reg class IB (p101), MMP-9, MLCK",
350,Effect of H. pylori infection on gastric epithelial cells motility,43,4.370E-03,1.747E-02,4.370E-03,1.747E-02,10,"ITGB1, PKC-alpha, Connexin 32, Lyn, alpha-5/beta-1 integrin, Actin cytoskeletal, c-Src, Claudin-1, Actin, PTPR-zeta",
351,Immune response_Substance P-stimulated expression of proinflammatory cytokines via MAPKs,43,4.370E-03,1.747E-02,4.370E-03,1.747E-02,10,"COX-2 (PTGS2), GRO-2, PKC-theta, CCL2, PKC-alpha, IL-8, IL-6, AKT(PKB), GRO-3, TNF-alpha",
352,Role of platelets in allograft rejection,43,4.370E-03,1.747E-02,4.370E-03,1.747E-02,10,"IL-1 beta, ICAM1, TGF-beta, PAR1, Tissue factor, PF4, P-selectin, Kainate receptor, TNF-alpha, Collagen III",
353,Ca(2+)-dependent NF-AT signaling in cardiac hypertrophy,57,4.501E-03,1.787E-02,4.501E-03,1.787E-02,12,"TRPC3, PKC-alpha, NCX1, G-protein alpha-i family, MEF2C, HAND1, MEF2, TRPC6, G-protein alpha-q/11, Angiotensin II, HAND2, Alpha-1B adrenergic receptor",
354,Development_Thromboxane A2 signaling pathway,50,4.509E-03,1.787E-02,4.509E-03,1.787E-02,11,"cPKC (conventional), PI3K cat class IA, B-Raf, PKC, Tcf(Lef), EGFR, G-protein alpha-i family, Adenylate cyclase, IL-6, AKT(PKB), c-Src",
355,The role of PTEN and PI3K signaling in melanoma,50,4.509E-03,1.787E-02,4.509E-03,1.787E-02,11,"N-cadherin, MCAM, PI3K cat class IA, B-Raf, AKT3, p15, alpha-5/beta-1 integrin, FasL(TNFSF6), TWIST1, AKT(PKB), Fibronectin",
356,Cell adhesion_Role of tetraspanins in the integrin-mediated cell adhesion,37,4.906E-03,1.917E-02,4.906E-03,1.917E-02,9,"ITGB1, alpha-4/beta-1 integrin, PKC-alpha, alpha-5/beta-1 integrin, Actin cytoskeletal, Fibronectin, c-Src, Actin, Cofilin",
357,Immune response_Generation of memory CD4+ T cells,37,4.906E-03,1.917E-02,4.906E-03,1.917E-02,9,"IL-15, MHC class II, IL-15RA, IL7RA, CD44, BFL1, STAT5, OX40(TNFRSF4), IL-2R alpha chain",
358,Development_Beta-adrenergic receptors transactivation of EGFR,37,4.906E-03,1.917E-02,4.906E-03,1.917E-02,9,"PI3K cat class IA, ADAM12, CD44, Beta-3 adrenergic receptor, EGFR, G-protein alpha-i family, Beta-2 adrenergic receptor, MYLK1, c-Src",
359,Immune response_Regulation of T cell function by CTLA-4,37,4.906E-03,1.917E-02,4.906E-03,1.917E-02,9,"PI3K cat class IA, ZAP70, CD3, Lyn, CD3 zeta, CTLA-4, Fyn, AKT(PKB), LAT",
360,Role of alveolar cell senescence in COPD,37,4.906E-03,1.917E-02,4.906E-03,1.917E-02,9,"IGFBP7, IL-8, Cyr61, IL-6, CTGF, AKT(PKB), Caveolin-1, p16INK4, IBP3",
361,Immune response_IL-13 signaling via JAK-STAT,44,5.206E-03,2.022E-02,5.206E-03,2.022E-02,10,"iNOS, SCCA-2, CCL2, Eotaxin-3, STAT5, MMP-8, COL1A2, Eotaxin, SCCA-1, UGRP2",
362,Cell adhesion_Integrin inside-out signaling,58,5.217E-03,2.022E-02,5.217E-03,2.022E-02,12,"ITGB1, ITGB2, ITGB3, G-protein alpha-i family, alpha-5/beta-1 integrin, Actin cytoskeletal, alpha-1/beta-1 integrin, PAR1, G-protein alpha-q/11, Angiotensin II, Fibronectin, c-Src",
363,Immune response_IL-33 signaling pathway,58,5.217E-03,2.022E-02,5.217E-03,2.022E-02,12,"PI3K cat class IA, VCAM1, GRO-1, ICAM1, CCL2, IL-8, IL-17F, GM-CSF, IL-33, IL-6, AKT(PKB), TNF-alpha",
364,Immune response_Histamine signaling in dendritic cells,51,5.288E-03,2.038E-02,5.288E-03,2.038E-02,11,"Histamine H1 receptor, IL-1 beta, CCL2, PKC-alpha, IL-8, G-protein alpha-i family, Adenylate cyclase, IL-6, G-protein alpha-q/11, Histamine H2 receptor, TNF-alpha",
365,Some pathways of EMT in cancer cells,51,5.288E-03,2.038E-02,5.288E-03,2.038E-02,11,"PI3K cat class IA, EGFR, PDGF-R-alpha, TWIST1, AKT(PKB), PDGF receptor, c-Src, Axin, EDNRA, PDGF-R-beta, TNF-alpha",
366,Neutrophil adhesion and transendothelial migration in asthma,31,5.356E-03,2.053E-02,5.356E-03,2.053E-02,8,"VCAM1, alpha-4/beta-1 integrin, ICAM1, alpha-9/beta-1 integrin, IL-8, cPLA2, P-selectin, TNF-alpha",
367,Development_Embryonal epaxial myogenesis,31,5.356E-03,2.053E-02,5.356E-03,2.053E-02,8,"PTCH1, WNT, BMP4, WNT11, GLI-1, Frizzled, WNT1, WNT6",
368,CHDI_Correlations from Discovery data_Causal network,73,5.463E-03,2.088E-02,5.463E-03,2.088E-02,14,"Syk, PI3K cat class IA, CCL2, Kir3.4, WNT, G-protein alpha-i family, p15, MEF2, PDGF-R-alpha, AKT(PKB), PI3K reg class IB (p101), c-Src, Axin, Frizzled",
369,Immune escape mechanisms in Prostate Cancer,25,5.581E-03,2.088E-02,5.581E-03,2.088E-02,7,"TAP1 (PSF1), CCL2, TLR4, TAP2 (PSF2), IL-6, TGF-beta, TAP",
370,Role of keratinocytes and Langerhans cells in skin sensitization,25,5.581E-03,2.088E-02,5.581E-03,2.088E-02,7,"IL-1 beta, TNF-R2, IL-18R1, MHC class II, IL-18, Caspase-1, TNF-alpha",
371,Generation of cytotoxic CD8+ T cells in COPD,25,5.581E-03,2.088E-02,5.581E-03,2.088E-02,7,"MHC class II, ICAM1, CTLA-4, CD137 ligand(TNFSF9), OX40(TNFRSF4), CD137(TNFRSF9), Perforin",
372,Immune response_T cell subsets: secreted signals,25,5.581E-03,2.088E-02,5.581E-03,2.088E-02,7,"CCL20, IL-1 alpha, IL-17F, GM-CSF, IL-6, TGF-beta, TNF-alpha",
373,Activation of pro-oncogenic TGF-beta potential in gastric cancer,25,5.581E-03,2.088E-02,5.581E-03,2.088E-02,7,"GSTP1, TGF-beta 2, TGF-beta receptor type II, MMP-2, Fibronectin, c-Src, MMP-9",
374,T cell generation in COPD,25,5.581E-03,2.088E-02,5.581E-03,2.088E-02,7,"MHC class II, CCL20, Langerin, ICAM1, CCL2, CTLA-4, CCL7",
375,Resolution of inflammation in healing myocardial infarction,25,5.581E-03,2.088E-02,5.581E-03,2.088E-02,7,"HGF, MMP-2, Angiopoietin 1, FGF2, AKT(PKB), HGF receptor (Met), MMP-9",
376,Dual role of BMP signaling in gastric cancer,25,5.581E-03,2.088E-02,5.581E-03,2.088E-02,7,"PI3K cat class IA, CDX2, BMP4, SMAD9 (SMAD8), AKT(PKB), LI-cadherin, BMP2",
377,Transcription_Role of AP-1 in regulation of cellular metabolism,38,5.922E-03,2.187E-02,5.922E-03,2.187E-02,9,"Alpha1-globin, CGB3, FasR(CD95), PLAUR (uPAR), FasL(TNFSF6), ITGA5, TSG-6, IFN-beta, Prolactin",
378,Cell adhesion_Cell-matrix glycoconjugates,38,5.922E-03,2.187E-02,5.922E-03,2.187E-02,9,"Neurocan, NCAM1, Tenascin-R, CD44, Tenascin-C, Elastin, Versican, MMP-9, Aggrecan",
379,Immune response_Role of integrins in NK cells cytotoxicity,38,5.922E-03,2.187E-02,5.922E-03,2.187E-02,9,"VCAM1, alpha-4/beta-1 integrin, ICAM1, IL-8, Lyn, CD94, FasL(TNFSF6), Fibronectin, ICAM2",
380,WNT signaling in proliferative-type melanoma cells,38,5.922E-03,2.187E-02,5.922E-03,2.187E-02,9,"B-Raf, DKK3, WNT, WNT2, Axin2, Fibronectin, Axin, Frizzled, DACT1",
381,Substance P-mediated inflammation and pain in Sickle cell disease,38,5.922E-03,2.187E-02,5.922E-03,2.187E-02,9,"IL-1 beta, VCAM1, alpha-4/beta-1 integrin, ICAM1, IL-8, GM-CSF, IL-6, Tissue factor, TNF-alpha",
382,Macrophage-induced immunosuppression in the tumor microenvironment,97,6.104E-03,2.231E-02,6.104E-03,2.231E-02,17,"COX-2 (PTGS2), S1P1 receptor, IDO1, CCL20, PD-L2, Adenosine A2b receptor, CD44, CCL2, IL-34, GM-CSF, IL-6, TIM-4, 5'-NTD, CD94, HLA-G, CSF1, PD-L1",
383,Retinal ganglion cell damage in glaucoma,45,6.161E-03,2.231E-02,6.161E-03,2.231E-02,10,"NGF, NGFR(TNFRSF16), TrkA, iNOS, A2M, C3, Factor H, TrkB, EDNRA, TNF-alpha",
384,Cell adhesion_Ephrin signaling,45,6.161E-03,2.231E-02,6.161E-03,2.231E-02,10,"HGK(MAP4K4), G-protein alpha-i family, Fyn, Ephrin-A receptors, Ephrin-B receptor 1, Ephrin-A, c-Src, Ephrin-B receptors, Ephrin-A receptor 2, Ephrin-A2",
385,Proinflammatory mediators production and activation of basophils in asthma,45,6.161E-03,2.231E-02,6.161E-03,2.231E-02,10,"NGF, TrkA, MHC class II, PI3K cat class IA, DHA2, ITGA4, IL-8, IL-33, ENPP3, AKT(PKB)",
386,Mechanisms of resistance to EGFR inhibitors in lung cancer,45,6.161E-03,2.231E-02,6.161E-03,2.231E-02,10,"HGF, PI3K cat class IA, EGFR, CIN85, AKT(PKB), HGF receptor (Met), Fibronectin, Vimentin, c-Src, TCF8",
387,Cell adhesion_Integrin inside-out signaling in T cells,52,6.169E-03,2.231E-02,6.169E-03,2.231E-02,11,"ITGB1, CCL20, VCAM1, ITGB2, alpha-4/beta-1 integrin, ICAM1, ZAP70, CD3, CD3 zeta, G-protein alpha-i family, FYB1",
388,Development_Self-renewal of adult neural stem cells,52,6.169E-03,2.231E-02,6.169E-03,2.231E-02,11,"p14ARF, HES5, PTCH1, WNT7A, TLX, Nestin, NeuroD1, GLI-1, FKHL1, p16INK4, GLI-2",
389,Neurophysiological process_Synaptic vesicle fusion and recycling in nerve terminals,52,6.169E-03,2.231E-02,6.169E-03,2.231E-02,11,"CHL1, Alpha-synuclein, SV2A, AP180, F-Actin, P/Q-type calcium channel alpha-1A subunit, RIM-bp2, CaMK I, Synapsin II, Endophilin A1, Complexin",
390,"Stem cells_Cooperation between Hedgehog, IGF-2 and HGF signaling pathways in medulloblastoma stem cells",32,6.584E-03,2.357E-02,6.584E-03,2.357E-02,8,"HGF, PI3K cat class IA, PTCH1, Tcf(Lef), GLI-1, AKT(PKB), HGF receptor (Met), GLI-2",
391,Selective Insulin resistance in type 2 diabetes in liver,32,6.584E-03,2.357E-02,6.584E-03,2.357E-02,8,"PPCKC, PKC-theta, IRS-2, GYS2, PPARGC1 (PGC1-alpha), MTP, AKT(PKB), HNF3-beta",
392,Protein folding and maturation_Bradykinin / Kallidin maturation,32,6.584E-03,2.357E-02,6.584E-03,2.357E-02,8,"Aminopeptidase P2, Neprilysin, Tissue kallikreins, MMP-8, Carboxypeptidase N (cat), Plasma kallikrein, ACE2, CD13",
393,Development_Schema: Histone H3 demethylases in stem cells,32,6.584E-03,2.357E-02,6.584E-03,2.357E-02,8,"HOXA13, p14ARF, p15, HOXA1, SCN2A, HOXA7, p16INK4, HOXA11",
394,Immune response_LTBR1 signaling,60,6.921E-03,2.459E-02,6.921E-03,2.459E-02,12,"Syk, COX-2 (PTGS2), PI3K cat class IA, G-protein alpha-15, iNOS, PKC, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), G-protein alpha-q/11, PI3K reg class IB (p101), nNOS",
395,Immune response_TREM1 signaling pathway,60,6.921E-03,2.459E-02,6.921E-03,2.459E-02,12,"Syk, IL-1 beta, PI3K cat class IA, CCL2, IL-8, TLR4, GM-CSF, IL-6, AKT(PKB), TLR2, WBSCR5(NTAL), TNF-alpha",
396,Development_Regulation of endothelial progenitor cell differentiation from adult stem cells,60,6.921E-03,2.459E-02,6.921E-03,2.459E-02,12,"PI3K cat class IA, VCAM1, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, GM-CSF, Angiopoietin 1, PAR1, AKT(PKB), CSF1, P-selectin, MMP-9",
397,Pioglitazone and Rosiglitazone in treatment of type 2 diabetes and metabolic syndrome X,26,7.050E-03,2.476E-02,7.050E-03,2.476E-02,7,"PPCKC, IRS-2, VLDLR, IL-6, SORBS1, LPL, TNF-alpha",
398,Immune response_Role of HMGB1 in dendritic cell maturation and migration,26,7.050E-03,2.476E-02,7.050E-03,2.476E-02,7,"IL-15, IL-1 beta, MHC class II, IL-18, IL-8, IL-6, TNF-alpha",
399,Development_Direct reprogramming of cardiac fibroblasts into cardiomyocytes,20,7.052E-03,2.476E-02,7.052E-03,2.476E-02,6,"Myocardin, MLC2, TBX5, MEF2C, ACTC, beta-MHC",
400,Cell cycle progression in Prostate Cancer,39,7.092E-03,2.476E-02,7.092E-03,2.476E-02,9,"Cyclin A1, STAT5A, Tcf(Lef), WNT, IL-6, AKT(PKB), Frizzled, Prolactin, CDK6",
401,PXR-mediated direct regulation of xenobiotic metabolizing enzymes / Rodent version,39,7.092E-03,2.476E-02,7.092E-03,2.476E-02,9,"CYP27A1, UGT1A1, CYP3A7, CYP24A1, CYP7A1, UGT1A4, MDR1, UGT1A6, CYP11A1",
402,Blood coagulation_Blood coagulation,39,7.092E-03,2.476E-02,7.092E-03,2.476E-02,9,"SERPINE2, PLAT (TPA), A2M, Coagulation factor XI, PAI2, Tissue factor, Plasma kallikrein, Protein S, PLAU (UPA)",
403,Cooperative action of IFN-gamma and TNF-alpha on astrocytes in multiple sclerosis,39,7.092E-03,2.476E-02,7.092E-03,2.476E-02,9,"MHC class II, iNOS, IP10, ICAM1, CCL2, Adenylate cyclase, HLA-DRA1, Beta-2 adrenergic receptor, TNF-alpha",
404,Proinflammatory cytokine production by Th17 cells in asthma,53,7.162E-03,2.494E-02,7.162E-03,2.494E-02,11,"COX-2 (PTGS2), IL-1 beta, MHC class II, CCL20, IL23A, C3, IL-8, IL-17F, IL-6, C3a, TNF-alpha",
405,FGF signaling in pancreatic cancer,46,7.247E-03,2.518E-02,7.247E-03,2.518E-02,10,"PI3K cat class IA, Heparanase 1, PLAT (TPA), MMP-14, FGF1, HBP17, FGF2, AKT(PKB), MMP-9, PLAU (UPA)",
406,Cytoskeleton remodeling_PDGF signaling via calcium and Rho GTPases,83,7.268E-03,2.519E-02,7.268E-03,2.519E-02,15,"N-cadherin, Lysyl oxidase, PKC, F-Actin, PKC-alpha, PDGF-C, Guanylate cyclase A (NPR1), Actin cytoskeletal, Fyn, PDGFR-ab, TRPC6, PDGF-R-alpha, PDGF receptor, c-Src, PDGF-R-beta",
407,Effect of H. pylori infection on inflammation in gastric epithelial cells,61,7.922E-03,2.739E-02,7.922E-03,2.739E-02,12,"COX-2 (PTGS2), iNOS, IL-18, PKC-alpha, IL-8, TLR4, GM-CSF, IL-6, IRAK1/2, c-Src, TLR2, TNF-alpha",
408,G-protein signaling_N-RAS regulation pathway,33,8.014E-03,2.750E-02,8.014E-03,2.750E-02,8,"MHC class II, B-Raf, ZAP70, CD3, CD3 zeta, EGFR, RASGRF1, LAT",
409,Normal and pathological TGF-beta-mediated regulation of cell proliferation,33,8.014E-03,2.750E-02,8.014E-03,2.750E-02,8,"ITGB3, TGF-beta receptor type II, FGF2, PDGF-R-alpha, PDGF receptor, c-Src, Axin, PDGF-R-beta",
410,Immune response_TLR3 and TLR4 induced TICAM1-specific signaling pathway,33,8.014E-03,2.750E-02,8.014E-03,2.750E-02,8,"PI3K cat class IA, IFN-alpha, TLR4, MD-2, AKT(PKB), TLR3, c-Src, IFN-beta",
411,Growth factors in regulation of oligodendrocyte precursor cells proliferation in multiple sclerosis,54,8.275E-03,2.826E-02,8.275E-03,2.826E-02,11,"HGF, NGF, Myelin basic protein, TrkA, PI3K cat class IA, PKC, FGF2, PDGF-R-alpha, AKT(PKB), HGF receptor (Met), Fibronectin",
412,ERBB family and HGF signaling in gastric cancer,54,8.275E-03,2.826E-02,8.275E-03,2.826E-02,11,"HGF, COX-2 (PTGS2), STAT5A, PI3K cat class IA, IL-8, Epiregulin, EGFR, Neuropilin-1, TGF-alpha, AKT(PKB), HGF receptor (Met)",
413,Memory CD8+ T cells in allergic contact dermatitis,40,8.431E-03,2.857E-02,8.431E-03,2.857E-02,9,"IL-15, IL-1 beta, IL7RA, VCAM1, alpha-4/beta-1 integrin, ICAM1, T-bet, P-selectin, TNF-alpha",
414,Immune response_Th1 and Th2 cell differentiation,40,8.431E-03,2.857E-02,8.431E-03,2.857E-02,9,"MHC class II, RUNX3, IL-18, STAT4, CD3, T-bet, CD137 ligand(TNFSF9), CD137(TNFRSF9), IL-12RB2",
415,Development_FGF signaling in pancreatic and hepatic differentiation of embryonic stem cells,40,8.431E-03,2.857E-02,8.431E-03,2.857E-02,9,"N-cadherin, Activin A, BMP4, SOX17, FGF1, FGF2, HNF4-alpha, HNF3-beta, BMP2",
416,Chemotaxis_Lipoxin inhibitory action on Formyl-Met-Leu-Phe-induced neutrophil chemotaxis,47,8.475E-03,2.857E-02,8.475E-03,2.857E-02,10,"FPRL1, ICAM1, Lyn, G-protein alpha-i family, F-Actin cytoskeleton, Actin cytoskeletal, AKT(PKB), PI3K reg class IB (p101), FPR, Cofilin",
417,Development_TGF-beta-dependent induction of EMT via MAPK ,47,8.475E-03,2.857E-02,8.475E-03,2.857E-02,10,"TGF-beta 2, ITGB1, ITGB3, TGF-beta receptor type II, MMP-2, TGF-beta, Fibronectin, Vimentin, c-Src, Claudin-1",
418,Stem cells_Aberrant Hedgehog signaling in medulloblastoma stem cells,15,8.486E-03,2.857E-02,8.486E-03,2.857E-02,5,"PTCH1, PTCH2, GLI-1, SFRP1, GLI-2",
419,Pancreatic cancer cell resistance to Tarceva (erlotinib),27,8.786E-03,2.950E-02,8.786E-03,2.950E-02,7,"PI3K cat class IA, EGFR, TGF-alpha, TWIST1, AKT(PKB), Vimentin, TCF8",
420,Signal transduction_Adenosine A1 receptor signaling pathway,62,9.034E-03,3.026E-02,9.034E-03,3.026E-02,12,"G-protein alpha-15, PKC, PKC-alpha, EGFR, G-protein alpha-i family, Adenylate cyclase, MMP-2, ADA, AKT(PKB), G-protein alpha-q/11, SFK, c-Src",
421,Development_Role of G-CSF in hematopoietic stem cell mobilization,21,9.127E-03,3.050E-02,9.127E-03,3.050E-02,6,"S1P1 receptor, ICAM1, MMP-14, DPP4, MMP-9, GFI-1",
422,PGE2 pathways in cancer,55,9.518E-03,3.166E-02,9.518E-03,3.166E-02,11,"COX-2 (PTGS2), PGE2R2, Tcf(Lef), EGFR, G-protein alpha-i family, Adenylate cyclase, TGF-alpha, AKT(PKB), c-Src, Axin, TNF-alpha",
423,Apoptosis and survival_NO synthesis and signaling,55,9.518E-03,3.166E-02,9.518E-03,3.166E-02,11,"COX-2 (PTGS2), IL-1 beta, iNOS, IFN-alpha, GM-CSF, CaMK I, AKT(PKB), c-Src, nNOS, PI3K cat class IA (p110-delta), TNF-alpha",
424,Development_FGF2 signaling during embryonic stem cell differentiation,34,9.665E-03,3.200E-02,9.665E-03,3.200E-02,8,"SOX1, NCAM1, PTCH1, Activin A, Nestin, FGF2, SPRY2, PAX6",
425,Development_Role of CDK5 in neuronal development,34,9.665E-03,3.200E-02,9.665E-03,3.200E-02,8,"PI3K cat class IA, VLDLR, Reelin, Actin cytoskeletal, Fyn, DAB1, AKT(PKB), Dynein 1, cytoplasmic, intermediate chains",
426,Neuropeptide signaling in pancreatic cancer,48,9.856E-03,3.248E-02,9.856E-03,3.248E-02,10,"HGF, Neuromedin U receptor 2, GRP(1-27), CCL2, PKC-alpha, V1a receptor, NT, G-protein alpha-q/11, Angiotensin II, HGF receptor (Met)",
427,Signal transduction_Adenosine A3 receptor signaling pathway,48,9.856E-03,3.248E-02,9.856E-03,3.248E-02,10,"IL-1 beta, PI3K cat class IA, PKC, G-protein alpha-i family, Adenylate cyclase, Rho GTPase, AKT(PKB), G-protein alpha-q/11, PI3K reg class IB (p101), TNF-alpha",
428,Breast cancer (general schema),41,9.953E-03,3.264E-02,9.953E-03,3.264E-02,9,"PTCH1, TGF-beta receptor type II, EGFR, IL-6, NOTCH4, TGF-beta, PTHrP, Jagged1, Prolactin",
429,Immune response_TLR2-induced platelet activation,41,9.953E-03,3.264E-02,9.953E-03,3.264E-02,9,"IL-1 beta, TLR1, PI3K cat class IA, PKC-alpha, cPLA2, AKT(PKB), PF4, P-selectin, TLR2",
430,Immune response_IFN-gamma actions on blood cells,28,1.082E-02,3.523E-02,1.082E-02,3.523E-02,7,"IL-15, PD-L2, Alpha1-globin, T-bet, IL-6, HNF3-beta, PD-L1",
431,The role of aberrations in CDKN2 locus and CDK4 in familial melanoma,28,1.082E-02,3.523E-02,1.082E-02,3.523E-02,7,"p14ARF, RUNX2, EGFR, p15, p16INK4, FLRT3, CDK6",
432,Th1 and Th17 cells in an autoimmune mechanism of emphysema formation in smokers,28,1.082E-02,3.523E-02,1.082E-02,3.523E-02,7,"MHC class II, Osteopontin, CCL20, IP10, CD44, Elastin, MMP-9",
433,MAPK-mediated proliferation of normal and asthmatic smooth muscle cells,56,1.090E-02,3.542E-02,1.090E-02,3.542E-02,11,"PKC-alpha, PLAT (TPA), EGFR, G-protein alpha-i family, PDGF-C, FGF2, PDGF-R-alpha, PDGF receptor, c-Src, EDNRA, PDGF-R-beta",
434,Immune response_Fc epsilon RI pathway: Lyn-mediated cytokine production,87,1.119E-02,3.629E-02,1.119E-02,3.629E-02,15,"Syk, IL-1 beta, PKC, CCL2, PKC-alpha, Lyn, IL-33, MEF2C, IL-6, BFL1, FYB1, TSLP, LAT, GRAP2, TNF-alpha",
435,Tissue Factor signaling in cancer via PAR1 and PAR2,49,1.140E-02,3.688E-02,1.140E-02,3.688E-02,10,"STAT5A, PI3K cat class IA, PKC-alpha, IL-8, EGFR, TGF-alpha, PAR1, AKT(PKB), G-protein alpha-q/11, Tissue factor",
436,Intercellular relations in asthma (general schema),16,1.144E-02,3.690E-02,1.144E-02,3.690E-02,5,"VCAM1, ICAM1, GM-CSF, TSLP, TNF-alpha",
437,Production and activation of TGF-beta in airway smooth muscle cells,35,1.156E-02,3.716E-02,1.156E-02,3.716E-02,8,"TGF-beta 2, TGF-beta receptor type II, G-protein alpha-i family, TLR4, GM-CSF, TGF-beta, Angiotensin II, PLAU (UPA)",
438,Immune response_IL-15 signaling via JAK-STAT cascade,22,1.161E-02,3.716E-02,1.161E-02,3.716E-02,6,"Syk, IL-15, STAT5A, IL-15RA, STAT5, sIL-15RA",
439,Myeloid-derived suppressor cells and M2 macrophages in cancer,64,1.162E-02,3.716E-02,1.162E-02,3.716E-02,12,"COX-2 (PTGS2), PGE2R2, IL-1 beta, IDO1, iNOS, TLR4, GM-CSF, SLC7A11, IL-6, STAT5, CSF1, PD-L1",
440,Apoptosis and survival_Anti-apoptotic TNFs/NF-kB/Bcl-2 pathway,42,1.167E-02,3.716E-02,1.167E-02,3.716E-02,9,"NGF, TNF-R2, NGFR(TNFRSF16), RANKL(TNFSF11), BFL1, OX40(TNFRSF4), IRAK1/2, RANK(TNFRSF11A), TNF-alpha",
441,PXR-mediated direct regulation of xenobiotic metabolizing enzymes / Human version,42,1.167E-02,3.716E-02,1.167E-02,3.716E-02,9,"CYP27A1, UGT1A1, CYP3A7, CYP24A1, CYP7A1, UGT1A4, MDR1, UGT1A6, CYP11A1",
442,Growth factors in regulation of oligodendrocyte precursor cells survival in multiple sclerosis,42,1.167E-02,3.716E-02,1.167E-02,3.716E-02,9,"NGF, NGFR(TNFRSF16), PI3K cat class IA, Lyn, Fyn, PDGF-R-alpha, AKT(PKB), IBP, TNF-alpha",
443,Apoptotic pathways and resistance to apoptosis in lung cancer cells,57,1.243E-02,3.939E-02,1.243E-02,3.939E-02,11,"c-IAP2, Caspase-10, B-Raf, PKC-alpha, FasR(CD95), BFL1, FGF2, FasL(TNFSF6), Apo-2L(TNFSF10), Caspase-1, TNF-alpha",
444,CCR7 signaling pathways in dendritic cells in allergic contact dermatitis,57,1.243E-02,3.939E-02,1.243E-02,3.939E-02,11,"alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, Myosin II, Actin cytoskeletal, Rac2, AKT(PKB), Fibronectin, PI3K reg class IB (p101), c-Src, Cofilin",
445,Immune response_CD40 signaling,65,1.311E-02,4.126E-02,1.311E-02,4.126E-02,12,"COX-2 (PTGS2), STAT5A, PI3K cat class IA, ICAM1, CCL2, IL-8, Lyn, FasR(CD95), IL-6, FasL(TNFSF6), AKT(PKB), A20",
446,"Cigarette smoke-induced proliferation, metaplasia and survival of airway epithelial cells ",50,1.313E-02,4.126E-02,1.313E-02,4.126E-02,10,"nAChR alpha-7, PI3K cat class IA, Keratin 14, Fra-1, EGFR, nAChR alpha-3, MMP-2, Keratin 5, c-Src, MMP-9",
447,Apoptosis and survival_nAChR in apoptosis inhibition and cell cycle progression,29,1.317E-02,4.126E-02,1.317E-02,4.126E-02,7,"nAChR alpha-7, PI3K cat class IA, nAChR alpha, Fyn, AKT(PKB), c-Src, nAChR beta",
448,Stem cells_Notch signaling in medulloblastoma stem cells,29,1.317E-02,4.126E-02,1.317E-02,4.126E-02,7,"HEY1, HES5, PTCH1, GLI-1, FKHL1, Jagged1, GLI-2",
449,EZH2 in Prostate Cancer,29,1.317E-02,4.126E-02,1.317E-02,4.126E-02,7,"Keratin 17, Alpha-synuclein, ITGB2, RUNX3, WNT2, DARC, Ephrin-B receptor 6",
450,Regulation and signaling of HGF receptor (Met) and MSP receptor (RON) in lung cancer,73,1.351E-02,4.210E-02,1.351E-02,4.210E-02,13,"HGF, COX-2 (PTGS2), IL-1 beta, PAX5, PI3K cat class IA, PKC-alpha, MMP-2, IL-6, FGF2, AKT(PKB), HGF receptor (Met), c-Src, MMP-9",
451,Immune response_IL-7 signaling in B lymphocytes,43,1.361E-02,4.210E-02,1.361E-02,4.210E-02,9,"STAT5A, PAX5, IL7RA, EBF, Lyn, STAT5, Fyn, AKT(PKB), Pim-1",
452,Cytoskeleton remodeling_Hyaluronic acid/ CD44 signaling pathways,43,1.361E-02,4.210E-02,1.361E-02,4.210E-02,9,"HGF, CD44, MSN (moesin), Actin cytoskeletal, Fyn, HGF receptor (Met), c-Src, Actin, MLCK",
453,Role of platelets in the initiation of in-stent restenosis,43,1.361E-02,4.210E-02,1.361E-02,4.210E-02,9,"ICAM1, CCL2, IL-8, PAR1, Tissue factor, ICAM2, PF4, P-selectin, Collagen III",
454,FGF signaling in Prostate Cancer,43,1.361E-02,4.210E-02,1.361E-02,4.210E-02,9,"PI3K cat class IA, FGF1, Matrilysin (MMP-7), HBP17, FGF2, AKT(PKB), FGF8, SPRY2, FGF9",
455,PR action in breast cancer: stimulation of cell growth and proliferation,36,1.371E-02,4.210E-02,1.371E-02,4.210E-02,8,"STAT5A, Cyclin E, EGFR, MMP-2, Cyclin A, c-Src, MMP-9, WNT1",
456,iNKT cell-keratinocyte interactions in allergic contact dermatitis,36,1.371E-02,4.210E-02,1.371E-02,4.210E-02,8,"TCR beta subunit, IP10, ICAM1, CD3, CD1d, T-bet, FasR(CD95), FasL(TNFSF6)",
457,Immune response_IL-12-induced IFN-gamma production,36,1.371E-02,4.210E-02,1.371E-02,4.210E-02,8,"IL-18R1, iNOS, IL-18, STAT4, CD3, T-bet, IL-12RB2, ERM",
458,Development_Thrombospondin 1 signaling,36,1.371E-02,4.210E-02,1.371E-02,4.210E-02,8,"alpha-4/beta-1 integrin, alpha-9/beta-1 integrin, VLDLR, ITGB3, G-protein alpha-i family, Adenylate cyclase, Fyn, FGF2",
459,Aberrant production of IL-2 and IL-17 in SLE T cells,58,1.412E-02,4.318E-02,1.412E-02,4.318E-02,11,"Syk, IL-1 beta, MHC class II, ZAP70, CD3, ETS1, IL-17F, CD3 zeta, IL-6, AKT(PKB), LAT",
460,Role of B cells in SLE,58,1.412E-02,4.318E-02,1.412E-02,4.318E-02,11,"Syk, MHC class II, PI3K cat class IA, ICAM1, IFN-alpha, Lyn, IL-6, OX40(TNFRSF4), AKT(PKB), ICOS, TNF-alpha",
461,Translation_Opioid receptors in regulation of translation ,23,1.452E-02,4.413E-02,1.452E-02,4.413E-02,6,"Metenkefalin, G-protein alpha-i family, AKT(PKB), Leu-enkephalin, PI3K reg class IB (p101), Kappa-type opioid receptor",
462,Cytoskeleton remodeling_ESR1 action on cytoskeleton remodeling and cell migration,23,1.452E-02,4.413E-02,1.452E-02,4.413E-02,6,"PI3K cat class IA, MSN (moesin), ERM proteins, F-Actin cytoskeleton, AKT(PKB), c-Src",
463,Stem cells_Aberrant Wnt signaling in medulloblastoma stem cells,23,1.452E-02,4.413E-02,1.452E-02,4.413E-02,6,"CD44, WNT, Matrilysin (MMP-7), AKT(PKB), Axin, Frizzled",
464,Signal transduction_PDGF signaling via JAK-STAT and reactive oxygen species (ROS),66,1.474E-02,4.469E-02,1.474E-02,4.469E-02,12,"IP10, CCL2, I-TAC, cPLA2, PDGF-C, PDGFR-ab, PDGF-R-alpha, PDGF receptor, c-Src, Cofilin, PDGF-R-beta, CCL7",
465,Development_Oligodendrocyte differentiation from adult stem cells,51,1.504E-02,4.541E-02,1.504E-02,4.541E-02,10,"Myelin basic protein, PTCH1, BMP4, OLIG2, SMAD9 (SMAD8), OATP-F, FGF2, PDGF-R-alpha, BMP2, EDNRA",
466,Immune response_NF-AT in immune response,51,1.504E-02,4.541E-02,1.504E-02,4.541E-02,10,"Syk, MHC class II, PI3K cat class IA, PKC-theta, ZAP70, CD3, Lyn, CD3 zeta, AKT(PKB), LAT",
467,Tinnitus-associated changes in auditory pathway ,82,1.517E-02,4.570E-02,1.517E-02,4.570E-02,14,"GRID1, GABA-A receptor, GAD2, GluR6, mGluR8, GluR1, mGluR7, GABA-A receptor alpha-1 subunit, KCNQ2, GAD1, nNOS, NR2A, SLC17A6, nAChR alpha-9",
468,Role of SHH and Notch in SCLC,30,1.586E-02,4.759E-02,1.586E-02,4.759E-02,7,"PTCH1, BMP4, AL1A1, Nestin, GLI-1, Jagged1, GLI-2",
469,Activation of TGF-beta signaling in advanced colorectal cancer,30,1.586E-02,4.759E-02,1.586E-02,4.759E-02,7,"TGF-beta 2, PI3K cat class IA, IL-8, TGF-beta receptor type II, AKT(PKB), MMP-9, IBP3",
470,Immune response_IL-11 signaling pathway via MEK/ERK and PI3K/AKT cascades,67,1.652E-02,4.934E-02,1.652E-02,4.934E-02,12,"IL-1 beta, RUNX2, ICAM1, IL-8, Cyclin E, ALPL, IL-6, Fyn, AKT(PKB), SFK, c-Src, TNF-alpha",
471,"Role of microRNAs in cell migration, survival and angiogenesis in colorectal cancer",67,1.652E-02,4.934E-02,1.652E-02,4.934E-02,12,"COX-2 (PTGS2), Fra-1, UFO, TGF-beta receptor type II, Neuropilin-1, MMP-2, CTGF, AKT(PKB), SPRY2, FLI1, HGF receptor (Met), MMP-9",
472,EGFR family signaling in pancreatic cancer,75,1.676E-02,4.996E-02,1.676E-02,4.996E-02,13,"COX-2 (PTGS2), PI3K cat class IA, Cyclin E, EGFR, Neuropilin-1, MMP-2, Mucin 4, BFL1, TGF-alpha, AKT(PKB), c-Src, MMP-9, PLAU (UPA)",
473,Cell adhesion_Endothelial cell contacts by non-junctional mechanisms,24,1.791E-02,5.317E-02,1.791E-02,5.317E-02,6,"N-cadherin, F-Actin cytoskeleton, alpha-5/beta-1 integrin, alpha-1/beta-1 integrin, Collagen IV, Fibronectin",
474,Development_Dopamine D2 receptor transactivation of EGFR,24,1.791E-02,5.317E-02,1.791E-02,5.317E-02,6,"PI3K cat class IA, ADAM12, EGFR, G-protein alpha-i family, AKT(PKB), c-Src",
475,EGFR signaling pathway in colorectal cancer,60,1.800E-02,5.333E-02,1.800E-02,5.333E-02,11,"COX-2 (PTGS2), B-Raf, Trypsin I, Epiregulin, EGFR, NT, Matrilysin (MMP-7), TGF-alpha, PAR1, c-Src, ACM3",
476,Regulation of relaxation of airway smooth muscle cells,45,1.817E-02,5.337E-02,1.817E-02,5.337E-02,9,"PGE2R2, PGD2R, PACAP, F-Actin cytoskeleton, VIP, Beta-2 adrenergic receptor, c-Src, MLCK, Cofilin",
477,Role of alpha-6/beta-4 integrins in carcinoma progression,45,1.817E-02,5.337E-02,1.817E-02,5.337E-02,9,"HGF, PI3K cat class IA, IRS-2, PKC-alpha, EGFR, Actin cytoskeletal, AKT(PKB), HGF receptor (Met), Cofilin",
478,G-protein signaling_Regulation of Cyclic AMP levels by ACM,45,1.817E-02,5.337E-02,1.817E-02,5.337E-02,9,"PDE1C, Adenylate cyclase type VIII, PKC-alpha, G-protein alpha-i family, ACM4, PDE1A, G-protein alpha-q/11, ACM3, Adenylate cyclase type VII",
479,Signal transduction_Angiotensin II/ AGTR1 signaling via JAK/STAT,45,1.817E-02,5.337E-02,1.817E-02,5.337E-02,9,"IL-18R1, Osteopontin, PKC, IL-6, Angiotensinogen, Fyn, beta-MHC, Angiotensin II, RGS2",
480,Immune response_Gastrin in inflammatory response,68,1.845E-02,5.409E-02,1.845E-02,5.409E-02,12,"COX-2 (PTGS2), GRO-2, PI3K cat class IA, PKC-alpha, IL-8, EGFR, MEF2C, PAI2, MEF2, AKT(PKB), G-protein alpha-q/11, c-Src",
481,SLE genetic marker-specific pathways in antigen-presenting cells (APC),84,1.850E-02,5.412E-02,1.850E-02,5.412E-02,14,"IL-1 beta, IL-1 alpha, ICAM1, STAT4, IFN-alpha, TLR4, TLR7, iC3b, WDFY4, Fc gamma RII alpha, KLRK1 (NKG2D), A20, IFN-beta, TNF-alpha",
482,Nociception_Nociceptin receptor signaling,76,1.859E-02,5.427E-02,1.859E-02,5.427E-02,13,"cPKC (conventional), G-protein alpha-15, PKC, PKC-alpha, Kir3.4, cPLA2, G-protein alpha-i family, Adenylate cyclase, Nociceptin, Prepronociceptin, c-Src, Actin, Cofilin",
483,WNT signaling in invasive-type melanoma cells,38,1.886E-02,5.458E-02,1.886E-02,5.458E-02,8,"cPKC (conventional), SFRP3 (FRZB1), PKC, CD44, FZD5, MMP-2, TLR3, Vimentin",
484,Role of Endothelin-1 in inflammation and vasoconstriction in Sickle cell disease,38,1.886E-02,5.458E-02,1.886E-02,5.458E-02,8,"PI3K cat class IA, CCL2, PLGF, PKC-alpha, IL-8, AKT(PKB), Endothelin-3, EDNRA",
485,NETosis in SLE,31,1.893E-02,5.458E-02,1.893E-02,5.458E-02,7,"IL-1 beta, PKC, IL-18, IFN-alpha, TLR7, Fc gamma RII alpha, Alpha-defensin",
486,Role of inhibition of WNT signaling in the progression of lung cancer,31,1.893E-02,5.458E-02,1.893E-02,5.458E-02,7,"N-cadherin, WNT7A, FZD9, Vimentin, Axin, MMP-9, Frizzled",
487,Development_Dopamine-induced transactivation of EGFR in SVZ neural stem cells,31,1.893E-02,5.458E-02,1.893E-02,5.458E-02,7,"PKC, ADAM12, EGFR, G-protein alpha-i family, TGF-alpha, c-Src, PAX6",
488,Alternative complement cascade disruption in age-related macular degeneration,31,1.893E-02,5.458E-02,1.893E-02,5.458E-02,7,"CRP, C3, Factor I, C3b, Factor H, iC3b, C3a",
489,FGF2 in multiple myeloma,18,1.927E-02,5.532E-02,1.927E-02,5.532E-02,5,"PI3K cat class IA, Heparanase 1, IL-6, FGF2, AKT(PKB)",
490,Rb proteins signaling in multiple myeloma,18,1.927E-02,5.532E-02,1.927E-02,5.532E-02,5,"Cyclin E, p15, IL-6, p16INK4, CDK6",
491,Chemotaxis_CCR1 signaling,53,1.947E-02,5.558E-02,1.947E-02,5.558E-02,10,"G-protein alpha-15, IL-8, cPLA2, G-protein alpha-i family, Adenylate cyclase, IL-6, PI3K reg class IB (p101), c-Src, MMP-9, CCL7",
492,Notch signaling in breast cancer,53,1.947E-02,5.558E-02,1.947E-02,5.558E-02,10,"NOTCH4 (ICD4), HEY1, HES5, CD44, SLUG, EGFR, NOTCH4, Cyclin A, Jagged1, PLAU (UPA)",
493,Signal transduction_CXCR4 signaling via MAPKs cascades,53,1.947E-02,5.558E-02,1.947E-02,5.558E-02,10,"CD69, PAK, ZAP70, CD3, CD3 zeta, G-protein alpha-i family, IL-6, CTGF, GAD1, c-Src",
494,Development_c-Kit ligand signaling pathway during hemopoiesis,61,2.022E-02,5.748E-02,2.022E-02,5.748E-02,11,"PI3K cat class IA, PLGF, PKC-alpha, Lyn, SLUG, GRAP, STAT5, Fyn, AKT(PKB), GRAP2, MMP-9",
495,Immune response_IL-9 signaling pathway,61,2.022E-02,5.748E-02,2.022E-02,5.748E-02,11,"PI3K cat class IA, MC-CPA, VCAM1, IRS-2, CCL2, STAT5, Eotaxin, AKT(PKB), Granzyme A, Pim-1, CCL7",
496,Mucin expression in CF airways,69,2.055E-02,5.813E-02,2.055E-02,5.813E-02,12,"COX-2 (PTGS2), PGE2R2, IL-1 beta, PI3K cat class IA, PKC-theta, PKC-alpha, EGFR, PGF2aR, TGF-alpha, AKT(PKB), G-protein alpha-q/11, c-Src",
497,Immune response_CD16 signaling in NK cells,69,2.055E-02,5.813E-02,2.055E-02,5.813E-02,12,"Syk, PI3K cat class IA, PKC-theta, ZAP70, CD3 zeta, GM-CSF, Actin cytoskeletal, CD94, FasL(TNFSF6), PLA2, LAT, TNF-alpha",
498,Cell adhesion_Integrin inside-out signaling in neutrophils,77,2.057E-02,5.813E-02,2.057E-02,5.813E-02,13,"Syk, GRO-1, iNOS, ITGB2, ICAM1, CD44, IL-8, Lyn, G-protein alpha-i family, FYB1, PI3K reg class IB (p101), P-selectin, FPR",
499,Immune response_Naive CD4+ T cell differentiation,46,2.083E-02,5.837E-02,2.083E-02,5.837E-02,9,"IL-1 beta, MHC class II, RUNX3, IL-18, STAT4, IL-17F, T-bet, IL-6, TNF-alpha",
500,Immune response_Inhibitory action of Lipoxins on pro-inflammatory TNF-alpha signaling,46,2.083E-02,5.837E-02,2.083E-02,5.837E-02,9,"FPRL1, IL-1 beta, TNF-R2, PI3K cat class IA, IL-8, Cyclin E, IL-6, AKT(PKB), TNF-alpha",
501,Nociception_Expression and role of Nociceptin in immune system,46,2.083E-02,5.837E-02,2.083E-02,5.837E-02,9,"IL-1 beta, CCL2, TLR4, Nociceptin, LIF, Prepronociceptin, IL-6, NT-3, TNF-alpha",
502,Transcription_Androgen Receptor nuclear signaling,46,2.083E-02,5.837E-02,2.083E-02,5.837E-02,9,"WNT, TGF-beta receptor type II, EGFR, MMP-2, IL-6, PAK6, AKT(PKB), HIC5, Frizzled",
503,Development_Trophectoderm differentiation,25,2.180E-02,6.075E-02,2.180E-02,6.075E-02,6,"P-cadherin, Oct-3/4, CDX2, BMP4, CRIPTO, HAND1",
504,Immune response_IL-2 signaling via JAK/ STAT,25,2.180E-02,6.075E-02,2.180E-02,6.075E-02,6,"Syk, STAT5A, STAT4, STAT5, IL-2R alpha chain, Perforin",
505,Gamma-secretase regulation of gastrointestinal epithelial cell development,25,2.180E-02,6.075E-02,2.180E-02,6.075E-02,6,"HEY1, p57, PAX4, NeuroD1, Jagged1, PAX6",
506,Dysregulation of indirect glucose-induced inhibition of Glucagon secretion from alpha-cells in type 2 diabetes ,54,2.202E-02,6.111E-02,2.202E-02,6.111E-02,10,"Glucagon, PI3K cat class IA, GABA-A receptor, IRS-2, GLP-1 (7-36) amide, GABA-A receptor alpha-1 subunit, GLP-1 (7-37), GIP, Proglucagon, PAX6",
507,Membrane-bound ESR1: interaction with G-proteins signaling,54,2.202E-02,6.111E-02,2.202E-02,6.111E-02,10,"ADAM12, PKC-alpha, EGFR, G-protein alpha-i family, Adenylate cyclase, MMP-14, MMP-2, Caveolin-1, c-Src, MMP-9",
508,EML4/ALK fusion protein in nonsmoking-related lung cancer ,32,2.239E-02,6.152E-02,2.239E-02,6.152E-02,7,"PI3K cat class IA, B-Raf, IRS-2, EGFR, ALK, AKT(PKB), c-Src",
509,The role of KEAP1/NRF2 pathway in skin sensitization,32,2.239E-02,6.152E-02,2.239E-02,6.152E-02,7,"IL-1 beta, TNF-R2, IL-18, IL-8, TLR4, Caspase-1, TNF-alpha",
510,Cytoskeleton remodeling_Reverse signaling by Ephrin-B,32,2.239E-02,6.152E-02,2.239E-02,6.152E-02,7,"F-Actin, G-protein alpha-i family, PINCH-2, Actin cytoskeletal, c-Src, Ephrin-B receptors, Axin",
511,Hedgehog signaling in pancreatic cancer,32,2.239E-02,6.152E-02,2.239E-02,6.152E-02,7,"IL-1 beta, B-Raf, PTCH1, GLI-1, MMP-9, GLI-2, TNF-alpha",
512,Development_H3K4 demethylases in stem cell maintenance,32,2.239E-02,6.152E-02,2.239E-02,6.152E-02,7,"ACM4, TLX, HOXA1, SCN2A, HOXA7, SCN3A, HOXA5",
513,Mechanisms of drug resistance in SCLC,70,2.283E-02,6.249E-02,2.283E-02,6.249E-02,12,"ITGB1, Osteopontin, PI3K cat class IA, VCAM1, B-Raf, alpha-4/beta-1 integrin, alpha-5/beta-1 integrin, FGF2, AKT(PKB), Collagen IV, Fibronectin, MDR1",
514,Immune response_IL-4-responsive genes in type 2 immunity,70,2.283E-02,6.249E-02,2.283E-02,6.249E-02,12,"COX-2 (PTGS2), VCAM1, Eotaxin-2, CCL2, Eotaxin-3, ACTA2, COL1A2, Eotaxin, AKT(PKB), Fibronectin, P-selectin, CCL7",
515,Immune response_PGE2 in immune and neuroendocrine system interactions,47,2.375E-02,6.476E-02,2.375E-02,6.476E-02,9,"COX-2 (PTGS2), IL-1 beta, GABA-A receptor, P/Q-type calcium channel alpha-1A subunit, cPLA2, G-protein alpha-i family, TLR4, PGF2aR, TNF-alpha",
516,Immune response_KLRK1 (NKG2D) signaling pathway,47,2.375E-02,6.476E-02,2.375E-02,6.476E-02,9,"Syk, PI3K cat class IA, ZAP70, GM-CSF, DAP10, STAT5, Fyn, AKT(PKB), KLRK1 (NKG2D)",
517,Development_NOTCH-induced EMT,19,2.424E-02,6.584E-02,2.424E-02,6.584E-02,5,"HEY1, SLUG, NOTCH4, Fibronectin, Jagged1",
518,Cytoskeleton remodeling_Alpha-1A adrenergic receptor-dependent inhibition of PI3K,19,2.424E-02,6.584E-02,2.424E-02,6.584E-02,5,"MRLC, Myosin II, AKT(PKB), MELC, MLCK",
519,Immune response_Platelet activating factor/ PTAFR pathway signaling,55,2.480E-02,6.710E-02,2.480E-02,6.710E-02,10,"IL-1 beta, PI3K cat class IA, CCL2, G-protein alpha-i family, Adenylate cyclase, F-Actin cytoskeleton, STAT5, AKT(PKB), c-Src, MMP-9",
520,Proteases and EGFR-induced mucin synthesis in normal and asthmatic epithelium,55,2.480E-02,6.710E-02,2.480E-02,6.710E-02,10,"ICAM1, CD44, PKC-alpha, EGFR, GM-CSF, TGF-alpha, G-protein alpha-q/11, Kallikrein 1, HNF3-beta, TNF-alpha",
521,Stem cells_NOTCH1-induced self-renewal of glioblastoma stem cells,40,2.526E-02,6.775E-02,2.526E-02,6.775E-02,8,"HEY1, HES5, BMP4, EGFR, SMAD9 (SMAD8), Nestin, Jagged1, BMP2",
522,Development_Role of Activin A in cell differentiation and proliferation,40,2.526E-02,6.775E-02,2.526E-02,6.775E-02,8,"Activin A, Oct-3/4, Lefty-1, Adenylate cyclase, SF1, p15, Lefty-2, CYP11A1",
523,Development_SLIT-ROBO1 signaling,40,2.526E-02,6.775E-02,2.526E-02,6.775E-02,8,"PI3K cat class IA, F-Actin cytoskeleton, SLIT2, SLIT3, Myosin II, Fyn, AKT(PKB), Cofilin",
524,The role of UV radiation in melanoma development,40,2.526E-02,6.775E-02,2.526E-02,6.775E-02,8,"B-Raf, EGFR, FasR(CD95), TGF-alpha, FasL(TNFSF6), AKT(PKB), p16INK4, TNF-alpha",
525,Blood coagulation_GPCRs in platelet aggregation,71,2.528E-02,6.775E-02,2.528E-02,6.775E-02,12,"PKC-alpha, ITGB3, G-protein alpha-i family, Adenylate cyclase, MRLC, HTR2A, Myosin II, Actin cytoskeletal, PAR1, MELC, PI3K reg class IB (p101), Cofilin",
526,Nicotine / nAChR alpha-3/nAChR beta-2 signaling in NSCLC,26,2.623E-02,6.996E-02,2.623E-02,6.996E-02,6,"PKC-alpha, nAChR alpha-3, AKT(PKB), nAChR beta-2, c-Src, PI3K cat class IA (p110-delta)",
527,Downregulation of MITF in melanoma,26,2.623E-02,6.996E-02,2.623E-02,6.996E-02,6,"IL-1 beta, SOX10, IL-6, c-Src, Cofilin, GLI-2",
528,Development_Role of PKR1 and ILK in cardiac progenitor cells,33,2.625E-02,6.996E-02,2.625E-02,6.996E-02,7,"ITGB1, PI3K cat class IA, alpha-4/beta-1 integrin, Tcf(Lef), AKT(PKB), G-protein alpha-q/11, Fibronectin",
529,Immune response_NF-AT signaling and leukocyte interactions,48,2.696E-02,7.156E-02,2.696E-02,7.156E-02,9,"COX-2 (PTGS2), MHC class II, ZAP70, CD3, cPLA2, FasR(CD95), FasL(TNFSF6), Eotaxin, LAT",
530,Development_Role of Thyroid hormone in regulation of oligodendrocyte differentiation,48,2.696E-02,7.156E-02,2.696E-02,7.156E-02,9,"NGF, UGT8, Myelin basic protein, p14ARF, p15, OATP-F, PDGF-R-alpha, AKT(PKB), ID4",
531,Regulation of metabolism_Bile acids regulation of glucose and lipid metabolism via FXR,41,2.897E-02,7.604E-02,2.897E-02,7.604E-02,8,"PPCKC, CYP7A1, MTP, APOC2, AKT(PKB), HNF4-alpha, HNF3-beta, HNF3",
532,Development_Neurotrophin family signaling,41,2.897E-02,7.604E-02,2.897E-02,7.604E-02,8,"NGF, NGFR(TNFRSF16), TrkA, PI3K cat class IA, B-Raf, AKT(PKB), TrkB, NT-3",
533,Regulation of beta-adrenergic receptors signaling in pancreatic cancer,41,2.897E-02,7.604E-02,2.897E-02,7.604E-02,8,"COX-2 (PTGS2), nAChR alpha-7, cPLA2, EGFR, G-protein alpha-i family, Adenylate cyclase, IL-6, Beta-2 adrenergic receptor",
534,Development_VEGF-family signaling,41,2.897E-02,7.604E-02,2.897E-02,7.604E-02,8,"Neuropilin-2, PI3K cat class IA, PLGF, PKC-alpha, Neuropilin-1, alpha-5/beta-1 integrin, AKT(PKB), Fibronectin",
535,Development_Regulation of lung epithelial progenitor cell differentiation,41,2.897E-02,7.604E-02,2.897E-02,7.604E-02,8,"Tcf(Lef), WNT, BMP4, SMAD9 (SMAD8), Jagged1, Frizzled, Podoplanin, ERM",
536,Cytoskeleton remodeling_Role of PKA in cytoskeleton reorganisation,41,2.897E-02,7.604E-02,2.897E-02,7.604E-02,8,"alpha-4/beta-1 integrin, Adenylate cyclase, F-Actin cytoskeleton, Actin cytoskeletal, Beta adducin, MELC, MLCK, Cofilin",
537,Development_Negative regulation of WNT/Beta-catenin signaling in the nucleus,89,2.924E-02,7.661E-02,2.924E-02,7.661E-02,14,"RUNX3, Oct-3/4, Tcf(Lef), WNT, CDX2, SOX17, PAX7, TLE, HIC5, Axin, TCF7 (TCF1), CDX1, Frizzled, DACT1",
538,Neurophysiological process_HTR2A signaling in the nervous system,49,3.046E-02,7.932E-02,3.046E-02,7.932E-02,9,"cPKC (conventional), iNOS, PKC, GABA-A receptor, HTR2A, AKT(PKB), G-protein alpha-q/11, Caveolin-1, SFK",
539,Development_PEDF signaling,49,3.046E-02,7.932E-02,3.046E-02,7.932E-02,9,"IL-1 beta, NGF, c-IAP2, PI3K cat class IA, Fra-1, IL-6, BFL1, AKT(PKB), TNF-alpha",
540,Mechanism of action of CCR4 antagonists in asthma and atopic dermatitis (Variant 1),34,3.056E-02,7.932E-02,3.056E-02,7.932E-02,7,"ITGB1, VCAM1, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, c-Src",
541,CCR4-dependent immune cell chemotaxis in asthma and atopic dermatitis ,34,3.056E-02,7.932E-02,3.056E-02,7.932E-02,7,"ITGB1, VCAM1, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, c-Src",
542,Chemotaxis_CCR4-induced chemotaxis of immune cells,34,3.056E-02,7.932E-02,3.056E-02,7.932E-02,7,"ITGB1, VCAM1, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, c-Src",
543,Skeletal muscle atrophy in COPD,57,3.109E-02,7.985E-02,3.109E-02,7.985E-02,10,"KCRM, iNOS, MLC2, Beta TnTF, PPARGC1 (PGC1-alpha), AKT(PKB), beta-MHC, Vimentin, MyHC, TNF-alpha",
544,Gamma-Secretase regulation of neuronal cell development and function,57,3.109E-02,7.985E-02,3.109E-02,7.985E-02,10,"N-cadherin, NGF, NGFR (ICD), NGFR(TNFRSF16), NGFR (CTF), S100B, Transgelin, ACTA2, N-cadherin (CTF1), N-cadherin (CTF2)",
545,MicroRNAs in melanoma,57,3.109E-02,7.985E-02,3.109E-02,7.985E-02,10,"Osteopontin, Cadherin 11, RUNX3, ITGB3, ETS1, TGF-beta receptor type II, BMP4, FGF2, Calponin-1, HGF receptor (Met)",
546,Signal transduction_Angiotensin II signaling via Beta-arrestin,57,3.109E-02,7.985E-02,3.109E-02,7.985E-02,10,"TRPC3, EGFR, MRLC, DGK, AKT(PKB), Angiotensin II, MYLK1, c-Src, MLCK, Cofilin",
547,Development_Generation of pancreatic beta-cells from induced pluripotent stem cells,27,3.122E-02,7.985E-02,3.122E-02,7.985E-02,6,"Activin A, Oct-3/4, SOX17, FGF2, NeuroD1, HNF3-beta",
548,Inhibition of TGF-beta 1 signaling in early colorectal cancer,27,3.122E-02,7.985E-02,3.122E-02,7.985E-02,6,"PI3K cat class IA, TGF-beta receptor type II, MAP2, MMP-2, AKT(PKB), MMP-9",
549,Neurophysiological process_GABA-A receptor life cycle,27,3.122E-02,7.985E-02,3.122E-02,7.985E-02,6,"GABA-A receptor, PLCL2, GABA-A receptor alpha-1 subunit, Dynamin, Dynein 1, cytoplasmic, intermediate chains, c-Src",
550,Th2-cytokines and IFN-mediated regulation of airway smooth muscle contraction,27,3.122E-02,7.985E-02,3.122E-02,7.985E-02,6,"Histamine H1 receptor, IRS-2, CD38, IFN-beta, PI3K cat class IA (p110-delta), TNF-alpha",
551,Transport_ACM3 signaling in salivary glands,42,3.304E-02,8.375E-02,3.304E-02,8.375E-02,8,"G-protein alpha-i1, Adenylate cyclase type VIII, PKC, G-protein alpha-i family, G-protein alpha-q/11, nNOS, MLCK, ACM3",
552,GLP-1 in inhibition of beta cell proliferation and function in type 2 diabetes,42,3.304E-02,8.375E-02,3.304E-02,8.375E-02,8,"B-Raf, IRS-2, EGFR, GLP-1 (7-36) amide, GLP-1 (7-37), GLP-1 receptor, c-Src, HNF3-beta",
553,Chemoresistance pathways mediated by constitutive activation of PI3K pathway and BCL-2 in small cell lung cancer,42,3.304E-02,8.375E-02,3.304E-02,8.375E-02,8,"BMX, PI3K cat class IA, LAMC2, alpha-5/beta-1 integrin, FGF2, AKT(PKB), Collagen IV, Fibronectin",
554,Signal transduction_Angiotensin II/ AGTR1 signaling via TGF-beta 1 and SMADs,42,3.304E-02,8.375E-02,3.304E-02,8.375E-02,8,"IL-1 beta, TGF-beta receptor type II, CTGF, AKT(PKB), Angiotensin II, OSF-2, Caspase-1, HNF4-alpha",
555,"Oxidative stress_Activation of NOX1, NOX5, DUOX1 and DUOX2 NADPH Oxidases",42,3.304E-02,8.375E-02,3.304E-02,8.375E-02,8,"cPKC (conventional), PKC, PKC-alpha, DUOXA2, DUOX2, Rac2, c-Src, DUOXA1",
556,Signal transduction_HTR2A signaling outside the nervous system,74,3.380E-02,8.537E-02,3.380E-02,8.537E-02,12,"COX-2 (PTGS2), cPKC (conventional), PI3K cat class IA, PKC, EGFR, G-protein alpha-i family, Adenylate cyclase, HTR2A, AKT(PKB), G-protein alpha-q/11, Caveolin-1, c-Src",
557,Neurophysiological process_Regulation of intrinsic membrane properties and excitability of cortical pyramidal neurons,74,3.380E-02,8.537E-02,3.380E-02,8.537E-02,12,"TRPC5, cPKC (conventional), PKC, HTR2C (HTR1C), G-protein alpha-i family, Adenylate cyclase, HTR2A, SCN2A, KCNQ2, G-protein alpha-q/11, TrkB, ACM3",
558,Pro-inflammatory action of Gastrin in gastric cancer,50,3.426E-02,8.608E-02,3.426E-02,8.608E-02,9,"COX-2 (PTGS2), GRO-2, PI3K cat class IA, IL-8, EGFR, PAI2, AKT(PKB), G-protein alpha-q/11, c-Src",
559,Proteases and EGFR-activated mucin production in airway epithelium in COPD,50,3.426E-02,8.608E-02,3.426E-02,8.608E-02,9,"PI3K cat class IA, CD44, EGFR, PPARGC1 (PGC1-alpha), TGF-alpha, AKT(PKB), Kallikrein 1, MMP-9, TNF-alpha",
560,HBV-dependent NF-kB and PI3K/AKT pathways leading to HCC,50,3.426E-02,8.608E-02,3.426E-02,8.608E-02,9,"PI3K cat class IA, iNOS, PKC-alpha, A2M, Cyclin E, AKT(PKB), c-Src, MMP-9, PLAU (UPA)",
561,Immune response_IL-15 signaling,58,3.463E-02,8.670E-02,3.463E-02,8.670E-02,10,"IL-15, PI3K cat class IA, IL-15RA, UFO, IL-8, ETS1, IL-6, sIL-15RA, AKT(PKB), c-Src",
562,"Immune response_TLR5, TLR7, TLR8 and TLR9 signaling pathways",58,3.463E-02,8.670E-02,3.463E-02,8.670E-02,10,"IL-1 beta, PI3K cat class IA, IFN-alpha, IL-8, IRAK2, IL-6, TLR7, AKT(PKB), IFN-beta, TNF-alpha",
563,Neurophysiological process_Ephrin-B receptors in dendritic spine morphogenesis and synaptogenesis,35,3.531E-02,8.823E-02,3.531E-02,8.823E-02,7,"GABA-A receptor, Ephrin-B receptor 2, Actin cytoskeletal, Fyn, Ephrin-B receptors, SHANK, Syndecan-2",
564,Main chemotherapy drugs and their action in SCLC cells,100,3.594E-02,8.967E-02,3.594E-02,8.967E-02,15,"CCL2, PKC-alpha, RANKL(TNFSF11), IL-8, Cyclin E, EGFR, Cyclin A, Apo-2L(TNFSF10), AKT(PKB), Caveolin-1, c-Src, PLAU (UPA), MDR1, RANK(TNFRSF11A), TNF-alpha",
565,Development_Generation of pancreatic beta-cells from embryonic stem cells (early stages),21,3.648E-02,9.069E-02,3.648E-02,9.069E-02,5,"Activin A, Oct-3/4, SOX17, HNF4-alpha, HNF3-beta",
566,Role of ZNF202 in regulation of expression of genes involved in atherosclerosis,21,3.648E-02,9.069E-02,3.648E-02,9.069E-02,5,"APOA4, Beta-3 adrenergic receptor, HDL proteins, HNF4-alpha, LPL",
567,Immune response_Innate immune response to RNA viral infection,28,3.678E-02,9.110E-02,3.678E-02,9.110E-02,6,"Caspase-10, IFN-alpha, IL-8, TLR7, TLR3, IFN-beta",
568,Regulation of Beta-catenin activity  in melanoma,28,3.678E-02,9.110E-02,3.678E-02,9.110E-02,6,"Osteopontin, WISP1, MMP-2, AKT(PKB), p16INK4, MMP-9",
569,Regulation of proinflammatory cytokine production by Th2 cells in asthma,43,3.748E-02,9.219E-02,3.748E-02,9.219E-02,8,"IL-15, MHC class II, CD3, IL-33, STAT5, TSLP, TNF-alpha, TSLPR",
570,ESR1 (membrane) 36 kDa isoform signaling in breast cancer,43,3.748E-02,9.219E-02,3.748E-02,9.219E-02,8,"STAT5A, PI3K cat class IA, PKC-alpha, RANKL(TNFSF11), EGFR, AL1A1, AKT(PKB), c-Src",
571,Development_S1P3 receptor signaling pathway,43,3.748E-02,9.219E-02,3.748E-02,9.219E-02,8,"PI3K cat class IA, CD44, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), PDGF receptor, PI3K reg class IB (p101), c-Src",
572,Regulation of immune cell differentiation by Notch signaling,43,3.748E-02,9.219E-02,3.748E-02,9.219E-02,8,"NOTCH4 (ICD4), PI3K cat class IA, IFI16, T-bet, NOTCH4, AKT(PKB), Jagged1, ADAM19",
573,Immune response_Antigen presentation by MHC class II,118,3.769E-02,9.256E-02,3.769E-02,9.256E-02,17,"MHC class II alpha chain, Syk, Dectin-1, MHC class II, PI3K cat class IA, Langerin, PKC, PKC-alpha, TLR4, LY75, MHC class II beta chain, ARL14, Dynein 1, cytoplasmic, intermediate chains, Cathepsin S, Cathepsin V, TAP, TLR2",
574,Ligand-independent activation of Androgen receptor in Prostate Cancer,67,3.793E-02,9.297E-02,3.793E-02,9.297E-02,11,"STAT5A, PI3K cat class IA, B-Raf, Tcf(Lef), EGFR, FGF1, FGF2, AKT(PKB), Frizzled, Prolactin, IBP3",
575,Neurophysiological process_GABAergic neurotransmission,51,3.838E-02,9.357E-02,3.838E-02,9.357E-02,9,"SLC32A1, GABA-A receptor, GAD2, GLSK, G-protein alpha-i family, ALDR, GAD1, GAT1, SLC7A7",
576,Signal transduction_NF-kB activation pathways,51,3.838E-02,9.357E-02,3.838E-02,9.357E-02,9,"IL-1 beta, c-IAP2, IL-1 alpha, Pellino 1, Pellino 2, TLR4, IRAK2, TLR2, TNF-alpha",
577,Neurophysiological process_Constitutive and activity-dependent synaptic AMPA receptor delivery,59,3.844E-02,9.357E-02,3.844E-02,9.357E-02,10,"Neuroligin 1, PKC, PKC-alpha, Dynamin-3, GluR1, Actin cytoskeletal, Complexin, nNOS, SHANK, DLGAP1 (GKAP)",
578,Inhibition of apoptosis in pancreatic cancer,59,3.844E-02,9.357E-02,3.844E-02,9.357E-02,10,"COX-2 (PTGS2), PI3K cat class IA, PKR2, EGFR, G-protein alpha-i family, Neuropilin-1, IL-6, Mucin 4, STAT5, AKT(PKB)",
579,Immune response_B cell antigen receptor (BCR) pathway,110,3.975E-02,9.659E-02,3.975E-02,9.659E-02,16,"Syk, VCAM1, B-Raf, CalDAG-GEFIII, alpha-4/beta-1 integrin, CKLFSF7, ICAM1, ETS1, Lyn, CIN85, Actin cytoskeletal, AKT(PKB), Fibronectin, PI3K cat class IA (p110-delta), CARD11, CDK6",
580,Development_Positive regulation of WNT/Beta-catenin signaling in the cytoplasm,76,4.050E-02,9.712E-02,4.050E-02,9.712E-02,12,"COX-2 (PTGS2), ITGB1, IRS-2, NKD1, Tcf(Lef), WNT, RIPK4, AKT(PKB), NKD2, Axin, Frizzled, DACT1",
581,Gamma-secretase proteolytic targets,76,4.050E-02,9.712E-02,4.050E-02,9.712E-02,12,"NOTCH4 (ICD4), N-cadherin, NGFR (ICD), NGFR(TNFRSF16), NGFR (CTF), CD44, CD44 soluble, CD44 (EXT), NOTCH4, N-cadherin (CTF1), N-cadherin (CTF2), CD44 (ICD)",
582,Development_Beta adrenergic receptors in brown adipocyte differentiation,36,4.052E-02,9.712E-02,4.052E-02,9.712E-02,7,"EGR2 (Krox20), Beta-3 adrenergic receptor, Adenylate cyclase, FOXC2, PPARGC1 (PGC1-alpha), Beta-2 adrenergic receptor, LPL",
583,IGF-1 signaling in pancreatic cancer,36,4.052E-02,9.712E-02,4.052E-02,9.712E-02,7,"COX-2 (PTGS2), PI3K cat class IA, NUAK1, IRS-2, MMP-14, MMP-2, MMP-9",
584,Cigarette smoke components TCDD and Benzo[a]pyrene and receptor AHR signaling in lung epithelial cells,36,4.052E-02,9.712E-02,4.052E-02,9.712E-02,7,"COX-2 (PTGS2), IL-1 beta, CYP1A1, CCL2, TGF-beta receptor type II, TGF-alpha, TNF-alpha",
585,Inhibition of apoptosis in multiple myeloma,36,4.052E-02,9.712E-02,4.052E-02,9.712E-02,7,"c-IAP2, TLR4, FasR(CD95), IL-6, FasL(TNFSF6), Apo-2L(TNFSF10), Jagged1",
586,Development_SSTR2 in regulation of cell proliferation,36,4.052E-02,9.712E-02,4.052E-02,9.712E-02,7,"PI3K cat class IA, B-Raf, Cyclin E, G-protein alpha-i family, AKT(PKB), c-Src, nNOS",
587,"Development_Lipoxin inhibitory action on PDGF, EGF and LTD4 signaling",36,4.052E-02,9.712E-02,4.052E-02,9.712E-02,7,"FPRL1, EGFR, G-protein alpha-i family, Adenylate cyclase, G-protein alpha-q/11, c-Src, PDGF-R-beta",
588,Development_VEGF signaling via VEGFR2 - generic cascades,93,4.067E-02,9.731E-02,4.067E-02,9.731E-02,14,"COX-2 (PTGS2), PI3K cat class IA, iNOS, PKC, CCL2, PKC-alpha, PLAUR (uPAR), Actin cytoskeletal, Fyn, AKT(PKB), c-Src, TSAD, PLAU (UPA), MLCK",
589,IGF signaling in lung cancer,44,4.230E-02,1.005E-01,4.230E-02,1.005E-01,8,"PI3K cat class IA, IRS-2, MMP-2, AKT(PKB), MMP-9, IBP, PLAU (UPA), IBP3",
590,"Development_Activation of Erk by ACM1, ACM3 and ACM5",44,4.230E-02,1.005E-01,4.230E-02,1.005E-01,8,"B-Raf, PKC-alpha, cPLA2, EGFR, Cyr61, TGF-alpha, c-Src, ACM3",
591,Influence of smoking on activation of EGFR signaling in lung cancer cells,44,4.230E-02,1.005E-01,4.230E-02,1.005E-01,8,"B-Raf, Fra-1, Epiregulin, EGFR, Adenylate cyclase, MMP-2, c-Src, MMP-9",
592,Development_S1P1 signaling pathway,44,4.230E-02,1.005E-01,4.230E-02,1.005E-01,8,"CD69, G-protein alpha-i1, S1P1 receptor, CD44, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), c-Src",
593,Development_FGF-family signaling,52,4.282E-02,1.007E-01,4.282E-02,1.007E-01,9,"PI3K cat class IA, FGF3, PKC-alpha, FGF1, FGF2, AKT(PKB), FGF8, FGF9, FGF19",
594,Signal transduction_Additional pathways of NF-kB activation (in the cytoplasm),52,4.282E-02,1.007E-01,4.282E-02,1.007E-01,9,"PI3K cat class IA, PKC-theta, PKC-alpha, Adenylate cyclase, AKT(PKB), PI3K reg class IB (p101), c-Src, Pim-1, CDK6",
595,Glucagon-induced glucose upregulation in type 2 diabetes in liver ,52,4.282E-02,1.007E-01,4.282E-02,1.007E-01,9,"PPCKC, Glucagon, iNOS, GYS2, G-protein alpha-i family, Adenylate cyclase, PPARGC1 (PGC1-alpha), G-protein alpha-q/11, HNF4-alpha",
596,Signal transduction_Adenosine A2A receptor signaling pathway,52,4.282E-02,1.007E-01,4.282E-02,1.007E-01,9,"TrkA, Osteopontin, Adenylate cyclase, AKT(PKB), TrkB, SFK, c-Src, G-protein alpha-olf, Collagen III",
597,Immune response_T cell subsets: cell surface markers,52,4.282E-02,1.007E-01,4.282E-02,1.007E-01,9,"IL-15RA, IL7RA, TCR beta subunit, CD44, CD3, CTLA-4, CD94, IL-2R alpha chain, IL-12RB2",
598,Pro-oncogenic action of PTHrP in breast cancer,29,4.294E-02,1.007E-01,4.294E-02,1.007E-01,6,"ITGB1, MMP-13, PKC-alpha, PTHrP, G-protein alpha-q/11, ITGA5",
599,Suppression of TGF-beta signaling in pancreatic cancer,29,4.294E-02,1.007E-01,4.294E-02,1.007E-01,6,"Biglycan, ETS1, TGF-beta receptor type II, p15, MMP-9, PLAU (UPA)",
600,Abnormalities in cell cycle in SCLC,29,4.294E-02,1.007E-01,4.294E-02,1.007E-01,6,"p14ARF, Cyclin E, p15, Cyclin A, p16INK4, CDK6",
601,Chemotaxis_Lysophosphatidic acid signaling via GPCRs,129,4.361E-02,1.017E-01,4.361E-02,1.017E-01,18,"cPKC (conventional), PAK, PKC, Tcf(Lef), IL-8, EGFR, G-protein alpha-i family, F-Actin cytoskeleton, FasR(CD95), Cyr61, Rho GTPase, Actin cytoskeletal, TAZ, CTGF, AKT(PKB), G-protein alpha-q/11, c-Src, Cofilin",
602,PXR signaling via cross-talk / Rodent version,22,4.380E-02,1.017E-01,4.380E-02,1.017E-01,5,"PPCKC, PPARGC1 (PGC1-alpha), CYP7A1, HNF4-alpha, HNF3-beta",
603,Differences between Langerhans cells and dermal dendritic cells in allergic contact dermatitis,22,4.380E-02,1.017E-01,4.380E-02,1.017E-01,5,"MHC class II, PD-1, ICOS, PD-L1, TNF-alpha",
604,Immune response_Oncostatin M signaling via JAK-Stat,22,4.380E-02,1.017E-01,4.380E-02,1.017E-01,5,"CCL2, ACTA2, STAT5, OSMR, Eotaxin",
605,PXR signaling via cross-talk / Human Version,22,4.380E-02,1.017E-01,4.380E-02,1.017E-01,5,"PPCKC, PPARGC1 (PGC1-alpha), CYP7A1, HNF4-alpha, HNF3-beta",
606,Development_H3K9 demethylases in pluripotency maintenance of stem cells,22,4.380E-02,1.017E-01,4.380E-02,1.017E-01,5,"Oct-3/4, CDX2, MSX1, AKT(PKB), LBP9",
607,Apoptosis and survival_NGF/ TrkA PI3K-mediated signaling,77,4.418E-02,1.024E-01,4.418E-02,1.024E-01,12,"NGF, TrkA, PI3K cat class IA, MSN (moesin), CLCN4, MRLC, Myosin II, Actin cytoskeletal, AKT(PKB), c-Src, ARAP3, Cofilin",
608,Immune response_OX40L/ OX40 signaling pathway,69,4.569E-02,1.057E-01,4.569E-02,1.057E-01,11,"PI3K cat class IA, PKC-theta, CD3, T-bet, BFL1, OX40(TNFRSF4), AKT(PKB), IL-2R alpha chain, Perforin, IL-12RB2, CARD11",
609,Down-regulation of mast cell functions through ITIM-containing inhibitory receptors in asthma,37,4.621E-02,1.064E-01,4.621E-02,1.064E-01,7,"Syk, SHPS-1, CCL2, LAIR1, Lyn, Fyn, CD200 (OX-2)",
610,A shift in alveolar macrophage phenotype in COPD,37,4.621E-02,1.064E-01,4.621E-02,1.064E-01,7,"MHC class II, iNOS, CD44, MMP-2, Matrilysin (MMP-7), AKT(PKB), MARCO",
611,Development_Delta-type opioid receptor mediated cardioprotection,37,4.621E-02,1.064E-01,4.621E-02,1.064E-01,7,"PI3K cat class IA, Metenkefalin, ADAM12, EGFR, G-protein alpha-i family, AKT(PKB), c-Src",
612,Dysregulation of direct glucose-induced inhibition of Glucagon secretion from alpha-cells in type 2 diabetes  ,53,4.760E-02,1.091E-01,4.760E-02,1.091E-01,9,"Glucagon, Kv2.2, iNOS, P/Q-type calcium channel alpha-1A subunit, CDX2, CACNA1E, NeuroD1, Proglucagon, PAX6",
613,Non-genomic signaling of ESR2 (membrane) in lung cancer cells,53,4.760E-02,1.091E-01,4.760E-02,1.091E-01,9,"nAChR alpha-7, PI3K cat class IA, EGFR, G-protein alpha-i family, Adenylate cyclase, TGF-alpha, AKT(PKB), Caveolin-1, c-Src",
614,TLRs-mediated IFN-alpha production by plasmacytoid dendritic cells in SLE,53,4.760E-02,1.091E-01,4.760E-02,1.091E-01,9,"IFN-alpha, IRAK2, TLR7, AKT(PKB), Fc gamma RII alpha, Alpha-defensin, A20, Pim-1, PI3K cat class IA (p110-delta)",
615,Signal transduction_Angiotensin II/ AGTR1 signaling via RhoA and JNK,78,4.808E-02,1.100E-01,4.808E-02,1.100E-01,12,"RECK, CCL2, TLR4, MRLC, MMP-2, CTGF, G-protein alpha-q/11, Angiotensin II, c-Src, MMP-9, MLCK, Collagen III",
616,Gamma-secretase regulation of angiogenesis,30,4.971E-02,1.130E-01,4.971E-02,1.130E-01,6,"NOTCH4 (ICD4), HEY1, Ephrin-B receptor 2, Angiopoietin 1, NOTCH4, c-Src",
617,Development_Osteopontin signaling in osteoclasts,30,4.971E-02,1.130E-01,4.971E-02,1.130E-01,6,"Syk, Osteopontin, CD44, MSN (moesin), Actin cytoskeletal, c-Src",
618,T regulatory cells in asthma,30,4.971E-02,1.130E-01,4.971E-02,1.130E-01,6,"MHC class II, CD3, TGF-beta receptor type II, PD-1, CTLA-4, ICOS",
619,Role of prenatal nicotine exposure in apoptosis and proliferation of pancreatic beta cells,30,4.971E-02,1.130E-01,4.971E-02,1.130E-01,6,"nAChR alpha-7, nAChR alpha-3, FasR(CD95), FasL(TNFSF6), nAChR beta-2, nAChR alpha-6",
620,Cytoskeleton remodeling_Substance P mediated membrane blebbing,16,5.090E-02,1.155E-01,5.090E-02,1.155E-01,4,"MRLC, Myosin II, Dynamin, MLCK",
621,Noise-induced hair cell death and spiral ganglion neuron degeneration,96,5.110E-02,1.158E-01,5.110E-02,1.158E-01,14,"COX-2 (PTGS2), IL-1 beta, TrkA, iNOS, CCL2, ERM proteins, F-Actin cytoskeleton, FasR(CD95), IL-6, TrkB, c-Src, Actin, NT-3, TNF-alpha",
622,Stem cells_MMP-14-induced COX-2 expression in glioblastoma stem cells,23,5.193E-02,1.166E-01,5.193E-02,1.166E-01,5,"COX-2 (PTGS2), cPLA2, MMP-14, MMP-2, AKT(PKB)",
623,Apoptosis and survival_Beta-2 adrenergic receptor anti-apoptotic action,23,5.193E-02,1.166E-01,5.193E-02,1.166E-01,5,"G-protein alpha-i family, Beta-2 adrenergic receptor, AKT(PKB), PI3K reg class IB (p101), Adenylate cyclase type VII",
624,FGF signaling in gastric cancer,23,5.193E-02,1.166E-01,5.193E-02,1.166E-01,5,"FGF1, FGF2, c-Src, MMP-9, PLAU (UPA)",
625,Development_Delta- and kappa-type opioid receptors signaling via beta-arrestin,23,5.193E-02,1.166E-01,5.193E-02,1.166E-01,5,"Metenkefalin, PKC, G-protein alpha-i family, Leu-enkephalin, Kappa-type opioid receptor",
626,Development_Thrombopoietin signaling via JAK-STAT pathway,23,5.193E-02,1.166E-01,5.193E-02,1.166E-01,5,"TAP1 (PSF1), STAT5A, STAT5, PAR1, Pim-1",
627,Neurogenesis_NGF/ TrkA MAPK-mediated signaling,105,5.194E-02,1.166E-01,5.194E-02,1.166E-01,15,"NGF, SHPS-1, TrkA, B-Raf, Fra-1, MEF2C, PLAUR (uPAR), SGK1, M-Ras, RASGRF1, SORBS1, RGS2, VGF, c-Src, Ephrin-A receptor 2",
628,Development_Gastrin in differentiation of the gastric mucosa,38,5.239E-02,1.170E-01,5.239E-02,1.170E-01,7,"cPKC (conventional), PKC-theta, PKC, PKC-alpha, G-protein alpha-q/11, ICRF, c-Src",
629,Cell cycle_Regulation of G1/S transition (part 1),38,5.239E-02,1.170E-01,5.239E-02,1.170E-01,7,"TGF-beta 2, Cyclin E, TGF-beta receptor type II, p15, Cyclin A, p16INK4, CDK6",
630,Insulin-like growth factor family signaling in melanoma,38,5.239E-02,1.170E-01,5.239E-02,1.170E-01,7,"PI3K cat class IA, PKC, IL-8, Cyclin E, Cyclin A, AKT(PKB), IBP3",
631,Neurophysiological process_Dynein-dynactin motor complex in axonal transport in neurons,54,5.272E-02,1.174E-01,5.272E-02,1.174E-01,9,"NGF, TrkA, PRNP, AKT(PKB), TrkB, Dynein 1, cytoplasmic, intermediate chains, DYNC1I1, Vimentin, NT-3",
632,Immune response_IFN-gamma actions on extracellular matrix and cell differentiation,54,5.272E-02,1.174E-01,5.272E-02,1.174E-01,9,"ACTA1, iNOS, IP10, ICAM1, ACTA2, MYLPF, COL1A2, MMP-9, RANK(TNFRSF11A)",
633,Cell adhesion_Role of CDK5 in cell adhesion,10,5.524E-02,1.228E-01,5.524E-02,1.228E-01,3,"ITGB1, Tcf(Lef), c-Src",
634,Development_FGF and BMP signaling in early embryonic hepatogenesis,31,5.709E-02,1.263E-01,5.709E-02,1.263E-01,6,"BMP4, FGF1, FGF2, HNF4-alpha, HNF3-beta, BMP2",
635,Mechanisms of K-RAS addiction in lung cancer cells,31,5.709E-02,1.263E-01,5.709E-02,1.263E-01,6,"Syk, IL-8, AKT(PKB), Stk33, Vimentin, TCF8",
636,Immune response_IL-23 signaling pathway,31,5.709E-02,1.263E-01,5.709E-02,1.263E-01,6,"PI3K cat class IA, STAT4, RANKL(TNFSF11), IL23A, STAT5, AKT(PKB)",
637,Chemotaxis_CCL2-induced chemotaxis,55,5.818E-02,1.281E-01,5.818E-02,1.281E-01,9,"PI3K cat class IA, CCL2, cPLA2, Lyn, G-protein alpha-i family, Actin cytoskeletal, PA24A, PI3K reg class IB (p101), c-Src",
638,Immune response_IL-16 signaling pathway,55,5.818E-02,1.281E-01,5.818E-02,1.281E-01,9,"IL-15, IL-1 beta, cPKC (conventional), PKC, IL-6, Eotaxin, AKT(PKB), IL-2R alpha chain, TNF-alpha",
639,Role of Thyroid hormone in regulation of oligodendrocyte differentiation in multiple sclerosis,55,5.818E-02,1.281E-01,5.818E-02,1.281E-01,9,"NGF, UGT8, Myelin basic protein, p14ARF, p15, OATP-F, PDGF-R-alpha, AKT(PKB), ID4",
640,Nociception_Pro-nociceptive action of Nociceptin in spinal cord at low doses,39,5.906E-02,1.287E-01,5.906E-02,1.287E-01,7,"Histamine H1 receptor, GABA-A receptor, NR2, Nociceptin, Prepronociceptin, nNOS, NR2A",
641,Role of neurotrophins in activation of p53 in major depressive disorder,39,5.906E-02,1.287E-01,5.906E-02,1.287E-01,7,"NGF, NGFR(TNFRSF16), TrkA, PI3K cat class IA, PLAT (TPA), TrkB, NT-3",
642,Immune response_HMGB1 release from the cell,39,5.906E-02,1.287E-01,5.906E-02,1.287E-01,7,"IL-1 beta, TNF-R2, PI3K cat class IA, PKC-alpha, TLR4, TLR2, TNF-alpha",
643,Signal transduction_Leptin signaling via JAK/STAT and MAPK cascade,39,5.906E-02,1.287E-01,5.906E-02,1.287E-01,7,"PPCKC, STAT5A, cPLA2, STAT5, NT/NN, MMP-9, BMP2",
644,Activation of Notch signaling in breast cancer,39,5.906E-02,1.287E-01,5.906E-02,1.287E-01,7,"p63, HEY1, Tenascin-C, NOTCH4, MAML2, Jagged1, TCF8",
645,Development_Beta-adrenergic receptor-induced regulation of ERK,47,5.917E-02,1.287E-01,5.917E-02,1.287E-01,8,"B-Raf, CD44, Beta-3 adrenergic receptor, G-protein alpha-i family, Adenylate cyclase, Beta-2 adrenergic receptor, PI3K reg class IB (p101), c-Src",
646,Immune response_Fc gamma R-mediated phagocytosis in macrophages,47,5.917E-02,1.287E-01,5.917E-02,1.287E-01,8,"Syk, PI3K cat class IA, PKC-alpha, Lyn, F-Actin cytoskeleton, Myosin II, Actin cytoskeletal, Fc gamma RII alpha",
647,"Development_TNF-alpha, IL-1 alpha and WNT5A-dependent regulation of osteogenesis and adipogenesis in mesenchymal stem cells",47,5.917E-02,1.287E-01,5.917E-02,1.287E-01,8,"Osteopontin, IL-1 alpha, RUNX2, RANKL(TNFSF11), ALPL, TAZ, IRAK1/2, TNF-alpha",
648,Proteolysis_Role of Parkin in the Ubiquitin-Proteasomal Pathway,24,6.088E-02,1.320E-01,6.088E-02,1.320E-01,5,"Tubulin beta, Alpha-synuclein, Cyclin E, Caspase-1, Synphilin 1",
649,G-protein signaling_M-RAS regulation pathway,24,6.088E-02,1.320E-01,6.088E-02,1.320E-01,5,"B-Raf, CalDAG-GEFIII, M-Ras, RASGRF1, c-Src",
650,Transition of Smoldering multiple myeloma to active multiple myeloma (schema),17,6.194E-02,1.339E-01,6.194E-02,1.339E-01,4,"IL-1 beta, CCL2, IL-8, IL-6",
651,IL-1 production in melanoma,17,6.194E-02,1.339E-01,6.194E-02,1.339E-01,4,"IL-1 beta, IL-1 alpha, B-Raf, Caspase-1",
652,SLE genetic marker-specific pathways in B cells,99,6.324E-02,1.365E-01,6.324E-02,1.365E-01,14,"Syk, BLK, PAX5, Ikaros, CalDAG-GEFIII, CD38, IFN-alpha, ETS1, Lyn, TLR4, TLR7, IFN-beta, BLIMP1 (PRDI-BF1), TNF-alpha",
653,Th2 cytokine-induced alternative activation of alveolar macrophages in asthma,32,6.510E-02,1.398E-01,6.510E-02,1.398E-01,6,"CHI3L1, Eotaxin-2, IL-33, Eotaxin, TSLP, TSLPR",
654,Androstenedione and testosterone biosynthesis and metabolism p.2,32,6.510E-02,1.398E-01,6.510E-02,1.398E-01,6,"AKR1C3, UGT1A1, UGT1A10, AKR1C1, AKR1C2, UGT1A4",
655,Activation of ACTH production in pituitary gland in major depressive disorder,32,6.510E-02,1.398E-01,6.510E-02,1.398E-01,6,"IL-1 beta, TNF-R2, V1b receptor, IL-6, IRAK1/2, TNF-alpha",
656,Muscle contraction_Relaxin signaling pathway,48,6.561E-02,1.407E-01,6.561E-02,1.407E-01,8,"LGR7, B-Raf, iNOS, G-protein alpha-i family, MMP-2, AKT(PKB), PDE4C, MMP-9",
657,Neurophysiological process_Delta-type opioid receptor in the nervous system,40,6.623E-02,1.412E-01,6.623E-02,1.412E-01,7,"CLCA4, PDE1C, Metenkefalin, P/Q-type calcium channel alpha-1A subunit, G-protein alpha-i family, PDE1A, Leu-enkephalin",
658,Activation of Cortisol production in major depressive disorder,40,6.623E-02,1.412E-01,6.623E-02,1.412E-01,7,"SF1, IL-6, CYP17, CYP21A2, MDR1, TNF-alpha, CYP11A1",
659,Development_FGF2-induced self-renewal of adult neural stem cells,40,6.623E-02,1.412E-01,6.623E-02,1.412E-01,7,"PI3K cat class IA, PKC, FGF2, NeuroD1, AKT(PKB), Jagged1, Syndecan-2",
660,Inhibition of Vitamin D pathway in Prostate Cancer,40,6.623E-02,1.412E-01,6.623E-02,1.412E-01,7,"CYP27A1, RUNX2, CYP24A1, IL-6, GFI-1, IBP3, CDK6",
661,Development_Role of IL-8 in angiogenesis,65,6.737E-02,1.434E-01,6.737E-02,1.434E-01,10,"PI3K cat class IA, IL-8, EGFR, G-protein alpha-i family, MMP-14, AKT(PKB), Caveolin-1, PI3K reg class IB (p101), c-Src, CARD11",
662,Role of nicotine in pathogenesis of SCLC,57,7.016E-02,1.484E-01,7.016E-02,1.484E-01,9,"nAChR alpha-7, GRP(1-27), PKC-alpha, P/Q-type calcium channel alpha-1A subunit, HTR1D, GRP precursor, FGF2, AKT(PKB), c-Src",
663,Development_Cytokine-mediated regulation of megakaryopoiesis,57,7.016E-02,1.484E-01,7.016E-02,1.484E-01,9,"IL-1 beta, NF-E2 (45 kDa), PI3K cat class IA, IL-1 alpha, MYCT1, LIF, IL-6, STAT5, AKT(PKB)",
664,Immune response_Role of PKR in stress-induced antiviral cell response,57,7.016E-02,1.484E-01,7.016E-02,1.484E-01,9,"IL-1 beta, IFN-alpha, IL-8, TLR4, IL-6, TLR3, IFN-beta, TLR2, TNF-alpha",
665,Regulation of intrinsic membrane properties and excitability of striatopallidal medium spiny neurons in Huntington's disease,57,7.016E-02,1.484E-01,7.016E-02,1.484E-01,9,"cPKC (conventional), PKC, Kir2.3, P/Q-type calcium channel alpha-1A subunit, G-protein alpha-i family, SCN2A, KCNQ2, G-protein alpha-q/11, SHANK",
666,Development_Cross-talk between VEGF and Angiopoietin 1 signaling pathways,25,7.065E-02,1.484E-01,7.065E-02,1.484E-01,5,"VCAM1, ICAM1, PKC-alpha, Angiopoietin 1, c-Src",
667,A proinflammatory phenotype of senescent alveolar epithelial cells in COPD,25,7.065E-02,1.484E-01,7.065E-02,1.484E-01,5,"IL-8, IL-6, p16INK4, PI3K cat class IA (p110-delta), TNF-alpha",
668,Zinc deficiency in Prostate Cancer,25,7.065E-02,1.484E-01,7.065E-02,1.484E-01,5,"c-IAP2, ICAM1, IL-8, IL-6, MMP-9",
669,HBV-dependent transcription regulation leading to HCC,25,7.065E-02,1.484E-01,7.065E-02,1.484E-01,5,"EGR2 (Krox20), IL-8, MMP-14, MMP-2, FasL(TNFSF6)",
670,Cytoskeleton remodeling_Neurofilaments,25,7.065E-02,1.484E-01,7.065E-02,1.484E-01,5,"Tubulin beta, Nestin, Actin cytoskeletal, Alpha-internexin, Vimentin",
671,Regulation of lipid metabolism_Regulation of lipid metabolism by niacin and isoprenaline,49,7.247E-02,1.508E-01,7.247E-02,1.508E-01,8,"Adenylate cyclase type VIII, PKC, Beta-3 adrenergic receptor, PKC-alpha, G-protein alpha-i family, MTP, Beta-2 adrenergic receptor, Adenylate cyclase type VII",
672,Mechanisms of drug resistance in multiple myeloma,49,7.247E-02,1.508E-01,7.247E-02,1.508E-01,8,"HAS1, CD44, IL-8, IL-6, Jagged1, c-Src, Frizzled, MDR1",
673,Demyelination in multiple sclerosis,49,7.247E-02,1.508E-01,7.247E-02,1.508E-01,8,"Myelin basic protein, iNOS, FasR(CD95), FasL(TNFSF6), Apo-2L(TNFSF10), AKT(PKB), MMP-9, TNF-alpha",
674,Cytoskeleton remodeling_Integrin outside-in signaling,49,7.247E-02,1.508E-01,7.247E-02,1.508E-01,8,"alpha-11/beta-1 integrin, Tcf(Lef), alpha-5/beta-1 integrin, Actin cytoskeletal, AKT(PKB), Collagen IV, Fibronectin, c-Src",
675,Immune response_PD-1-induced metabolic changes in T cells,49,7.247E-02,1.508E-01,7.247E-02,1.508E-01,8,"PI3K cat class IA, PD-L2, ZAP70, CD3 zeta, PD-1, Fyn, AKT(PKB), PD-L1",
676,Development_G-CSF signaling,49,7.247E-02,1.508E-01,7.247E-02,1.508E-01,8,"ITGA9, c-IAP2, PI3K cat class IA, Lyn, BFL1, STAT5, AKT(PKB), GFI-1",
677,Development_BMP signaling,33,7.373E-02,1.531E-01,7.373E-02,1.531E-01,6,"Cerberus, BMP6, Gremlin, BMP4, SMAD9 (SMAD8), BMP2",
678,Development_Muscle progenitor cell migration in hypaxial myogenesis,41,7.390E-02,1.531E-01,7.390E-02,1.531E-01,7,"HGF, G-protein alpha-i family, MEF2C, LBX1, FGF8, HGF receptor (Met), c-Src",
679,Stem cells_Inhibition of Hedgehog signaling in medulloblastoma stem cells,41,7.390E-02,1.531E-01,7.390E-02,1.531E-01,7,"PACAP receptor 1, PTCH1, PACAP, FGF1, FGF2, GLI-1, GLI-2",
680,NMDA-independent presynaptic long-term potentiation in Huntington's disease,58,7.669E-02,1.587E-01,7.669E-02,1.587E-01,9,"Complexin 2, Adenylate cyclase type VIII, GABA-A receptor, PKC-alpha, GluR6, CACNA1E, Actin cytoskeletal, TrkB, c-Src",
681,Immune response_IL-3 signaling via ERK and PI3K,102,7.718E-02,1.595E-01,7.718E-02,1.595E-01,14,"Syk, ITGB1, cPKC (conventional), PI3K cat class IA, B-Raf, alpha-4/beta-1 integrin, NGAL, cPLA2, Lyn, STAT5, alpha-5/beta-1 integrin, AKT(PKB), PDE4, PI3K cat class IA (p110-delta)",
682,Development_GM-CSF signaling,50,7.975E-02,1.638E-01,7.975E-02,1.638E-01,8,"STAT5A, PI3K cat class IA, CCL2, Lyn, GM-CSF, STAT5, AKT(PKB), Pim-1",
683,Development_EDNRB signaling,50,7.975E-02,1.638E-01,7.975E-02,1.638E-01,8,"B-Raf, G-protein alpha-i family, AKT(PKB), G-protein alpha-q/11, Caveolin-1, Endothelin-3, PI3K reg class IB (p101), c-Src",
684,IGF-1 signaling in multiple myeloma,50,7.975E-02,1.638E-01,7.975E-02,1.638E-01,8,"ITGB1, c-IAP2, PI3K cat class IA, IRS-2, RANKL(TNFSF11), BFL1, AKT(PKB), Fibronectin",
685,Immune response_C5a signaling,50,7.975E-02,1.638E-01,7.975E-02,1.638E-01,8,"IL-1 beta, B-Raf, PKC, IL-8, G-protein alpha-i family, Rac2, AKT(PKB), TNF-alpha",
686,"Immune response_IL-5 signaling via PI3K, MAPK and NF-kB",76,8.115E-02,1.656E-01,8.115E-02,1.656E-01,11,"Syk, PI3K cat class IA, ITGB2, ICAM1, cPLA2, Lyn, MMP-2, Fyn, AKT(PKB), Fc gamma RII alpha, MMP-9",
687,Hedgehog signaling in prostate cancer,26,8.123E-02,1.656E-01,8.123E-02,1.656E-01,5,"PTCH1, Nestin, GLI-1, IBP6, GLI-2",
688,Neurophysiological process_Dopamine D2 receptor transactivation of PDGFR in CNS,26,8.123E-02,1.656E-01,8.123E-02,1.656E-01,5,"PKC, G-protein alpha-i family, PDGF receptor, c-Src, PDGF-R-beta",
689,Cell adhesion_Endothelial cell contacts by junctional mechanisms,26,8.123E-02,1.656E-01,8.123E-02,1.656E-01,5,"Connexin 37, N-cadherin, Actin cytoskeletal, Vimentin, Claudin-1",
690,Signal transduction_HTR2A-dependent arachidonic acid production,26,8.123E-02,1.656E-01,8.123E-02,1.656E-01,5,"COX-2 (PTGS2), cPLA2, G-protein alpha-i family, HTR2A, G-protein alpha-q/11",
691,Development_VEGF signaling and activation,42,8.207E-02,1.671E-01,8.207E-02,1.671E-01,7,"PI3K cat class IA, VCAM1, PKC, ICAM1, PKC-alpha, AKT(PKB), c-Src",
692,Signal transduction_Erk Interactions: Inhibition of Erk,34,8.299E-02,1.687E-01,8.299E-02,1.687E-01,6,"PKC, ZAP70, CD3, AKT(PKB), STEP, PTPRR",
693,Immune response_Sublytic effects of membrane attack complex,68,8.596E-02,1.743E-01,8.596E-02,1.743E-01,10,"PKC, cPLA2, EGFR, G-protein alpha-i family, IL-6, Actin cytoskeletal, AKT(PKB), PI3K reg class IB (p101), RGC32, XAF1",
694,Immune response_Fc epsilon RI pathway: calcium-dependent signaling,68,8.596E-02,1.743E-01,8.596E-02,1.743E-01,10,"Syk, TRPC5, PKC-alpha, ERM proteins, cPLA2, Lyn, Myosin II, Fyn, AKT(PKB), c-Src",
695,Blood coagulation_GPIb-IX-V-dependent platelet activation,77,8.731E-02,1.768E-01,8.731E-02,1.768E-01,11,"Syk, PKC-alpha, ITGB3, cPLA2, Lyn, Fyn, Fc gamma RII alpha, LAT, c-Src, Actin, Cofilin",
696,Ethanol/Acetaldehyde-dependent stimulation of MMP-9 expression in HCC,19,8.744E-02,1.768E-01,8.744E-02,1.768E-01,4,"ADHG, ADH1, ADH4, MMP-9",
697,Translation_Non-genomic (rapid) action of Androgen Receptor,43,9.074E-02,1.807E-01,9.074E-02,1.807E-01,7,"Tcf(Lef), WNT, EGFR, AKT(PKB), Caveolin-1, c-Src, Frizzled",
698,Prostaglandins and leukotrienes-mediated induction of expression of mucins in normal and asthmatic epithelium ,43,9.074E-02,1.807E-01,9.074E-02,1.807E-01,7,"PGE2R2, PKC-alpha, EGFR, G-protein alpha-i family, Adenylate cyclase, PGF2aR, G-protein alpha-q/11",
699,Th2-cytokines-induced expression of mucins in asthma ,43,9.074E-02,1.807E-01,9.074E-02,1.807E-01,7,"GRO-2, TGF-beta 2, GRO-1, IL-8, TGF-beta receptor type II, IL-6, HNF3-beta",
700,HGF receptor (Met) and MSP receptor (RON) signaling pathways in SCLC,43,9.074E-02,1.807E-01,9.074E-02,1.807E-01,7,"HGF, PAX5, PI3K cat class IA, FGF2, AKT(PKB), HGF receptor (Met), c-Src",
701,Neurophysiological process_HTR1A receptor signaling in neuronal cells,43,9.074E-02,1.807E-01,9.074E-02,1.807E-01,7,"Kir3.4, P/Q-type calcium channel alpha-1A subunit, G-protein alpha-i family, Adenylate cyclase, MAP2, GluR1, PI3K reg class IB (p101)",
702,Nicotine / nAChR alpha-7 signaling in NSCLC,43,9.074E-02,1.807E-01,9.074E-02,1.807E-01,7,"nAChR alpha-7, PI3K cat class IA, PKC-alpha, Cyclin E, AKT(PKB), Fibronectin, c-Src",
703,Development_EPO-induced PI3K/AKT pathway and Ca(2+) influx,43,9.074E-02,1.807E-01,9.074E-02,1.807E-01,7,"Syk, PI3K cat class IA, Alpha1-globin, TRPC3, IRS-2, Lyn, AKT(PKB)",
704,Signal transduction_Modulation of calcium and potassium channels by Adenosine A1 receptor,43,9.074E-02,1.807E-01,9.074E-02,1.807E-01,7,"cPKC (conventional), PKC-alpha, P/Q-type calcium channel alpha-1A subunit, cPLA2, G-protein alpha-i family, Adenylate cyclase, CACNA1E",
705,Regulation of Tissue factor signaling in cancer,43,9.074E-02,1.807E-01,9.074E-02,1.807E-01,7,"TNF-R2, Heparanase 1, EGFR, AKT(PKB), Tissue factor, P-selectin, TNF-alpha",
706,Immune response_ICOS signaling pathway in T-helper cell,60,9.082E-02,1.807E-01,9.082E-02,1.807E-01,9,"MHC class II, Osteopontin, PI3K cat class IA, CD3, IL-17F, T-bet, AKT(PKB), ICOS, TNF-alpha",
707,Neutrophil resistance to apoptosis in COPD and proresolving impact of lipid mediators,60,9.082E-02,1.807E-01,9.082E-02,1.807E-01,9,"FPRL1, PI3K cat class IA, SAA1, TNF-R2 soluble, FasR(CD95) soluble, FasR(CD95), FasL(TNFSF6), AKT(PKB), TNF-alpha",
708,Activation of osteoclast differentiation in bone lesions formation in multiple myeloma,27,9.260E-02,1.830E-01,9.260E-02,1.830E-01,5,"VCAM1, alpha-4/beta-1 integrin, RANKL(TNFSF11), Osteoprotegerin, RANK(TNFRSF11A)",
709,HCV-dependent regulation of membrane receptors signaling in HCC,27,9.260E-02,1.830E-01,9.260E-02,1.830E-01,5,"IL-1 beta, EGFR, TGF-alpha, c-Src, TNF-alpha",
710,Immune response_Inflammasome in inflammatory response,35,9.285E-02,1.830E-01,9.285E-02,1.830E-01,6,"IL-1 beta, Biglycan, IL-18, TLR4, Caspase-1, TNF-alpha",
711,Pro-oncogenic action of Androgen receptor in breast cancer,35,9.285E-02,1.830E-01,9.285E-02,1.830E-01,6,"AKR1C3, RUNX2, SGK1, FGF8, TCF8, Kallikrein 15",
712,IL-6 signaling pathway in lung cancer,35,9.285E-02,1.830E-01,9.285E-02,1.830E-01,6,"COX-2 (PTGS2), PI3K cat class IA, EGFR, IL-6, AKT(PKB), c-Src",
713,Immune response_Th17 cell differentiation,35,9.285E-02,1.830E-01,9.285E-02,1.830E-01,6,"IL-1 beta, MHC class II, IL23A, IL-17F, TGF-beta receptor type II, IL-6",
714,Role of Tissue factor in cancer independent of coagulation protease signaling,35,9.285E-02,1.830E-01,9.285E-02,1.830E-01,6,"PKC-alpha, Lyn, Actin cytoskeletal, AKT(PKB), Tissue factor, c-Src",
715,Signal transduction_Activation of PKC via G-Protein coupled receptor,52,9.556E-02,1.878E-01,9.556E-02,1.878E-01,8,"PKC-theta, PKC-alpha, MEF2, CPI-17, G-protein alpha-q/11, MELC, c-Src, MLCK",
716,Stem cells_mGluR3 signaling in glioblastoma stem cells,52,9.556E-02,1.878E-01,9.556E-02,1.878E-01,8,"P/Q-type calcium channel alpha-1A subunit, G-protein alpha-i family, Adenylate cyclase, SLC7A11, AKT(PKB), PI3K reg class IB (p101), c-Src, GLAST1/EAAT1",
717,Immune response_Fc epsilon RI pathway: signaling through Fyn and PI3K,61,9.842E-02,1.931E-01,9.842E-02,1.931E-01,9,"Syk, Lyn, STAT5, SGK1, Fyn, FYB1, AKT(PKB), LAMP3, PI3K cat class IA (p110-delta)",
718,Immune response_TCR alpha/beta signaling pathway,97,9.967E-02,1.945E-01,9.967E-02,1.945E-01,13,"MHC class II, B-Raf, PKC-theta, TRPC3, PKC-alpha, ZAP70, CD3, Fyn, FYB1, AKT(PKB), LAT, GRAP2, CARD11",
719,Impaired Lipoxin A4 signaling in CF,44,9.990E-02,1.945E-01,9.990E-02,1.945E-01,7,"FPRL1, EGFR, G-protein alpha-i family, Adenylate cyclase, G-protein alpha-q/11, c-Src, PDGF-R-beta",
720,Role of TLR signaling in skin sensitization,44,9.990E-02,1.945E-01,9.990E-02,1.945E-01,7,"IL-1 beta, TLR4, IL-6, IRAK1/2, IFN-beta, TLR2, TNF-alpha",
721,Immune response_CRTH2 signaling in Th2 cells,44,9.990E-02,1.945E-01,9.990E-02,1.945E-01,7,"PKC, ITGB2, ICAM1, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), PI3K reg class IB (p101)",
722,Leptin signaling in colorectal cancer,44,9.990E-02,1.945E-01,9.990E-02,1.945E-01,7,"PI3K cat class IA, IL-8, Cyclin E, IL-6, Matrilysin (MMP-7), AKT(PKB), c-Src",
723,Retinol metabolism,70,9.992E-02,1.945E-01,9.992E-02,1.945E-01,10,"DHA6, LRAT, DHA2, CYP1A1, CYP2C18, CYP3A7, Xanthine oxidase, AL1A1, RPE65, UGT2B7",
724,Role of Langerin+ dermal dendritic cells in contact hypersensitivity,20,1.018E-01,1.962E-01,1.018E-01,1.962E-01,4,"Langerin, ITGB2, CCL2, P-selectin",
725,PR action in breast cancer: stimulation of metastasis,20,1.018E-01,1.962E-01,1.018E-01,1.962E-01,4,"IRS-2, PAR1, Tissue factor, c-Src",
726,Development_FGF2-dependent induction of EMT,20,1.018E-01,1.962E-01,1.018E-01,1.962E-01,4,"IL-1 beta, PI3K cat class IA, FGF2, AKT(PKB)",
727,Development_H3K36 demethylation in stem cell maintenance,20,1.018E-01,1.962E-01,1.018E-01,1.962E-01,4,"p14ARF, p15, p16INK4, CDK6",
728,CCL2 in Prostate Cancer,20,1.018E-01,1.962E-01,1.018E-01,1.962E-01,4,"CCL2, G-protein alpha-i family, AKT(PKB), PI3K reg class IB (p101)",
729,Role of XBP1 protein in multiple myeloma,20,1.018E-01,1.962E-01,1.018E-01,1.962E-01,4,"PAX5, BOB1, IL-6, BLIMP1 (PRDI-BF1)",
730,wtCFTR and deltaF508-CFTR traffic / Clathrin coated vesicles formation (normal and CF),20,1.018E-01,1.962E-01,1.018E-01,1.962E-01,4,"AP180, BIN1 (Amphiphysin II), Actin cytoskeletal, Actin",
731,Development_EPO-induced Jak-STAT pathway,36,1.033E-01,1.989E-01,1.033E-01,1.989E-01,6,"STAT5A, Lyn, STAT5, c-Fes, c-Src, Pim-1",
732,Aryl hydrocarbon receptor signaling,53,1.041E-01,1.989E-01,1.041E-01,1.989E-01,8,"COX-2 (PTGS2), UGT1A1, CYP1A1, TGM3, IL-8, Epiregulin, SLUG, UGT1A6",
733,Effect of H. pylori infection on apoptosis in gastric epithelial cells,53,1.041E-01,1.989E-01,1.041E-01,1.989E-01,8,"COX-2 (PTGS2), c-IAP2, MHC class II, FasR(CD95), FasL(TNFSF6), Caspase-1, PTPR-zeta, TNF-alpha",
734,Immune response_Antiviral actions of Interferons,53,1.041E-01,1.989E-01,1.041E-01,1.989E-01,8,"IDO1, MxA, MHC class II, iNOS, HLA-A, IFN-alpha, HLA-DRA1, IFN-beta",
735,Proliferative action of Gastrin in gastric cancer,53,1.041E-01,1.989E-01,1.041E-01,1.989E-01,8,"cPKC (conventional), PI3K cat class IA, PKC, PKC-alpha, EGFR, G-protein alpha-q/11, ICRF, c-Src",
736,Impaired inhibition of Th17 cell differentiation by IFN-beta in multiple sclerosis,28,1.047E-01,1.989E-01,1.047E-01,1.989E-01,5,"IL-1 beta, Osteopontin, TGF-beta receptor type II, IL-6, IFN-beta",
737,Cell cycle_Regulation of G1/S transition (part 2),28,1.047E-01,1.989E-01,1.047E-01,1.989E-01,5,"Cyclin A1, Cyclin E, Cyclin A, AKT(PKB), CDK6",
738,GLP-1 in inhibition of insulin secretion in type 2 diabetes,28,1.047E-01,1.989E-01,1.047E-01,1.989E-01,5,"Adenylate cyclase type VIII, EGFR, GLP-1 (7-36) amide, GLP-1 (7-37), GLP-1 receptor",
739,Platelet activation during ADAM-TS13-deficient thrombotic microangiopathy development,28,1.047E-01,1.989E-01,1.047E-01,1.989E-01,5,"Fc gamma RII alpha, Fibronectin, Collagen VI, P-selectin, Collagen III",
740,Muscle contraction_nNOS signaling in skeletal muscle ,28,1.047E-01,1.989E-01,1.047E-01,1.989E-01,5,"Syntrophin B1, Dystrophin, SLC18A3, nNOS, Actin",
741,Possible influence of low doses of Arsenite on glucose uptake in muscle,28,1.047E-01,1.989E-01,1.047E-01,1.989E-01,5,"PI3K cat class IA, PTGIS, IRS-2, MEF2C, AKT(PKB)",
742,Renin-Angiotensin-Aldosterone System,62,1.064E-01,2.012E-01,1.064E-01,2.012E-01,9,"Angiotensin I, PKC-alpha, cPLA2, CaMK I, Angiotensinogen, G-protein alpha-q/11, Angiotensin II, RGS2, MDR1",
743,Muscle contraction_Oxytocin signaling in uterus and mammary gland,62,1.064E-01,2.012E-01,1.064E-01,2.012E-01,9,"COX-2 (PTGS2), cPKC (conventional), AKR1C3, PKC, PKC-alpha, cPLA2, EGFR, PGF2aR, G-protein alpha-q/11",
744,Regulation of intrinsic membrane properties and excitability of striatonigral medium spiny neurons in Huntington's disease,62,1.064E-01,2.012E-01,1.064E-01,2.012E-01,9,"cPKC (conventional), PKC, P/Q-type calcium channel alpha-1A subunit, SCN2A, KCNQ2, DARPP-32, G-protein alpha-q/11, SHANK, G-protein alpha-olf",
745,Development_EGFR signaling pathway,71,1.074E-01,2.027E-01,1.074E-01,2.027E-01,10,"PI3K cat class IA, PKC-theta, PKC-alpha, Epiregulin, EGFR, MMP-2, TGF-alpha, AKT(PKB), c-Src, MMP-9",
746,Main pathways of Schwann cells transformation in neurofibromatosis type 1 ,80,1.075E-01,2.027E-01,1.075E-01,2.027E-01,11,"ITGB1, Myelin basic protein, PI3K cat class IA, S100B, EGFR, IL-6, Rac2, TGF-alpha, AKT(PKB), PDGF receptor, PDGF-R-beta",
747,Immune response_PGE2 signaling in immune response,45,1.096E-01,2.061E-01,1.096E-01,2.061E-01,7,"HGF, COX-2 (PTGS2), PGE2R2, IL-8, GM-CSF, Adenylate cyclase, TNF-alpha",
748,"Role of TNF-alpha, IL-1beta and IL-6 in development of obesity and type 2 diabetes in liver",45,1.096E-01,2.061E-01,1.096E-01,2.061E-01,7,"IL-1 beta, TNF-R2, CRP, IL-6, MTP, HNF3-beta, TNF-alpha",
749,Oxidative stress_ROS-induced cellular signaling,108,1.106E-01,2.078E-01,1.106E-01,2.078E-01,14,"GSTP1, Syk, COX-2 (PTGS2), IL-1 beta, PAX5, iNOS, PKC, HES5, IL-8, IL-6, AKT(PKB), c-Src, Carbonic anhydrase IX, TNF-alpha",
750,Immune response_Antigen presentation by MHC class I: cross-presentation,99,1.123E-01,2.108E-01,1.123E-01,2.108E-01,13,"Syk, Dectin-1, UFO, cPLA2, TLR4, LY75, Rac2, TLR7, Fc gamma RII alpha, TLR3, Cathepsin S, TAP, TLR2",
751,NRF2 regulation of oxidative stress response,54,1.130E-01,2.112E-01,1.130E-01,2.112E-01,8,"GSTP1, PI3K cat class IA, UGT1A1, PKC, SLC7A11, Actin cytoskeletal, Fyn, AKT(PKB)",
752,Regulation of AKT(PKB)/ GSK3 beta cascade in bipolar disorder,54,1.130E-01,2.112E-01,1.130E-01,2.112E-01,8,"NGF, G-protein alpha-i1, TrkA, PI3K cat class IA, G-protein alpha-i family, FGF2, AKT(PKB), TrkB",
753,Development_Differentiation of white adipocytes ,54,1.130E-01,2.112E-01,1.130E-01,2.112E-01,8,"CIDEC, BMP4, FOXC2, PPARGC1 (PGC1-alpha), Angiotensinogen, PSAT, BMP2, LPL",
754,IL-6 signaling in colorectal cancer,37,1.144E-01,2.131E-01,1.144E-01,2.131E-01,6,"TNF-R2, ICAM1, CRP, Cyclin E, TGF-beta receptor type II, IL-6",
755,G-protein signaling_H-RAS regulation pathway,37,1.144E-01,2.131E-01,1.144E-01,2.131E-01,6,"PI3K cat class IA, CalDAG-GEFIII, Angiopoietin 1, RASGRF1, c-Src, PDGF-R-beta",
756,Nicotine signaling (general schema),21,1.172E-01,2.178E-01,1.172E-01,2.178E-01,4,"nAChR alpha-7, HTR3, GABA-A receptor, nAChR alpha-3",
757,Inhibition of tumor suppressive pathways in pancreatic cancer,21,1.172E-01,2.178E-01,1.172E-01,2.178E-01,4,"p14ARF, p15, p16INK4, CDK6",
758,Immune response_Delta-type opioid receptor signaling in T-cells,29,1.176E-01,2.183E-01,1.176E-01,2.183E-01,5,"Metenkefalin, G-protein alpha-i family, AKT(PKB), PI3K reg class IB (p101), c-Src",
759,Signal transduction_CXCR4 signaling via PI3K cascade,46,1.197E-01,2.213E-01,1.197E-01,2.213E-01,7,"PPCKC, PI3K cat class IA, G-protein alpha-i family, IL-6, SGK1, AKT(PKB), PI3K reg class IB (p101)",
760,Cytoskeleton remodeling_Regulation of actin cytoskeleton nucleation and polymerization by Rho GTPases,46,1.197E-01,2.213E-01,1.197E-01,2.213E-01,7,"DRF, Rac1-related, Cdc42 subfamily, FMNL2, F-Actin cytoskeleton, Actin cytoskeletal, Rac2",
761,Development_Endothelin-1/EDNRA transactivation of EGFR,46,1.197E-01,2.213E-01,1.197E-01,2.213E-01,7,"PI3K cat class IA, EGFR, STAT5, AKT(PKB), G-protein alpha-q/11, c-Src, EDNRA",
762,Aberrant B-Raf signaling in melanoma progression,55,1.224E-01,2.250E-01,1.224E-01,2.250E-01,8,"ITGB1, B-Raf, ITGB3, MAP2, AKT3, RhoE, AKT(PKB), SPRY2",
763,Development_WNT/Beta-catenin signaling in the cytoplasm,55,1.224E-01,2.250E-01,1.224E-01,2.250E-01,8,"Tcf(Lef), WNT, Axin2, AKT(PKB), Nucleoredoxin, c-Src, Axin, Frizzled",
764,Immune response_CD28 signaling,55,1.224E-01,2.250E-01,1.224E-01,2.250E-01,8,"PI3K cat class IA, PKC-theta, ZAP70, CD3, Fyn, AKT(PKB), LAT, GRAP2",
765,Development_Fetal brown fat cell differentiation,55,1.224E-01,2.250E-01,1.224E-01,2.250E-01,8,"STAT5A, PI3K cat class IA, IRS-2, Beta-3 adrenergic receptor, Adenylate cyclase, PPARGC1 (PGC1-alpha), AKT(PKB), Prolactin",
766,"Immune response_IL-2 signaling via ERK, PI3K, and PLC-gamma",73,1.232E-01,2.263E-01,1.232E-01,2.263E-01,10,"Syk, PI3K cat class IA, PKC-theta, IRS-2, Cyclin E, Lyn, Cyclin A, Fyn, AKT(PKB), IL-2R alpha chain",
767,Impaired macrophage phagocytic function in asthma,38,1.260E-01,2.308E-01,1.260E-01,2.308E-01,6,"GSTP1, TNF-R2, PA24A, iC3b, MMP-9, TNF-alpha",
768,"Dysregulation of Adiponectin secretion from adipocytes in obesity, type 2 diabetes and metabolic syndrome X",38,1.260E-01,2.308E-01,1.260E-01,2.308E-01,6,"IL-18R1, IL-18, CRP, IL18RAP, AKT(PKB), TNF-alpha",
769,IL-6 signaling in tumor-associated monocytes/macrophages in breast cancer,14,1.281E-01,2.343E-01,1.281E-01,2.343E-01,3,"Fra-1, IL-6, MMP-9",
770,Mitogenic action of ESR1 (membrane) in breast cancer,47,1.303E-01,2.374E-01,1.303E-01,2.374E-01,7,"Cyclin E, EGFR, MMP-2, SGK1, AKT(PKB), c-Src, MMP-9",
771,Development_HGF signaling pathway,47,1.303E-01,2.374E-01,1.303E-01,2.374E-01,7,"HGF, COX-2 (PTGS2), PI3K cat class IA, FasR(CD95), AKT(PKB), HGF receptor (Met), PLAU (UPA)",
772,Canonical Leptin pathways in breast cancer,47,1.303E-01,2.374E-01,1.303E-01,2.374E-01,7,"IL-1 beta, PI3K cat class IA, IL-1 alpha, IRS-2, Tcf(Lef), AKT(PKB), Axin",
773,PDGF activation of prostacyclin synthesis ,30,1.312E-01,2.382E-01,1.312E-01,2.382E-01,5,"COX-2 (PTGS2), PTGIS, PKC-alpha, PA24A, PDGF-R-beta",
774,Retinoic acid maintains mucocilliary differentiation and mucins expression in normal and asthmatic airway epithelium,30,1.312E-01,2.382E-01,1.312E-01,2.382E-01,5,"PKC-alpha, CYP26A1, Mucin 4, GCNT3, TNF-alpha",
775,"Immune response_Mast cell proliferation, differentiation and survival",30,1.312E-01,2.382E-01,1.312E-01,2.382E-01,5,"Syk, Lyn, STAT5, Fyn, AKT(PKB)",
776,Signal transduction_mTORC1 upstream signaling,74,1.316E-01,2.385E-01,1.316E-01,2.385E-01,10,"MAG1, WNT, EGFR, TLR4, AKT(PKB), PDGF receptor, Angiotensin II, Axin, Frizzled, TNF-alpha",
777,Platelet activation as a result of endothelial dysfunction after stenting,56,1.321E-01,2.392E-01,1.321E-01,2.392E-01,8,"PKC, PLAT (TPA), G-protein alpha-i family, Adenylate cyclase, Actin cytoskeletal, PDE2A, PAR1, PDE3A",
778,EGF- and HGF-dependent stimulation of metastasis in gastric cancer,22,1.335E-01,2.408E-01,1.335E-01,2.408E-01,4,"HGF, EGFR, HGF receptor (Met), PLAU (UPA)",
779,Ubiquitin-proteasome system in Huntington's disease,22,1.335E-01,2.408E-01,1.335E-01,2.408E-01,4,"PKC-alpha, NR2, PSMB9, NR2A",
780,Inhibition of RUNX3 signaling in gastric cancer,22,1.335E-01,2.408E-01,1.335E-01,2.408E-01,4,"Gasdermin, RUNX3, MMP-9, MDR1",
781,"Immune response_Th17, Th22 and Th9 cell differentiation ",39,1.382E-01,2.483E-01,1.382E-01,2.483E-01,6,"IL-1 beta, MHC class II, IL-17F, TGF-beta receptor type II, IL-6, TNF-alpha",
782,TrkB signaling in Huntington's disease,39,1.382E-01,2.483E-01,1.382E-01,2.483E-01,6,"NGFR(TNFRSF16), PI3K cat class IA, PKC, GluR1, TrkB, NR2A",
783,"VLDL, LDL dyslipidemia in type 2 diabetes and metabolic syndrome X",39,1.382E-01,2.483E-01,1.382E-01,2.483E-01,6,"Biglycan proteoglycan, Versican proteoglycan, Decorin proteoglycan, MTP, CETP, LPL",
784,GLP-1 in beta cell apoptosis in type 2 diabetes,48,1.413E-01,2.536E-01,1.413E-01,2.536E-01,7,"IL-1 beta, c-IAP2, IRS-2, GLP-1 (7-36) amide, GLP-1 (7-37), GLP-1 receptor, TNF-alpha",
785,Proinflammatory mediators release and arachidonic acid metabolites production in basophils in asthma,57,1.422E-01,2.545E-01,1.422E-01,2.545E-01,8,"Syk, NGF, TrkA, PI3K cat class IA, cPLA2, Lyn, G-protein alpha-i family, Eotaxin",
786,Lysophospholipid mediators-induced inflammatory signaling in normal and asthmatic airway epithelium,57,1.422E-01,2.545E-01,1.422E-01,2.545E-01,8,"COX-2 (PTGS2), CCL20, IL-8, Lyn, G-protein alpha-i family, AKT(PKB), TSLP, MMP-9",
787,Neurophysiological process_Kappa-type opioid receptor in transmission of nerve impulses,31,1.454E-01,2.590E-01,1.454E-01,2.590E-01,5,"Kir3.4, P/Q-type calcium channel alpha-1A subunit, G-protein alpha-i family, NHE3, Kappa-type opioid receptor",
788,Putative glucocorticoid- and LABA-mediated inhibition of pro-fibrotic signaling in airway fibroblasts/myofibroblasts,31,1.454E-01,2.590E-01,1.454E-01,2.590E-01,5,"ACTA2, Beta-2 adrenergic receptor, Fibronectin, MMP-9, Collagen III",
789,Development_Activation of ERK by Kappa-type opioid receptor,31,1.454E-01,2.590E-01,1.454E-01,2.590E-01,5,"PKC-alpha, G-protein alpha-i family, PI3K reg class IB (p101), c-Src, Kappa-type opioid receptor",
790,Development_Transactivation of PDGFR in non-neuronal cells by Dopamine D2 receptor,31,1.454E-01,2.590E-01,1.454E-01,2.590E-01,5,"PI3K cat class IA, G-protein alpha-i family, PDGF receptor, c-Src, PDGF-R-beta",
791,Metabolic syndrome X (general schema),15,1.498E-01,2.656E-01,1.498E-01,2.656E-01,3,"IL-1 beta, IL-6, TNF-alpha",
792,Development_EGFR signaling via PIP3,23,1.507E-01,2.656E-01,1.507E-01,2.656E-01,4,"PI3K cat class IA, IRS-2, EGFR, AKT(PKB)",
793,G-protein signaling_Cross-talk between Ras-family GTPases,23,1.507E-01,2.656E-01,1.507E-01,2.656E-01,4,"PI3K cat class IA, B-Raf, M-Ras, AKT(PKB)",
794,Development_ERK5 in cell proliferation and neuronal survival,23,1.507E-01,2.656E-01,1.507E-01,2.656E-01,4,"NGF, TrkA, MEF2C, TSAD",
795,Action of GSK3 beta in bipolar disorder,23,1.507E-01,2.656E-01,1.507E-01,2.656E-01,4,"MAP-1B, Tcf(Lef), NeuroD1, KCNQ2",
796,Role of IGH translocations in multiple myeloma,40,1.509E-01,2.656E-01,1.509E-01,2.656E-01,6,"N-cadherin, NCAM1, RhoE, ITGA5, BLIMP1 (PRDI-BF1), CDK6",
797,G-protein signaling_Rap1A regulation pathway,40,1.509E-01,2.656E-01,1.509E-01,2.656E-01,6,"B-Raf, CalDAG-GEFIII, ZAP70, CD3, G-protein alpha-i family, M-Ras",
798,Stem cells_Response to hypoxia in glioblastoma stem cells,40,1.509E-01,2.656E-01,1.509E-01,2.656E-01,6,"HEY1, HES5, BMP4, SMAD9 (SMAD8), Jagged1, BMP2",
799,Neurophysiological process_ACM1 and ACM2 in neuronal membrane polarization,40,1.509E-01,2.656E-01,1.509E-01,2.656E-01,6,"G-protein alpha-i1, Kir2.3, PKC-alpha, Kir2.1, KCNQ2, c-Src",
800,Development_Prolactin receptor signaling,58,1.527E-01,2.682E-01,1.527E-01,2.682E-01,8,"STAT5A, PI3K cat class IA, NMI, STAT5, Fyn, AKT(PKB), c-Src, Prolactin",
801,Hyaluronic acid/ CD44 signaling in cancer,58,1.527E-01,2.682E-01,1.527E-01,2.682E-01,8,"HOXD10, CD44, Actin cytoskeletal, TWIST1, Collagen IV, c-Src, MMP-9, MDR1",
802,Tumor metabolic pathways promoting development of Treg cells,96,1.599E-01,2.799E-01,1.599E-01,2.799E-01,12,"MHC class II, TGF-beta receptor type II, STAT5, PD-1, CTLA-4, 5'-NTD, TSLP, ICOS, c-Src, IL-2R alpha chain, PD-L1, TSLPR",
803,Immune responses in asthma (schema),8,1.600E-01,2.799E-01,1.600E-01,2.799E-01,2,"IL-1 beta, TNF-alpha",
804,Putative pathways for stimulation of fat cell differentiation by Bisphenol A,32,1.603E-01,2.799E-01,1.603E-01,2.799E-01,5,"PI3K cat class IA, PPARGC1 (PGC1-alpha), AKT(PKB), Esrrg, LPL",
805,Inhibition of LKB1 / AMPK signaling in breast cancer,32,1.603E-01,2.799E-01,1.603E-01,2.799E-01,5,"IL-6, PPARGC1 (PGC1-alpha), TWIST1, AKT(PKB), Vimentin",
806,Role of IL-6 in obesity and type 2 diabetes in adipocytes,32,1.603E-01,2.799E-01,1.603E-01,2.799E-01,5,"CCL2, CRP, IL-6, STAT5, PPARGC1 (PGC1-alpha)",
807,Signal transduction_mTORC2 downstream signaling,68,1.613E-01,2.812E-01,1.613E-01,2.812E-01,9,"PPCKC, cPKC (conventional), IL7RA, PKC, PKC-alpha, TLR4, F-Actin cytoskeleton, SGK1, AKT(PKB)",
808,Renal secretion of inorganic electrolytes,59,1.635E-01,2.836E-01,1.635E-01,2.836E-01,8,"NCX1, SLC4A4, SLC12A3, Carbonic anhydrase II, NHE3, Epithelial calcium channel, Aquaporin 1, CALB1",
809,Oxidative stress_Activation of NADPH oxidase,59,1.635E-01,2.836E-01,1.635E-01,2.836E-01,8,"cPKC (conventional), PI3K cat class IA, PKC, PKC-alpha, Rac2, AKT(PKB), PI3K reg class IB (p101), c-Src",
810,Signal transduction_Production and main functions of biologically active prostaglandins and Thromboxane A2,59,1.635E-01,2.836E-01,1.635E-01,2.836E-01,8,"COX-2 (PTGS2), PGE2R2, PTGIS, AKR1C3, PGDS, PGD2R, cPLA2, PGF2aR",
811,Signaling Transduction_Role of MIF as an intracellular mediator,41,1.640E-01,2.836E-01,1.640E-01,2.836E-01,6,"IL-1 beta, FGF18, IL-18, FGF8, PRSS11 (HtrA1), Vimentin",
812,Apoptosis and survival_Phosphorylation in TNF-alpha-induced NF-kB signaling,41,1.640E-01,2.836E-01,1.640E-01,2.836E-01,6,"PI3K cat class IA, Adenylate cyclase, c-Src, Pim-1, TNF-alpha, CDK6",
813,Transport_The role of AVP in regulation of Aquaporin 2 and renal water reabsorption,50,1.647E-01,2.836E-01,1.647E-01,2.836E-01,7,"V2 receptor, MRLC, Myosin II, Non-muscle myosin IIA, Actin cytoskeletal, MyHC, MLCK",
814,Immune response_Inhibitory action of lipoxins on superoxide production induced by IL-8 and Leukotriene B4 in neutrophils,50,1.647E-01,2.836E-01,1.647E-01,2.836E-01,7,"FPRL1, G-protein alpha-15, PKC-alpha, IL-8, G-protein alpha-i family, Rac2, PI3K reg class IB (p101)",
815,Immune response_Function of MEF2 in T lymphocytes,50,1.647E-01,2.836E-01,1.647E-01,2.836E-01,7,"HDAC9, ZAP70, CD3, MEF2C, CaMK I, MEF2, LAT",
816,Survival pathways in Prostate Cancer,50,1.647E-01,2.836E-01,1.647E-01,2.836E-01,7,"TRUNDD(TNFRSF10D), PI3K cat class IA, Caspase-10, CCL2, IL-6, Apo-2L(TNFSF10), AKT(PKB)",
817,Signal transduction_CXCR4 signaling via second messengers and JAK/STAT,50,1.647E-01,2.836E-01,1.647E-01,2.836E-01,7,"alpha-1 Adrenergic receptor, G-protein alpha-i family, Adenylate cyclase, MRLC, Beta-2 adrenergic receptor, Alpha-1B adrenergic receptor, MLCK",
818,Apoptosis and survival_NO signaling in survival,24,1.686E-01,2.893E-01,1.686E-01,2.893E-01,4,"AKT(PKB), c-Src, nNOS, PI3K cat class IA (p110-delta)",
819,Immune response_IL-27 signaling pathway,24,1.686E-01,2.893E-01,1.686E-01,2.893E-01,4,"ICAM1, T-bet, Pim-1, IL-12RB2",
820,Prolactin/ JAK2 signaling in breast cancer,24,1.686E-01,2.893E-01,1.686E-01,2.893E-01,4,"STAT5A, STAT5, c-Src, Prolactin",
821,A shift from oxidative to glycolytic muscle fiber phenotype in quadriceps muscles in COPD,60,1.747E-01,2.990E-01,1.747E-01,2.990E-01,8,"H-FABP, MLC2, Troponin C, cardiac, Fatty acid-binding protein, PPARGC1 (PGC1-alpha), MEF2, beta-MHC, TNF-alpha",
822,Stimulation of gastric acid secretion in gastric cancer,60,1.747E-01,2.990E-01,1.747E-01,2.990E-01,8,"ATP4A, PKC-alpha, Kir2.1, Adenylate cyclase, G-protein alpha-q/11, Histamine H2 receptor, c-Src, ACM3",
823,Deficient alpha-MSH signaling in melanoma,33,1.758E-01,2.990E-01,1.758E-01,2.990E-01,5,"SOX10, PI3K cat class IA, B-Raf, AKT(PKB), Syndecan-2",
824,SDF-1 axis in endothelial progenitor cell recruitment in healing myocardial infarction,33,1.758E-01,2.990E-01,1.758E-01,2.990E-01,5,"ICAM1, Angiopoietin 1, Rac2, AKT(PKB), PI3K reg class IB (p101)",
825,Resistance of pancreatic cancer cells to death receptor signaling,33,1.758E-01,2.990E-01,1.758E-01,2.990E-01,5,"TRUNDD(TNFRSF10D), c-IAP2, FasR(CD95), FasL(TNFSF6), Apo-2L(TNFSF10)",
826,Chemotaxis_CCL19- and CCL21-mediated chemotaxis,33,1.758E-01,2.990E-01,1.758E-01,2.990E-01,5,"PGE2R2, G-protein alpha-i family, Adenylate cyclase, MMP-9, Cofilin",
827,Muscle contraction_Role of kappa-type opioid receptor in heart,33,1.758E-01,2.990E-01,1.758E-01,2.990E-01,5,"Beta-3 adrenergic receptor, G-protein alpha-i family, Adenylate cyclase, Beta-2 adrenergic receptor, Kappa-type opioid receptor",
828,Inflammatory factors-induced expression of mucins in normal and asthmatic epithelium,51,1.770E-01,2.992E-01,1.770E-01,2.992E-01,7,"COX-2 (PTGS2), Histamine H1 receptor, IL-1 beta, IL-8, IL-6, C3a, TNF-alpha",
829,HIF-1 in gastric cancer,51,1.770E-01,2.992E-01,1.770E-01,2.992E-01,7,"COX-2 (PTGS2), PGE2R2, Osteopontin, Cyr61, AKT(PKB), c-Src, MDR1",
830,Inhibition of Calcitriol/ VDR signaling in colorectal cancer,51,1.770E-01,2.992E-01,1.770E-01,2.992E-01,7,"DKK4, G0/G1switch 2, CYP27A1, SLUG, CYP24A1, Kallikrein 6 (Neurosin), Kallikrein 10 (KLK10)",
831,Development_Beta-adrenergic receptors signaling via Cyclic AMP,51,1.770E-01,2.992E-01,1.770E-01,2.992E-01,7,"AKAP6, Beta-3 adrenergic receptor, Troponin C, cardiac, Adenylate cyclase, PPARGC1 (PGC1-alpha), Beta-2 adrenergic receptor, PDE3A",
832,Epithelial cell anoikis in COPD,51,1.770E-01,2.992E-01,1.770E-01,2.992E-01,7,"BPAG2, PI3K cat class IA, IRS-2, Actin cytoskeletal, MMP-8, AKT(PKB), MMP-9",
833,Serotonin modulation of dopamine release in nicotine addiction,42,1.777E-01,2.998E-01,1.777E-01,2.998E-01,6,"HTR3, PKC, GABA-A receptor, HTR2C (HTR1C), G-protein alpha-i family, Adenylate cyclase",
834,Inhibition of GTPase prenylation by statins in asthma and COPD,42,1.777E-01,2.998E-01,1.777E-01,2.998E-01,6,"COX-2 (PTGS2), IL-8, GM-CSF, IL-6, AKT(PKB), TNF-alpha",
835,Immune response_iC3b-induced phagocytosis via alpha-M/beta-2 integrin,61,1.862E-01,3.133E-01,1.862E-01,3.133E-01,8,"Syk, PI3K cat class IA, PKC, ITGB2, Myosin II, Actin cytoskeletal, Rac2, iC3b",
836,IGF-1 receptor/EGFR cooperation in lung cancer,25,1.873E-01,3.133E-01,1.873E-01,3.133E-01,4,"PI3K cat class IA, IRS-2, EGFR, AKT(PKB)",
837,Apoptosis and survival_Role of nuclear PI3K in NGF/ TrkA signaling,25,1.873E-01,3.133E-01,1.873E-01,3.133E-01,4,"NGF, TrkA, PI3K cat class IA, AKT(PKB)",
838,G-protein signaling_K-RAS regulation pathway,25,1.873E-01,3.133E-01,1.873E-01,3.133E-01,4,"B-Raf, PKC-theta, EGFR, RASGRF1",
839,G-protein signaling_TC21 regulation pathway,25,1.873E-01,3.133E-01,1.873E-01,3.133E-01,4,"B-Raf, CalDAG-GEFIII, RASGRF1, c-Src",
840,Fenofibrate in treatment of type 2 diabetes and metabolic syndrome X,25,1.873E-01,3.133E-01,1.873E-01,3.133E-01,4,"APOA2, RBP4, Acyl-CoA synthetase, LPL",
841,Inhibition of TGF-beta signaling in gastric cancer,25,1.873E-01,3.133E-01,1.873E-01,3.133E-01,4,"TGF-beta 2, Gasdermin, RUNX3, TGF-beta receptor type II",
842,G-protein signaling_Proinsulin C-peptide signaling,52,1.896E-01,3.153E-01,1.896E-01,3.153E-01,7,"COX-2 (PTGS2), PI3K cat class IA, PKC-alpha, G-protein alpha-i family, AKT(PKB), PI3K reg class IB (p101), c-Src",
843,Development_Endothelin-1/EDNRA signaling,52,1.896E-01,3.153E-01,1.896E-01,3.153E-01,7,"PI3K cat class IA, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), G-protein alpha-q/11, c-Src, EDNRA",
844,Nicotine signaling in cholinergic neurons,52,1.896E-01,3.153E-01,1.896E-01,3.153E-01,7,"NGF, TrkA, PI3K cat class IA, P/Q-type calcium channel alpha-1A subunit, nAChR alpha-3, SLC18A3, nNOS",
845,Apoptosis and survival_Caspase cascade,34,1.918E-01,3.153E-01,1.918E-01,3.153E-01,5,"Caspase-10, FasR(CD95), FasL(TNFSF6), AKT(PKB), TNF-alpha",
846,Development_S1P1 receptor signaling via beta-arrestin,34,1.918E-01,3.153E-01,1.918E-01,3.153E-01,5,"G-protein alpha-i1, S1P1 receptor, G-protein alpha-i family, c-Src, PDGF-R-beta",
847,Apoptosis and survival_Role of CDK5 in neuronal death and survival,34,1.918E-01,3.153E-01,1.918E-01,3.153E-01,5,"NGF, NGFR(TNFRSF16), TrkA, PI3K cat class IA, AKT(PKB)",
848,Role of Apo-2L(TNFSF10) in Prostate Cancer cell apoptosis,34,1.918E-01,3.153E-01,1.918E-01,3.153E-01,5,"TRUNDD(TNFRSF10D), c-IAP2, Caspase-10, Apo-2L(TNFSF10), Osteoprotegerin",
849,G-protein signaling_RhoA regulation pathway,34,1.918E-01,3.153E-01,1.918E-01,3.153E-01,5,"BMX, Fyn, Ephrin-A receptors, G-protein alpha-q/11, Ephrin-A",
850,G-protein signaling_G-Protein beta/gamma signaling cascades,34,1.918E-01,3.153E-01,1.918E-01,3.153E-01,5,"G-protein alpha-15, AKT(PKB), Caveolin-1, PI3K reg class IB (p101), c-Src",
851,"Apoptosis and survival_Cytoplasmic/mitochondrial transport of proapoptotic proteins Bid, Bmf and Bim",34,1.918E-01,3.153E-01,1.918E-01,3.153E-01,5,"HGK(MAP4K4), Caspase-10, FasR(CD95), FasL(TNFSF6), TNF-alpha",
852,Development_ACM2 and ACM4 activation of ERK,43,1.918E-01,3.153E-01,1.918E-01,3.153E-01,6,"PKC-alpha, EGFR, G-protein alpha-i family, ACM4, Caldesmon, Fyn",
853,Immune response_Antimicrobial actions of IFN-gamma,43,1.918E-01,3.153E-01,1.918E-01,3.153E-01,6,"IDO1, GBP1, NGAL, Staf-50, MD-2, TLR3",
854,Role of Insulin in regulation of eating behavior in obesity,43,1.918E-01,3.153E-01,1.918E-01,3.153E-01,6,"PKC-theta, IRS-2, TLR4, NPY, AKT(PKB), Acyl-CoA synthetase",
855,Impaired inhibitory action of lipoxins and Resolvin E1 on neutrophil functions in CF,43,1.918E-01,3.153E-01,1.918E-01,3.153E-01,6,"FPRL1, IL-1 beta, IL-8, G-protein alpha-i family, PI3K reg class IB (p101), TNF-alpha",
856,Role of epigenetic alterations in survival and migration of SCLC cells,43,1.918E-01,3.153E-01,1.918E-01,3.153E-01,6,"LAMC2, Connexin 26, SLIT2, FasR(CD95), LAMB3, HGF receptor (Met)",
857,Development_Stimulation of differentiation of mouse embryonic fibroblasts into adipocytes by extracellular factors,71,1.930E-01,3.161E-01,1.930E-01,3.161E-01,9,"PPCKC, EGR2 (Krox20), Lysyl oxidase, IRS-2, NGAL, Adenylate cyclase, LIF, BMP2, LPL",
858,Development_Positive regulation of STK3/4 (Hippo) pathway and negative regulation of YAP/TAZ function,71,1.930E-01,3.161E-01,1.930E-01,3.161E-01,9,"Glucagon, Adenylate cyclase, FasR(CD95), LIF, Actin cytoskeletal, TAZ, Beta-2 adrenergic receptor, Angiomotin (AMOT), Axin",
859,Signal transduction_Adenosine A2B receptor signaling pathway,71,1.930E-01,3.161E-01,1.930E-01,3.161E-01,9,"PI3K cat class IA, B-Raf, PKC, Adenosine A2b receptor, Adenylate cyclase, IL-6, AKT(PKB), G-protein alpha-q/11, TNF-alpha",
860,Transcription_Transcription factor Tubby signaling pathways,17,1.963E-01,3.209E-01,1.963E-01,3.209E-01,3,"PKC, HTR2C (HTR1C), G-protein alpha-q/11",
861,Involvement of VEGF signaling in the progression of lung cancer,17,1.963E-01,3.209E-01,1.963E-01,3.209E-01,3,"Fyn, AKT(PKB), c-Src",
862,Development_Negative regulation of STK3/4 (Hippo) pathway and positive regulation of YAP/TAZ function,62,1.980E-01,3.229E-01,1.980E-01,3.229E-01,8,"CD44, EGFR, Actin cytoskeletal, TAZ, PAR1, G-protein alpha-q/11, Angiotensin II, Angiomotin (AMOT)",
863,Development_Alpha-2 adrenergic receptor activation of ERK,62,1.980E-01,3.229E-01,1.980E-01,3.229E-01,8,"G-protein alpha-i1, PI3K cat class IA, ADAM12, cPLA2, EGFR, G-protein alpha-i family, AKT(PKB), c-Src",
864,Apoptosis and survival_Role of PKR in stress-induced apoptosis,53,2.026E-01,3.281E-01,2.026E-01,3.281E-01,7,"IFN-alpha, TLR4, FasR(CD95), FasL(TNFSF6), TLR3, IFN-beta, TNF-alpha",
865,ENaC regulation in normal and CF airways ,53,2.026E-01,3.281E-01,2.026E-01,3.281E-01,7,"cPKC (conventional), PI3K cat class IA, SERPINE2, Adenylate cyclase, Beta-2 adrenergic receptor, G-protein alpha-q/11, c-Src",
866,Development_Role of growth factors in the maintenance of embryonic stem cell pluripotency,53,2.026E-01,3.281E-01,2.026E-01,3.281E-01,7,"PI3K cat class IA, Activin A, Oct-3/4, TGF-beta receptor type II, Myosin II, FGF2, AKT(PKB)",
867,"Development_Insulin, IGF-1 and TNF-alpha in brown adipocyte differentiation",53,2.026E-01,3.281E-01,2.026E-01,3.281E-01,7,"IRS-2, Beta-3 adrenergic receptor, FOXC2, PPARGC1 (PGC1-alpha), Beta-2 adrenergic receptor, AKT(PKB), TNF-alpha",
868,Regulation of VEGF expression in lung cancer,53,2.026E-01,3.281E-01,2.026E-01,3.281E-01,7,"COX-2 (PTGS2), IL-1 beta, PI3K cat class IA, MMP-2, IL-6, AKT(PKB), c-Src",
869,Cell cycle_Influence of Ras and Rho proteins on G1/S Transition,53,2.026E-01,3.281E-01,2.026E-01,3.281E-01,7,"PI3K cat class IA, Cyclin E, MRLC, alpha-5/beta-1 integrin, AKT(PKB), MLCK, CDK6",
870,CAR signaling via cross-talk / Human Version,26,2.066E-01,3.333E-01,2.066E-01,3.333E-01,4,"PPCKC, PPARGC1 (PGC1-alpha), CYP7A1, HNF4-alpha",
871,Development_S1P2 and S1P3 receptors in cell proliferation and differentiation,26,2.066E-01,3.333E-01,2.066E-01,3.333E-01,4,"Transgelin, ACTA2, Actin, Cofilin",
872,Cell adhesion_Classical cadherin-mediated cell adhesion,26,2.066E-01,3.333E-01,2.066E-01,3.333E-01,4,"N-cadherin, F-Actin, F-Actin cytoskeleton, Actin cytoskeletal",
873,Th2-cytokines induced expression of Mucin 5AC and maintenance of mucous cell phenotype in normal airway epithelium,35,2.083E-01,3.345E-01,2.083E-01,3.345E-01,5,"TGF-beta 2, TGF-beta receptor type II, SOX17, HNF3-beta, GCNT3",
874,G-protein signaling_S1P2 receptor signaling pathway,35,2.083E-01,3.345E-01,2.083E-01,3.345E-01,5,"G-protein alpha-i family, Adenylate cyclase, AKT(PKB), PI3K reg class IB (p101), Adenylate cyclase type VII",
875,Development_Angiopoietin - Tie2 signaling,35,2.083E-01,3.345E-01,2.083E-01,3.345E-01,5,"PI3K cat class IA, Angiopoietin 1, STAT5, Angiopoietin 4, AKT(PKB)",
876,Altered Ca2+ handling in heart failure,35,2.083E-01,3.345E-01,2.083E-01,3.345E-01,5,"NCX1, G-protein alpha-i family, Adenylate cyclase, BIN1 (Amphiphysin II), Beta-2 adrenergic receptor",
877,Degranulation of lung mast cells,63,2.102E-01,3.368E-01,2.102E-01,3.368E-01,8,"Syk, PGE2R2, cPKC (conventional), PI3K cat class IA, Lyn, G-protein alpha-i family, Fyn, Beta-2 adrenergic receptor",
878,Neuroprotective action of lithium,63,2.102E-01,3.368E-01,2.102E-01,3.368E-01,8,"WNT, NR2, FZD5, c-Src, nNOS, NR2A, Axin, Frizzled",
879,GTP metabolism,54,2.160E-01,3.445E-01,2.160E-01,3.445E-01,7,"PDE1C, PDE1A, GUCY1B1, Guanylate cyclase A (NPR1), PDE2A, PDE3A, Guanylate cyclase beta",
880,Blood coagulation_GPVI-dependent platelet activation,54,2.160E-01,3.445E-01,2.160E-01,3.445E-01,7,"Syk, PKC-alpha, ITGB3, Lyn, Fyn, LAT, GRAP2",
881,"Immune response_Antigen presentation by MHC class I, classical pathway",54,2.160E-01,3.445E-01,2.160E-01,3.445E-01,7,"MHC Class I alpha chain, TAP1 (PSF1), PSMB8(LMP7), TAP2 (PSF2), PSMB9, ERAP2, TAP",
882,Impaired inhibitory action of lipoxins on ROS production in neutrophils in CF,54,2.160E-01,3.445E-01,2.160E-01,3.445E-01,7,"FPRL1, G-protein alpha-15, PKC-alpha, IL-8, G-protein alpha-i family, Rac2, PI3K reg class IB (p101)",
883,"Role of inflammasome in macrophages, adipocytes and pancreatic beta cells in type 2 diabetes",18,2.208E-01,3.510E-01,2.208E-01,3.510E-01,3,"IL-1 beta, IL-18, Caspase-1",
884,Beta-adrenergic-dependent CFTR expression,18,2.208E-01,3.510E-01,2.208E-01,3.510E-01,3,"Beta-3 adrenergic receptor, Adenylate cyclase, Beta-2 adrenergic receptor",
885,Multiple myeloma (general schema),18,2.208E-01,3.510E-01,2.208E-01,3.510E-01,3,"RANKL(TNFSF11), IL-6, FGF2",
886,Immune response_TNF-R2 signaling pathways,45,2.212E-01,3.513E-01,2.212E-01,3.513E-01,6,"TNF-R2, c-IAP2, BMX, PI3K cat class IA, AKT(PKB), TNF-alpha",
887,Oxidative stress in adipocyte dysfunction in type 2 diabetes and metabolic syndrome X,64,2.226E-01,3.530E-01,2.226E-01,3.530E-01,8,"PI3K cat class IA, IRS-2, CCL2, Xanthine oxidase, IL-6, AKT(PKB), PLA2, TNF-alpha",
888,Prolactin/ ERK signaling in breast cancer,36,2.252E-01,3.551E-01,2.252E-01,3.551E-01,5,"PI3K cat class IA, MMP-2, AKT(PKB), c-Src, Prolactin",
889,Immune response_IL-22 signaling pathway,36,2.252E-01,3.551E-01,2.252E-01,3.551E-01,5,"MHC class II, STAT4, IL-22RA2, STAT5, IL22RA1",
890,HBV signaling via protein kinases leading to HCC,36,2.252E-01,3.551E-01,2.252E-01,3.551E-01,5,"cPKC (conventional), PKC, PKC-alpha, c-Src, MMP-9",
891,Microsatellite instability in colorectal cancer,36,2.252E-01,3.551E-01,2.252E-01,3.551E-01,5,"TGF-beta receptor type II, EGFR, Ephrin-B receptor 2, Axin2, HLA-DRA1",
892,Notch signaling in oligodendrocyte precursor cell differentiation in multiple sclerosis,27,2.264E-01,3.551E-01,2.264E-01,3.551E-01,4,"SOX10, Myelin basic protein, HES5, Jagged1",
893,G-protein signaling_G-Protein alpha-i signaling cascades,27,2.264E-01,3.551E-01,2.264E-01,3.551E-01,4,"B-Raf, G-protein alpha-i family, Caveolin-1, c-Src",
894,Activation of TGF-beta signaling in pancreatic cancer,27,2.264E-01,3.551E-01,2.264E-01,3.551E-01,4,"ICAM1, TGF-beta receptor type II, SLUG, GLI-2",
895,Desensitization of Beta-2 adrenergic receptor signaling and reduction of relaxation,27,2.264E-01,3.551E-01,2.264E-01,3.551E-01,4,"IL-1 beta, G-protein alpha-i family, Beta-2 adrenergic receptor, c-Src",
896,CAR signaling via cross-talk / Rodent version,27,2.264E-01,3.551E-01,2.264E-01,3.551E-01,4,"PPCKC, PPARGC1 (PGC1-alpha), CYP7A1, HNF4-alpha",
897,Regulation of VEGF signaling in pancreatic cancer,27,2.264E-01,3.551E-01,2.264E-01,3.551E-01,4,"Neuropilin-2, IL-1 alpha, Neuropilin-1, IL-6",
898,Signal transduction_Calcium signaling,46,2.364E-01,3.696E-01,2.364E-01,3.696E-01,6,"cPKC (conventional), AKAP6, CD44, NCX1, CaMK I, MEF2",
899,EGFR signaling in Prostate Cancer,46,2.364E-01,3.696E-01,2.364E-01,3.696E-01,6,"PI3K cat class IA, EGFR, TGF-alpha, AKT(PKB), Caveolin-1, c-Src",
900,Signal transduction_PTEN pathway,46,2.364E-01,3.696E-01,2.364E-01,3.696E-01,6,"PI3K cat class IA, Tcf(Lef), EGFR, alpha-5/beta-1 integrin, AKT(PKB), c-Src",
901,Development_Growth factors in regulation of oligodendrocyte precursor cell survival,37,2.425E-01,3.770E-01,2.425E-01,3.770E-01,5,"PI3K cat class IA, Lyn, Fyn, PDGF-R-alpha, AKT(PKB)",
902,FGFR3 signaling in multiple myeloma,37,2.425E-01,3.770E-01,2.425E-01,3.770E-01,5,"FGF1, FGF2, AKT(PKB), FGF8, FGF9",
903,G-protein signaling_Regulation of p38 and JNK signaling mediated by G-proteins,37,2.425E-01,3.770E-01,2.425E-01,3.770E-01,5,"G-protein alpha-i family, MEF2C, G-protein alpha-q/11, PI3K reg class IB (p101), c-Src",
904,Deregulation of PSD-95-dependent signaling in Huntington's disease,37,2.425E-01,3.770E-01,2.425E-01,3.770E-01,5,"B-Raf, NR2, c-Src, nNOS, NR2A",
905,Immune response_IL-7 signaling in T lymphocytes,37,2.425E-01,3.770E-01,2.425E-01,3.770E-01,5,"STAT5A, IRS-2, STAT5, Fyn, AKT(PKB)",
906,Immune response_IL-5 signaling via JAK/STAT,56,2.436E-01,3.774E-01,2.436E-01,3.774E-01,7,"IL-1 beta, c-IAP2, IL-8, STAT5, ECP (RNase 3), Pim-1, BLIMP1 (PRDI-BF1)",
907,Muscle contraction_ACM regulation of smooth muscle contraction,56,2.436E-01,3.774E-01,2.436E-01,3.774E-01,7,"TRPC5, PKC, MRLC, CPI-17, c-Src, MLCK, ACM3",
908,Mitogenic action of ErbB2 in breast cancer,56,2.436E-01,3.774E-01,2.436E-01,3.774E-01,7,"Cyclin A1, PI3K cat class IA, Cyclin E, EGFR, AKT(PKB), ER81, c-Src",
909,Development_Role of CNTF and LIF in regulation of oligodendrocyte development,28,2.466E-01,3.818E-01,2.466E-01,3.818E-01,4,"c-IAP2, PI3K cat class IA, LIF, AKT(PKB)",
910,Immune response_Reactive oxygen species (ROS) in IL-4 signaling,66,2.481E-01,3.837E-01,2.481E-01,3.837E-01,8,"cPKC (conventional), iNOS, PKC, PKC-alpha, DUOXA2, DUOX2, PDE3A, DUOXA1",
911,Role of proinflammatory cytokines in activation of p53 in major depressive disorder,47,2.520E-01,3.892E-01,2.520E-01,3.892E-01,6,"3HAO, IDO1, IFN-alpha, TGF-beta, TrkB, TNF-alpha",
912,Signal transduction_Cyclic AMP signaling,38,2.601E-01,3.992E-01,2.601E-01,3.992E-01,5,"Adenylate cyclase type VIII, PKC, PKC-alpha, G-protein alpha-i family, Adenylate cyclase type VII",
913,Development_Mu-type opioid receptor signaling,38,2.601E-01,3.992E-01,2.601E-01,3.992E-01,5,"STAT5A, G-protein alpha-i family, AKT(PKB), PI3K reg class IB (p101), c-Src",
914,Development_Noncanonical WNT signaling in cardiac myogenesis,38,2.601E-01,3.992E-01,2.601E-01,3.992E-01,5,"PKC, WNT11, ACTC, beta-MHC, FZD7",
915,Defective efferocytosis in COPD,38,2.601E-01,3.992E-01,2.601E-01,3.992E-01,5,"MFGE8, TIM-1, TIM-4, BAI1, Protein S",
916,Cytoskeleton remodeling_ACM3 and ACM4 in keratinocyte migration,38,2.601E-01,3.992E-01,2.601E-01,3.992E-01,5,"iNOS, G-protein alpha-i family, ACM4, G-protein alpha-q/11, ACM3",
917,IgE-dependent production of pro-inflammatory mediators by neutrophils in asthma,38,2.601E-01,3.992E-01,2.601E-01,3.992E-01,5,"COX-2 (PTGS2), IL-8, GM-CSF, ECP (RNase 3), Alpha-defensin",
918,Development_Thrombopoietin signaling via ERK1/2 and PI3K,67,2.613E-01,4.004E-01,2.613E-01,4.004E-01,8,"NF-E2 (45 kDa), PI3K cat class IA, B-Raf, IRS-2, BMP4, HOXA9, AKT(PKB), FLI1",
919,Immune response_CD137 signaling in immune cell,29,2.673E-01,4.091E-01,2.673E-01,4.091E-01,4,"Cyclin E, BFL1, CD137 ligand(TNFSF9), CD137(TNFRSF9)",
920,Oxidative stress_Role of IL-8 signaling pathway in respiratory burst,48,2.678E-01,4.091E-01,2.678E-01,4.091E-01,6,"PKC-alpha, IL-8, G-protein alpha-i family, Rac2, AKT(PKB), PI3K reg class IB (p101)",
921,IL-17-induced mucin expression in CF airways,48,2.678E-01,4.091E-01,2.678E-01,4.091E-01,6,"IL-1 beta, MHC class II, IL23A, TLR4, IL-6, TLR2",
922,DNA damage_Inhibition of telomerase activity and cellular senescence,20,2.712E-01,4.134E-01,2.712E-01,4.134E-01,3,"AKT(PKB), p16INK4, CDK6",
923,Cytoskeleton remodeling_Role of Activin A in cytoskeleton remodeling,20,2.712E-01,4.134E-01,2.712E-01,4.134E-01,3,"Activin A, ACTA2, Fibronectin",
924,Development_PACAP signaling in neural cells,39,2.781E-01,4.216E-01,2.781E-01,4.216E-01,5,"PACAP receptor 1, cPKC (conventional), B-Raf, PACAP, G-protein alpha-q/11",
925,NRSF-dependent transcription deregulation in Huntington's Disease,39,2.781E-01,4.216E-01,2.781E-01,4.216E-01,5,"ITGB1, Enkephalin A, ACM4, SLC18A3, nAChR beta-2",
926,Resistance of melanoma cells to Apo-2L(TNFSF10)-induced apoptosis,39,2.781E-01,4.216E-01,2.781E-01,4.216E-01,5,"TRUNDD(TNFRSF10D), PI3K cat class IA, B-Raf, IFN-alpha, Apo-2L(TNFSF10)",
927,Development_ERBB-family signaling,39,2.781E-01,4.216E-01,2.781E-01,4.216E-01,5,"PI3K cat class IA, Epiregulin, EGFR, TGF-alpha, AKT(PKB)",
928,Autocrine Somatotropin signaling in breast cancer,39,2.781E-01,4.216E-01,2.781E-01,4.216E-01,5,"PAX5, STAT5, HOXA1, c-Src, Podoplanin",
929,Development_Melanocyte development and pigmentation,49,2.838E-01,4.299E-01,2.838E-01,4.299E-01,6,"SOX10, PI3K cat class IA, B-Raf, Galpha(s)-specific peptide GPCRs, AKT(PKB), Frizzled",
930,Regulation of lipid metabolism_G-alpha(q) regulation of lipid metabolism,59,2.868E-01,4.339E-01,2.868E-01,4.339E-01,7,"COX-2 (PTGS2), APOC1, PKC, cPLA2, APOC2, G-protein alpha-q/11, LPL",
931,Muscle contraction_S1P2 receptor-mediated smooth muscle contraction,30,2.882E-01,4.347E-01,2.882E-01,4.347E-01,4,"PKC-alpha, MRLC, CPI-17, MLCK",
932,Inhibition of mast cell functions by Siglecs in asthma,30,2.882E-01,4.347E-01,2.882E-01,4.347E-01,4,"Syk, Lyn, LAT, GRAP2",
933,Role of CNTF and LIF in regulation of oligodendrocyte development in multiple sclerosis,30,2.882E-01,4.347E-01,2.882E-01,4.347E-01,4,"c-IAP2, PI3K cat class IA, LIF, AKT(PKB)",
934,Apoptosis and survival_Ceramides signaling pathway,40,2.963E-01,4.439E-01,2.963E-01,4.439E-01,5,"PI3K cat class IA, FasR(CD95), FasL(TNFSF6), AKT(PKB), TNF-alpha",
935,Role of glycosphingolipids in inhibition of Insulin signaling,40,2.963E-01,4.439E-01,2.963E-01,4.439E-01,5,"Actin cytoskeletal, SORBS1, B4G6, AKT(PKB), Caveolin-1",
936,Th2-cytokines-induced mucous metaplasia in asthma,40,2.963E-01,4.439E-01,2.963E-01,4.439E-01,5,"PI3K cat class IA, IRS-2, SOX17, HNF3-beta, GCNT3",
937,IL-6 signaling in Prostate Cancer,40,2.963E-01,4.439E-01,2.963E-01,4.439E-01,5,"BMX, PI3K cat class IA, IL-6, AKT(PKB), Pim-1",
938,Androstenedione and testosterone biosynthesis and metabolism p.3,40,2.963E-01,4.439E-01,2.963E-01,4.439E-01,5,"AKR1C3, UGT1A10, UGT2B7, AKR1C2, HSD11B1",
939,Development_Beta-catenin destruction complex signaling,21,2.969E-01,4.439E-01,2.969E-01,4.439E-01,3,"Tcf(Lef), Axin, TCF7 (TCF1)",
940,Cell cycle_Cell cycle (generic schema),21,2.969E-01,4.439E-01,2.969E-01,4.439E-01,3,"Cyclin E, Cyclin A, CDK6",
941,Gamma-secretase regulation of mammary cell development,21,2.969E-01,4.439E-01,2.969E-01,4.439E-01,3,"NOTCH4 (ICD4), STAT5A, NOTCH4",
942,B cell signaling in hematological malignancies,80,3.011E-01,4.491E-01,3.011E-01,4.491E-01,9,"Syk, ZAP70, CD38, Lyn, CD70(TNFSF7), IL-6, AKT(PKB), PI3K cat class IA (p110-delta), CARD11",
943,IGF family signaling in colorectal cancer,60,3.016E-01,4.491E-01,3.016E-01,4.491E-01,7,"COX-2 (PTGS2), IRS-2, IL-8, Apo-2L(TNFSF10), AKT(PKB), IBP, IBP3",
944,Development_Thyroliberin signaling,60,3.016E-01,4.491E-01,3.016E-01,4.491E-01,7,"PKC-alpha, ETS1, Adenylate cyclase, G-protein alpha-q/11, c-Src, nNOS, Prolactin",
945,Oxidative stress_ROS-mediated MAPK activation via canonical pathways,60,3.016E-01,4.491E-01,3.016E-01,4.491E-01,7,"GSTP1, EGFR, Fyn, SFK, c-Src, TSAD, PDGF-R-beta",
946,Apoptosis and survival_Role of IAP-proteins in apoptosis,31,3.094E-01,4.601E-01,3.094E-01,4.601E-01,4,"c-IAP2, FasR(CD95), FasL(TNFSF6), TNF-alpha",
947,Immune response_Neurotensin-induced activation of IL-8 in colonocytes,41,3.146E-01,4.670E-01,3.146E-01,4.670E-01,5,"PKC-alpha, IL-8, NT, G-protein alpha-i family, c-Src",
948,Development_Oxytocin receptor signaling,41,3.146E-01,4.670E-01,3.146E-01,4.670E-01,5,"cPKC (conventional), iNOS, MEF2C, G-protein alpha-q/11, nNOS",
949,Signal transduction_PKA signaling,51,3.165E-01,4.683E-01,3.165E-01,4.683E-01,6,"AKAP12, G-protein alpha-i family, Adenylate cyclase, AKAP82, DARPP-32, PDE3A",
950,IL-6 signaling in multiple myeloma,51,3.165E-01,4.683E-01,3.165E-01,4.683E-01,6,"PI3K cat class IA, Lyn, IL-6, FGF2, AKT(PKB), CDK6",
951,Immune response_IFN-gamma signaling via MAPK,51,3.165E-01,4.683E-01,3.165E-01,4.683E-01,6,"iNOS, IP10, IL-18, IFI16, COL1A2, TNF-alpha",
952,Regulation of Adenylate cyclase and IMPA1 by lithium in major depressive disorder,22,3.227E-01,4.759E-01,3.227E-01,4.759E-01,3,"G-protein alpha-i1, G-protein alpha-i family, Adenylate cyclase",
953,T regulatory cell migration in asthma,22,3.227E-01,4.759E-01,3.227E-01,4.759E-01,3,"G-protein alpha-i family, AKT(PKB), PI3K reg class IB (p101)",
954,LRRK2 and immune function in Parkinson's disease,22,3.227E-01,4.759E-01,3.227E-01,4.759E-01,3,"MHC class II, IFN-beta, TNF-alpha",
955,Neurophysiological process_NMDA-dependent postsynaptic long-term potentiation in CA1 hippocampal neurons,82,3.269E-01,4.817E-01,3.269E-01,4.817E-01,9,"B-Raf, Adenylate cyclase type VIII, PKC-alpha, NR2, GluR1, RASGRF1, AKT(PKB), c-Src, NR2A",
956,Development_Transcription regulation of granulocyte development,32,3.307E-01,4.867E-01,3.307E-01,4.867E-01,4,"PKC, STAT5, c-Fes, CD13",
957,Development_WNT/Beta-catenin signaling in the nucleus,62,3.317E-01,4.876E-01,3.317E-01,4.876E-01,7,"Tcf(Lef), RUNX, WNT, MEF2, TLE, TCF7 (TCF1), Frizzled",
958,Role of TNF-alpha in type 2 diabetes in skeletal muscle cells,42,3.331E-01,4.877E-01,3.331E-01,4.877E-01,5,"HGK(MAP4K4), PKC-theta, PKC-alpha, PPARGC1 (PGC1-alpha), TNF-alpha",
959,Immune response_PIP3 signaling in B lymphocytes,42,3.331E-01,4.877E-01,3.331E-01,4.877E-01,5,"Syk, PI3K cat class IA, Lyn, AKT(PKB), PI3K reg class IB (p101)",
960,Estradiol metabolism,42,3.331E-01,4.877E-01,3.331E-01,4.877E-01,5,"UGT1A1, CYP1A1, UGT1A10, UGT2B7, UGT1A4",
961,Chylomicron dyslipidemia in type 2 diabetes and metabolic syndrome X,42,3.331E-01,4.877E-01,3.331E-01,4.877E-01,5,"APOA4, MTP, APOC2, CETP, LPL",
962,Apoptosis and survival_CXCR3-B signaling,63,3.469E-01,5.073E-01,3.469E-01,5.073E-01,7,"IP10, IDO2, I-TAC, ITGB3, Adenylate cyclase, PF4, PF4V1",
963,Cytoskeleton remodeling_CDC42 in cellular processes,23,3.485E-01,5.091E-01,3.485E-01,5.091E-01,3,"F-Actin cytoskeleton, Actin cytoskeletal, Cofilin",
964,Apoptosis and survival_Anti-apoptotic action of Gastrin,43,3.517E-01,5.112E-01,3.517E-01,5.112E-01,5,"PI3K cat class IA, PKC-alpha, AKT(PKB), G-protein alpha-q/11, c-Src",
965,Development_WNT/Beta-catenin signaling pathway. Signalosome,43,3.517E-01,5.112E-01,3.517E-01,5.112E-01,5,"WNT, G-protein alpha-i family, DAAM2, Axin, Frizzled",
966,Development_Notch Signaling Pathway,43,3.517E-01,5.112E-01,3.517E-01,5.112E-01,5,"p63, HEY1, Manic fringe glycosyltransferase, TLE, Jagged1",
967,IL-2 as a growth factor for T cells in multiple sclerosis,33,3.520E-01,5.112E-01,3.520E-01,5.112E-01,4,"STAT5A, PI3K cat class IA, Cyclin E, AKT(PKB)",
968,Nicotine signaling in glutamatergic neurons,33,3.520E-01,5.112E-01,3.520E-01,5.112E-01,4,"PKC-alpha, P/Q-type calcium channel alpha-1A subunit, G-protein alpha-i family, mGluR7",
969,Signal transduction_Activin A signaling regulation,33,3.520E-01,5.112E-01,3.520E-01,5.112E-01,4,"Activin A, DLX1, MECOM, FKHL1",
970,Neurophysiological process_Activity-dependent synaptic AMPA receptor removal,64,3.621E-01,5.253E-01,3.621E-01,5.253E-01,7,"cPKC (conventional), MAP-1B, PKC, PKC-alpha, NPTX2, GluR1, Actin cytoskeletal",
971,Immune response  _Sialic-acid receptors (Siglecs) signaling,14,3.677E-01,5.322E-01,3.677E-01,5.322E-01,2,"CD43, Lyn",
972,Cell cycle_Nucleocytoplasmic transport of CDK/Cyclins,14,3.677E-01,5.322E-01,3.677E-01,5.322E-01,2,"Cyclin E, Cyclin A",
973,Development_Flt3 signaling,44,3.704E-01,5.350E-01,3.704E-01,5.350E-01,5,"STAT5A, PI3K cat class IA, Fyn, AKT(PKB), c-Src",
974,Chemotaxis_C5a-induced chemotaxis,44,3.704E-01,5.350E-01,3.704E-01,5.350E-01,5,"G-protein alpha-15, B-Raf, G-protein alpha-i family, F-Actin cytoskeleton, Actin cytoskeletal",
975,Development_HGF-dependent inhibition of TGF-beta-induced EMT,34,3.734E-01,5.366E-01,3.734E-01,5.366E-01,4,"HGF, COX-2 (PTGS2), TGF-beta receptor type II, HGF receptor (Met)",
976,Immune response_IL-11 signaling via JAK/STAT,34,3.734E-01,5.366E-01,3.734E-01,5.366E-01,4,"RANKL(TNFSF11), A2M, REG3G, Pim-1",
977,Cannabinoid receptor signaling in nicotine addiction,34,3.734E-01,5.366E-01,3.734E-01,5.366E-01,4,"nAChR alpha-7, G-protein alpha-i1, P/Q-type calcium channel alpha-1A subunit, G-protein alpha-i family",
978,Transport_Low density lipoproteins assembly and remodeling,34,3.734E-01,5.366E-01,3.734E-01,5.366E-01,4,"MTP, APOC2, CETP, LPL",
979,G-protein signaling_G-Protein alpha-q signaling cascades,34,3.734E-01,5.366E-01,3.734E-01,5.366E-01,4,"PI3K cat class IA, AKT(PKB), G-protein alpha-q/11, RGS2",
980,Tissue factor signaling in lung cancer,24,3.742E-01,5.366E-01,3.742E-01,5.366E-01,3,"PAR1, AKT(PKB), Tissue factor",
981,Development_MicroRNA-dependent regulation of EMT,24,3.742E-01,5.366E-01,3.742E-01,5.366E-01,3,"TGF-beta 2, SIP1 (ZFHX1B), TCF8",
982,Possible role of neonatal nicotine exposure in development of postnatal obesity,5,3.789E-01,5.429E-01,3.789E-01,5.429E-01,1,nAChR beta-2,
983,Nicotine signaling in chromaffin cells,45,3.890E-01,5.551E-01,3.890E-01,5.551E-01,5,"N-cadherin, Adenylate cyclase type VIII, PKC-alpha, nAChR alpha-3, DBH",
984,Apo-2L(TNFSF10)-induced apoptosis in melanoma,45,3.890E-01,5.551E-01,3.890E-01,5.551E-01,5,"IFN-alpha, IL-8, Apo-2L(TNFSF10), IFN-beta, XAF1",
985,Development_Activation of ERK by Alpha-1 adrenergic receptors,45,3.890E-01,5.551E-01,3.890E-01,5.551E-01,5,"G-protein alpha-15, PKC-alpha, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor, c-Src",
986,Development_Membrane-bound ESR1: interaction with growth factors signaling,45,3.890E-01,5.551E-01,3.890E-01,5.551E-01,5,"PI3K cat class IA, B-Raf, AKT(PKB), Caveolin-1, c-Src",
987,Immune response_T regulatory cell-mediated modulation of antigen-presenting cell functions,66,3.928E-01,5.599E-01,3.928E-01,5.599E-01,7,"3HAO, IDO1, MHC class II, ICAM1, CTLA-4, 5'-NTD, TNF-alpha",
988,TNF-alpha and IL-1 beta induce hyperglycemia in obesity and type 2 diabetes in adipocytes,35,3.947E-01,5.599E-01,3.947E-01,5.599E-01,4,"IL-1 beta, TNF-R2, NGAL, TNF-alpha",
989,Transcription_Role of the non-genomic action of Retinoic acid and phosphorylation of Retinoic acid receptors in the initiation of transcription,35,3.947E-01,5.599E-01,3.947E-01,5.599E-01,4,"RBP4, CYP26A1, STRA6, c-Src",
990,Oxidative stress_NOX and DUOX families of NADPH oxidases ,35,3.947E-01,5.599E-01,3.947E-01,5.599E-01,4,"DUOXA2, DUOX2, Rac2, DUOXA1",
991,Beta-alanine metabolism,35,3.947E-01,5.599E-01,3.947E-01,5.599E-01,4,"GAD2, DPYD, DPYS, GAD1",
992,Immune response_Lipoxins and Resolvin E1 inhibitory action on neutrophil functions,35,3.947E-01,5.599E-01,3.947E-01,5.599E-01,4,"FPRL1, IL-8, G-protein alpha-i family, PI3K reg class IB (p101)",
993,Putative pathways of activation of monoclonal protein secretion in multiple myeloma,25,3.997E-01,5.663E-01,3.997E-01,5.663E-01,3,"PAX5, BOB1, BLIMP1 (PRDI-BF1)",
994,Development_G-protein-mediated regulation of MAPK-ERK signaling,46,4.076E-01,5.764E-01,4.076E-01,5.764E-01,5,"B-Raf, G-protein alpha-i family, M-Ras, G-protein alpha-q/11, c-Src",
995,Transcription_Hypoxia- and receptor-mediated HIF-1 activation,46,4.076E-01,5.764E-01,4.076E-01,5.764E-01,5,"HGF, IL-1 beta, PI3K cat class IA, EGFR, AKT(PKB)",
996,Statin action on the PI3K/ Akt pathway in COPD,36,4.159E-01,5.858E-01,4.159E-01,5.858E-01,4,"PI3K cat class IA, FasL(TNFSF6), Apo-2L(TNFSF10), AKT(PKB)",
997,Nitrogen metabolism,36,4.159E-01,5.858E-01,4.159E-01,5.858E-01,4,"Carbonic anhydrase VI, GLSK, Carbonic anhydrase II, Carbonic anhydrase IX",
998,Endothelial cell apoptosis in COPD,36,4.159E-01,5.858E-01,4.159E-01,5.858E-01,4,"PI3K cat class IA, Neuropilin-1, BFL1, AKT(PKB)",
999,G-protein signaling_Regulation of RAC1 activity,36,4.159E-01,5.858E-01,4.159E-01,5.858E-01,4,"ARCGAP22, ZAP70, CD3, Caspase-1",
1000,Cytoskeleton remodeling_FAK signaling,57,4.167E-01,5.862E-01,4.167E-01,5.862E-01,6,"PI3K cat class IA, GRP(1-27), AKT(PKB), G-protein alpha-q/11, Fibronectin, c-Src",
1001,Production of reactive oxygen species and arachidonic acid metabolites by neutrophils in asthma,68,4.234E-01,5.946E-01,4.234E-01,5.946E-01,7,"PI3K cat class IA, PKC, IL-8, G-protein alpha-i family, GM-CSF, PA24A, TNF-alpha",
1002,Lipoprotein metabolism,68,4.234E-01,5.946E-01,4.234E-01,5.946E-01,7,"APOA4, APOA2, VLDLR, MTP, APOC2, CETP, LPL",
1003,Development_PIP3 signaling in cardiac myocytes,47,4.261E-01,5.960E-01,4.261E-01,5.960E-01,5,"HGF, PI3K cat class IA, AKT(PKB), HGF receptor (Met), PI3K reg class IB (p101)",
1004,Canonical Notch signaling pathway in colorectal cancer,47,4.261E-01,5.960E-01,4.261E-01,5.960E-01,5,"HES5, CD44, WNT, AKT(PKB), Jagged1",
1005,Immune response_PGE2 common pathways,47,4.261E-01,5.960E-01,4.261E-01,5.960E-01,5,"COX-2 (PTGS2), PGE2R2, G-protein alpha-i family, Adenylate cyclase, AKT(PKB)",
1006,Neurophysiological process_Dopamine D2 receptor signaling in CNS,47,4.261E-01,5.960E-01,4.261E-01,5.960E-01,5,"Adenylate cyclase type VIII, Kir3.4, G-protein alpha-i family, CACNA1E, Adenylate cyclase type VII",
1007,Effect of H. pylori infection on gastric epithelial cell proliferation,58,4.333E-01,6.055E-01,4.333E-01,6.055E-01,6,"B-Raf, Lyn, EGFR, TLR4, HGF receptor (Met), c-Src",
1008,Sorafenib-induced inhibition of cell proliferation and angiogenesis in HCC,16,4.339E-01,6.056E-01,4.339E-01,6.056E-01,2,"B-Raf, PDGF-R-beta",
1009,Development_Schema: Methods of somatic cell reprogramming into induced pluripotent stem cells,6,4.353E-01,6.071E-01,4.353E-01,6.071E-01,1,Oct-3/4,
1010,Cholehepatic circulation of bile acids / Rodent version,37,4.369E-01,6.087E-01,4.369E-01,6.087E-01,4,"OATP8, AKR1C1, BSEP, GSTA5",
1011,"Nicotine signaling in dopaminergic neurons, Pt. 1 - cell body",48,4.446E-01,6.181E-01,4.446E-01,6.181E-01,5,"nAChR alpha-7, GABA-A receptor, G-protein alpha-i family, nAChR beta-2, nAChR alpha-6",
1012,Development_Adiponectin signaling,48,4.446E-01,6.181E-01,4.446E-01,6.181E-01,5,"PI3K cat class IA, IL-6, FGF2, AKT(PKB), c-Src",
1013,Glomerular filtration and renal reabsorption of bile acids / Rodent version,27,4.496E-01,6.239E-01,4.496E-01,6.239E-01,3,"OATP8, AKR1C1, GSTA5",
1014,Apoptosis and survival_Anti-apoptotic TNFs/NF-kB/IAP pathway,27,4.496E-01,6.239E-01,4.496E-01,6.239E-01,3,"TNF-R2, c-IAP2, TNF-alpha",
1015,Apoptosis and survival_Anti-apoptotic action of membrane-bound ESR1,38,4.577E-01,6.339E-01,4.577E-01,6.339E-01,4,"PI3K cat class IA, PKC-alpha, AKT(PKB), c-Src",
1016,Development_SDF-1 signaling in hematopoietic stem cell homing,38,4.577E-01,6.339E-01,4.577E-01,6.339E-01,4,"PI3K cat class IA, alpha-4/beta-1 integrin, Lyn, MMP-9",
1017,"Development_The role of GDNF ligand family/ RET receptor in cell survival, growth and proliferation",92,4.597E-01,6.359E-01,4.597E-01,6.359E-01,9,"ITGB1, PI3K cat class IA, NRTN, B-Raf, MLC2, F-Actin cytoskeleton, AKT(PKB), c-Src, Cofilin",
1018,IgE- and MGF-induced Fyn-mediated activation of lung mast cells in asthma,49,4.628E-01,6.390E-01,4.628E-01,6.390E-01,5,"Syk, S1P1 receptor, Lyn, Fyn, AKT(PKB)",
1019,Transcription_CREB signaling pathway,49,4.628E-01,6.390E-01,4.628E-01,6.390E-01,5,"cPKC (conventional), PI3K cat class IA, Galpha(s)-specific amine GPCRs, PKC-alpha, AKT(PKB)",
1020,G-protein signaling_Rap2A regulation pathway,17,4.655E-01,6.422E-01,4.655E-01,6.422E-01,2,"G-protein alpha-i family, M-Ras",
1021,Triacylglycerol metabolism p.1,60,4.664E-01,6.427E-01,4.664E-01,6.427E-01,6,"ACSL6, ACSL4, ALDR, AKR1C1, AK1BA, PLCD",
1022,Regulation of lipid metabolism_Alpha-1 adrenergic receptors signaling via arachidonic acid,71,4.691E-01,6.458E-01,4.691E-01,6.458E-01,7,"COX-2 (PTGS2), PTGIS, PKC-alpha, cPLA2, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor, c-Src",
1023,Development_Regulation of CDK5 in CNS,28,4.740E-01,6.507E-01,4.740E-01,6.507E-01,3,"NGF, TrkA, TrkB",
1024,Development_Mu-type opioid receptor regulation of proliferation,28,4.740E-01,6.507E-01,4.740E-01,6.507E-01,3,"ADAM12, EGFR, G-protein alpha-i family",
1025,Development_Delta-type opioid receptor signaling via G-protein alpha-14,28,4.740E-01,6.507E-01,4.740E-01,6.507E-01,3,"Metenkefalin, PKC-alpha, c-Src",
1026,Regulation of degradation of deltaF508-CFTR in CF,39,4.783E-01,6.546E-01,4.783E-01,6.546E-01,4,"Alpha crystallin A, UCHL1, BAG-2, Dynein 1, cytoplasmic, intermediate chains",
1027,HIV-1 signaling via CCR5 in macrophages and T lymphocytes,39,4.783E-01,6.546E-01,4.783E-01,6.546E-01,4,"CCL2, PKC-alpha, FasL(TNFSF6), TNF-alpha",
1028,Translation _Regulation of EIF2 activity,39,4.783E-01,6.546E-01,4.783E-01,6.546E-01,4,"PI3K cat class IA, IRS-2, EGFR, AKT(PKB)",
1029,Neurophysiological process_Corticoliberin signaling via CRHR1 ,50,4.809E-01,6.556E-01,4.809E-01,6.556E-01,5,"cPKC (conventional), B-Raf, PKC-alpha, Adenylate cyclase, G-protein alpha-q/11",
1030,TGF-beta signaling via microRNA in breast cancer,50,4.809E-01,6.556E-01,4.809E-01,6.556E-01,5,"TGF-beta 2, ETS1, SLUG, SIP1 (ZFHX1B), TCF8",
1031,Apoptosis and survival_HTR1A signaling,50,4.809E-01,6.556E-01,4.809E-01,6.556E-01,5,"G-protein alpha-i family, Adenylate cyclase, AKT(PKB), PI3K reg class IB (p101), c-Src",
1032,Immune response_IL-13 signaling via PI3K-ERK pathway,50,4.809E-01,6.556E-01,4.809E-01,6.556E-01,5,"IRS-2, Tenascin-C, COL1A2, AKT(PKB), PI3K cat class IA (p110-delta)",
1033,Role of epigenetic alterations in proliferation and differentiation of SCLC cells,72,4.841E-01,6.594E-01,4.841E-01,6.594E-01,7,"MYO18B, HAND1, NeuroD1, Caveolin-1, DMRTA2, HNF3-beta, CDK6",
1034,Immune response_IL-4 signaling pathway,94,4.860E-01,6.609E-01,4.860E-01,6.609E-01,9,"Syk, PKC, IRS-2, STAT5, c-Fes, AKT(PKB), PDE3A, PDE4, PI3K cat class IA (p110-delta)",
1035,G-protein signaling_Rap2B regulation pathway,7,4.867E-01,6.609E-01,4.867E-01,6.609E-01,1,M-Ras,
1036,Regulatory T cells in human allergic contact dermatitis,7,4.867E-01,6.609E-01,4.867E-01,6.609E-01,1,MHC class II,
1037,Transcription_Assembly of RNA Polymerase II preinitiation complex on TATA-less promoters ,18,4.961E-01,6.725E-01,4.961E-01,6.725E-01,2,"p15, MDR1",
1038,Androgen signaling in HCC,18,4.961E-01,6.725E-01,4.961E-01,6.725E-01,2,"HGF, HGF receptor (Met)",
1039,Adiponectin in pathogenesis of type 2 diabetes,29,4.979E-01,6.732E-01,4.979E-01,6.732E-01,3,"PPCKC, H-FABP, PPARGC1 (PGC1-alpha)",
1040,Enterohepatic circulation of bile acids / Rodent version,40,4.985E-01,6.732E-01,4.985E-01,6.732E-01,4,"OATP8, AKR1C1, BSEP, GSTA5",
1041,Cortisone biosynthesis and metabolism,51,4.988E-01,6.732E-01,4.988E-01,6.732E-01,5,"AKR1C3, CYP17, CYP21A2, AKR1C2, HSD11B1",
1042,Putative pathways of n-3 and n-6 fatty acids in obesity and type 2 diabetes,51,4.988E-01,6.732E-01,4.988E-01,6.732E-01,5,"COX-2 (PTGS2), PTGIS, Adenylate cyclase, AKT(PKB), G-protein alpha-q/11",
1043,Reproduction_Gonadotropin-releasing hormone (GnRH) signaling,73,4.990E-01,6.732E-01,4.990E-01,6.732E-01,7,"Secretogranin 1, PACAP, Adenylate cyclase, CaMK I, G-protein alpha-q/11, c-Src, Secretogranin II",
1044,O-glycan biosynthesis,63,5.149E-01,6.940E-01,5.149E-01,6.940E-01,6,"GALNTL2, GALNT9, B3GT2, B3GT1, SIAT4B, GCNT3",
1045,Main growth factor signaling cascades in multiple myeloma cells,41,5.184E-01,6.973E-01,5.184E-01,6.973E-01,4,"PI3K cat class IA, IRS-2, FGF2, AKT(PKB)",
1046,Apoptosis and survival_Phosphorylation and acetylation in TNF-alpha-induced NF-kB signaling,41,5.184E-01,6.973E-01,5.184E-01,6.973E-01,4,"PI3K cat class IA, PKC-alpha, c-Src, TNF-alpha",
1047,Role of histone modificators in progression of multiple myeloma,30,5.212E-01,6.977E-01,5.212E-01,6.977E-01,3,"IL-6, Dynein 1, cytoplasmic, intermediate chains, CDK6",
1048,Development_G-CSF-induced myeloid differentiation,30,5.212E-01,6.977E-01,5.212E-01,6.977E-01,3,"ITGB2, NGAL, GFI-1",
1049,Inhibition of mast cell functions by Fc gamma RII beta in asthma,30,5.212E-01,6.977E-01,5.212E-01,6.977E-01,3,"Syk, Lyn, AKT(PKB)",
1050,Neurophysiological process_Mu-type opioid receptor-mediated analgesia,30,5.212E-01,6.977E-01,5.212E-01,6.977E-01,3,"P/Q-type calcium channel alpha-1A subunit, G-protein alpha-i family, Adenylate cyclase type VII",
1051,Transcription_Ligand-dependent activation of the ESR1/SP pathway,30,5.212E-01,6.977E-01,5.212E-01,6.977E-01,3,"Cyclin E, EGFR, ADA",
1052,Development_Alpha-1 adrenergic receptors signaling via Cyclic AMP,19,5.256E-01,7.009E-01,5.256E-01,7.009E-01,2,"Adenylate cyclase, Alpha-1B adrenergic receptor",
1053,Protein folding_Membrane trafficking and signal transduction of G-alpha (i) heterotrimeric G-protein,19,5.256E-01,7.009E-01,5.256E-01,7.009E-01,2,"G-protein gamma, G-protein alpha-i family",
1054,Immune response_ETV3 affect on CSF1-promoted macrophage differentiation,19,5.256E-01,7.009E-01,5.256E-01,7.009E-01,2,"CSF1, PLAU (UPA)",
1055,Inhibition of WNT5A-dependent non-canonical pathway in colorectal cancer,19,5.256E-01,7.009E-01,5.256E-01,7.009E-01,2,"PKC-alpha, TCF7 (TCF1)",
1056,"Development_NCAM1-mediated neurite outgrowth, synapse assembly and neuronal survival",75,5.284E-01,7.033E-01,5.284E-01,7.033E-01,7,"NCAM1, PKC, GluR1, Fyn, AKT(PKB), nNOS, Cofilin",
1057,Transport_ACM3 signaling in lacrimal glands,75,5.284E-01,7.033E-01,5.284E-01,7.033E-01,7,"Lactoperoxidase, LBP, PKC-alpha, G-protein alpha-q/11, c-Src, Mucin 7, ACM3",
1058,Development_Role of HDAC and calcium/calmodulin-dependent kinase (CaMK) in control of skeletal myogenesis,53,5.338E-01,7.098E-01,5.338E-01,7.098E-01,5,"HDAC9, PI3K cat class IA, MEF2C, MEF2, AKT(PKB)",
1059,Transcription_FXR-regulated cholesterol and bile acids cellular transport,42,5.379E-01,7.139E-01,5.379E-01,7.139E-01,4,"OATP8, BSEP, HNF4-alpha, MDR1",
1060,Transport_HDL-mediated reverse cholesterol transport,42,5.379E-01,7.139E-01,5.379E-01,7.139E-01,4,"CES1, APOA2, LIPE, CETP",
1061,Development_Inhibition of angiogenesis by PEDF,31,5.438E-01,7.192E-01,5.438E-01,7.192E-01,3,"FasR(CD95), PA24A, FasL(TNFSF6)",
1062,IL-1 beta-dependent CFTR expression,31,5.438E-01,7.192E-01,5.438E-01,7.192E-01,3,"IL-1 beta, Pellino 1, Pellino 2",
1063,Influence of low doses of Arsenite on glucose uptake in adipocytes,31,5.438E-01,7.192E-01,5.438E-01,7.192E-01,3,"PI3K cat class IA, IRS-2, AKT(PKB)",
1064,Regulation of lipid metabolism_FXR-dependent negative-feedback regulation of bile acids concentration,31,5.438E-01,7.192E-01,5.438E-01,7.192E-01,3,"CYP7A1, HNF4-alpha, FGF19",
1065,Muscle contraction_Regulation of eNOS activity in endothelial cells,65,5.463E-01,7.211E-01,5.463E-01,7.211E-01,6,"PI3K cat class IA, ETS1, G-protein alpha-i family, AKT(PKB), Caveolin-1, c-Src",
1066,Signal transduction_mTORC2 upstream signaling,65,5.463E-01,7.211E-01,5.463E-01,7.211E-01,6,"PI3K cat class IA, V1a receptor, Protor-2, EGFR, AKT(PKB), Frizzled",
1067,Immune response_IFN-gamma signaling via JAK/STAT and PLC-gamma,54,5.508E-01,7.264E-01,5.508E-01,7.264E-01,5,"PKC-alpha, Fyn, c-Src, XAF1, Aquaporin 1",
1068,Neurophysiological process_Olfactory transduction,20,5.538E-01,7.283E-01,5.538E-01,7.283E-01,2,"Olfactory receptor, G-protein alpha-olf",
1069,Stem cells_Putative pathways of telomerase regulation in glioblastoma stem cells,20,5.538E-01,7.283E-01,5.538E-01,7.283E-01,2,"PI3K cat class IA, AKT(PKB)",
1070,Regulation of caspase activity in Huntington's disease,20,5.538E-01,7.283E-01,5.538E-01,7.283E-01,2,"Caspase-12, Caspase-1",
1071,"POMC, alpha-MSH and AGRP in regulation of food intake and energy expenditure in obesity in hypothalamus",43,5.569E-01,7.303E-01,5.569E-01,7.303E-01,4,"PKC-alpha, G-protein alpha-i family, PC1, MC4R",
1072,"Nicotine signaling in dopaminergic neurons, Pt. 2 - axon terminal",43,5.569E-01,7.303E-01,5.569E-01,7.303E-01,4,"PLAT (TPA), G-protein alpha-i family, PAR1, DARPP-32",
1073,Signal transduction_AKT signaling,43,5.569E-01,7.303E-01,5.569E-01,7.303E-01,4,"PI3K cat class IA, FasL(TNFSF6), AKT(PKB), HGF receptor (Met)",
1074,Neurophysiological process_Glucose-excited neurons of ventromedial nucleus (rodent model),32,5.659E-01,7.400E-01,5.659E-01,7.400E-01,3,"Glucagon, SLC5A1, GABA-A receptor",
1075,Signal transduction_ERK1/2 signaling pathway,32,5.659E-01,7.400E-01,5.659E-01,7.400E-01,3,"B-Raf, PKC-alpha, M-Ras",
1076,Epithelial cell apoptosis in COPD,32,5.659E-01,7.400E-01,5.659E-01,7.400E-01,3,"PAR1, Apo-2L(TNFSF10), AKT(PKB)",
1077,Tau pathology in Alzheimer disease,55,5.676E-01,7.415E-01,5.676E-01,7.415E-01,5,"PKC, Glypican-3, NR2, MAP2, Syndecan-2",
1078,K-RAS signaling in pancreatic cancer,44,5.756E-01,7.485E-01,5.756E-01,7.485E-01,4,"B-Raf, IL-8, AKT(PKB), PLAU (UPA)",
1079,Development_Ligand-independent activation of ESR1 and ESR2,44,5.756E-01,7.485E-01,5.756E-01,7.485E-01,4,"PI3K cat class IA, EGFR, AKT(PKB), Caveolin-1",
1080,Apoptosis and survival_FAS signaling cascades,44,5.756E-01,7.485E-01,5.756E-01,7.485E-01,4,"Caspase-10, FasR(CD95) soluble, FasR(CD95), FasL(TNFSF6)",
1081,Neurophysiological process_Melatonin signaling,44,5.756E-01,7.485E-01,5.756E-01,7.485E-01,4,"Melatonin receptor 1B, G-protein alpha-i family, Adenylate cyclase, Melatonin receptor 1A",
1082,Ganglioside Metabolism p2,44,5.756E-01,7.485E-01,5.756E-01,7.485E-01,4,"SIA7C, SIA7E, SIAT8A, SIAT4B",
1083,Possible regulation of HSF-1/ chaperone pathway in Huntington's disease,21,5.809E-01,7.547E-01,5.809E-01,7.547E-01,2,"PKC-alpha, PLA2",
1084,Regulation of Beta-catenin activity in colorectal cancer,56,5.840E-01,7.581E-01,5.840E-01,7.581E-01,5,"PGE2R2, PI3K cat class IA, Adenylate cyclase, AKT(PKB), Axin",
1085,G-protein signaling_Regulation of CDC42 activity,33,5.873E-01,7.581E-01,5.873E-01,7.581E-01,3,"CDGAP, Fyn, Caspase-1",
1086,p53 signaling in Prostate Cancer,33,5.873E-01,7.581E-01,5.873E-01,7.581E-01,3,"PI3K cat class IA, AKT(PKB), IBP3",
1087,Apoptosis and survival_Regulation of Apoptosis by Mitochondrial Proteins,33,5.873E-01,7.581E-01,5.873E-01,7.581E-01,3,"FasR(CD95), BFL1, Bcl-B",
1088,Prolactin signaling in Prostate Cancer,33,5.873E-01,7.581E-01,5.873E-01,7.581E-01,3,"STAT5A, c-Src, Prolactin",
1089,Development_Activation of astroglial cells proliferation by ACM3,33,5.873E-01,7.581E-01,5.873E-01,7.581E-01,3,"PI3K cat class IA, AKT(PKB), ACM3",
1090,LRRK2 in neurons in Parkinson's disease,33,5.873E-01,7.581E-01,5.873E-01,7.581E-01,3,"Alpha-synuclein, MSN (moesin), Actin cytoskeletal",
1091,Heme metabolism,103,5.992E-01,7.728E-01,5.992E-01,7.728E-01,9,"Ceruloplasmin, Apotransferrin, UGT1A1, UGT1A10, Holotransferrin, Ferritin mitochondrial, Neuroglobin, UGT1A4, UGT1A6",
1092,Development_Positive regulation of WNT/Beta-catenin signaling in the nucleus,69,6.062E-01,7.782E-01,6.062E-01,7.782E-01,6,"Tcf(Lef), RUNX, WNT, TLE, TCF7 (TCF1), Frizzled",
1093,Inhibition of GSK3 beta by lithium in major depressive disorder,22,6.067E-01,7.782E-01,6.067E-01,7.782E-01,2,"AKT(PKB), TrkB",
1094,Translation_Role of Retinoic acid signaling in the initiation of translation,22,6.067E-01,7.782E-01,6.067E-01,7.782E-01,2,"MAP2, GluR1",
1095,Microsatellite instability in gastric cancer,22,6.067E-01,7.782E-01,6.067E-01,7.782E-01,2,"TGF-beta receptor type II, p16INK4",
1096,Amitraz-induced inhibition of Insulin secretion,22,6.067E-01,7.782E-01,6.067E-01,7.782E-01,2,"G-protein alpha-i1, G-protein alpha-i family",
1097,Role of Huntingtin in regulation of BDNF in Huntington's disease,22,6.067E-01,7.782E-01,6.067E-01,7.782E-01,2,"PI3K cat class IA, AKT(PKB)",
1098,TMPRSS2-ERG fusion in Prostate Cancer,46,6.115E-01,7.820E-01,6.115E-01,7.820E-01,4,"MxA, IL-8, B3GT1, ICAM2",
1099,Role of GIP in pathogenesis of type 2 diabetes,46,6.115E-01,7.820E-01,6.115E-01,7.820E-01,4,"B-Raf, Adenylate cyclase type VIII, GIP, AKT(PKB)",
1100,Serotonin - melatonin biosynthesis and metabolism,46,6.115E-01,7.820E-01,6.115E-01,7.820E-01,4,"IDO1, CYP1A1, ALDR, MAOB",
1101,CHDI_DEGs from Replication data_Causal network,81,6.120E-01,7.820E-01,6.120E-01,7.820E-01,7,"PKC, cPLA2, WNT, AKT(PKB), Axin, Frizzled, ACM3",
1102,Putative role of Estrogen receptor and Androgen receptor signaling in progression of lung cancer,58,6.159E-01,7.856E-01,6.159E-01,7.856E-01,5,"CYP1A1, EGFR, G-protein alpha-i family, Caveolin-1, c-Src",
1103,Signal transduction_Leptin signaling in non-neuronal cells,58,6.159E-01,7.856E-01,6.159E-01,7.856E-01,5,"PI3K cat class IA, IRS-2, IL-8, IL-6, AKT(PKB)",
1104,Th2-cytokine-induced airway epithelium mucous metaplasia in COPD,70,6.205E-01,7.907E-01,6.205E-01,7.907E-01,6,"iNOS, Adenosine A2b receptor, Actin cytoskeletal, G-protein alpha-q/11, nNOS, HNF3-beta",
1105,Development_Regulation of telomere length and cellular immortalization,35,6.280E-01,7.917E-01,6.280E-01,7.917E-01,3,"PI3K cat class IA, PKC-alpha, AKT(PKB)",
1106,Neurophysiological process_Thyroliberin in cell hyperpolarization and excitability,35,6.280E-01,7.917E-01,6.280E-01,7.917E-01,3,"cPKC (conventional), PKC-alpha, Kir3.4",
1107,Action of lithium on synaptic transmission and autophagy,35,6.280E-01,7.917E-01,6.280E-01,7.917E-01,3,"PKC-alpha, Adenylate cyclase, Adenylate cyclase type VII",
1108,Development_Growth hormone signaling via STATs and PLC/IP3,35,6.280E-01,7.917E-01,6.280E-01,7.917E-01,3,"STAT5A, Fyn, c-Src",
1109,Anti-apoptotic action of Gastrin in pancreatic cancer,35,6.280E-01,7.917E-01,6.280E-01,7.917E-01,3,"PI3K cat class IA, AKT(PKB), c-Src",
1110,Cell cycle_ESR1 regulation of G1/S transition,35,6.280E-01,7.917E-01,6.280E-01,7.917E-01,3,"Cyclin E, Cyclin A, CDK6",
1111,Signal transduction_JNK pathway,47,6.288E-01,7.917E-01,6.288E-01,7.917E-01,4,"HGK(MAP4K4), FasR(CD95), FasL(TNFSF6), TNF-alpha",
1112,Development_Hedgehog signaling,47,6.288E-01,7.917E-01,6.288E-01,7.917E-01,4,"GAS1, PTCH1, GLI-1, GLI-2",
1113,Mechanisms of deltaF508 CFTR activation by S-nitrosoglutathione,47,6.288E-01,7.917E-01,6.288E-01,7.917E-01,4,"Ceruloplasmin, iNOS, IL-8, nNOS",
1114,Transport_Alpha-2 adrenergic receptor regulation of ion channels,47,6.288E-01,7.917E-01,6.288E-01,7.917E-01,4,"G-protein alpha-i1, PKC, G-protein alpha-i family, AKT(PKB)",
1115,Neurophysiological process_PGE2-induced pain processing,47,6.288E-01,7.917E-01,6.288E-01,7.917E-01,4,"COX-2 (PTGS2), PGE2R2, cPLA2, Adenylate cyclase",
1116,Development_WNT5A signaling,47,6.288E-01,7.917E-01,6.288E-01,7.917E-01,4,"PKC-alpha, Tcf(Lef), FZD5, Axin",
1117,L-Methionine metabolism,59,6.312E-01,7.917E-01,6.312E-01,7.917E-01,5,"BHMT2, SLC38A4, BHMT, SLC7A7, SLC6A19",
1118,KLF6 and regulation of KLF6 alternative splicing in HCC,23,6.313E-01,7.917E-01,6.313E-01,7.917E-01,2,"PI3K cat class IA, EGFR",
1119,Ascorbate metabolism,23,6.313E-01,7.917E-01,6.313E-01,7.917E-01,2,"PAM, DBH",
1120,Apoptosis and survival_NO signaling in apoptosis,23,6.313E-01,7.917E-01,6.313E-01,7.917E-01,2,"iNOS, nNOS",
1121,Role of Leptin in regulation of eating behavior in obesity,23,6.313E-01,7.917E-01,6.313E-01,7.917E-01,2,"NPY, AKT(PKB)",
1122,Transcription_ChREBP regulation pathway,23,6.313E-01,7.917E-01,6.313E-01,7.917E-01,2,"G-protein alpha-i family, Acyl-CoA synthetase",
1123,ATP metabolism,107,6.455E-01,8.081E-01,6.455E-01,8.081E-01,9,"PDE1C, Adenylate cyclase type VIII, BST1, CD38, ENPP3, PDE2A, PDE3A, PDE4C, Adenylate cyclase type VII",
1124,Aberrant lipid trafficking and metabolism in age-related macular degeneration pathogenesis,60,6.462E-01,8.081E-01,6.462E-01,8.081E-01,5,"CYP27A1, Caspase-12, CRP, TLR2, TNF-alpha",
1125,Higher ESR1 / ESR2 ratio in breast cancer,36,6.472E-01,8.081E-01,6.472E-01,8.081E-01,3,"ITGA1, Cyclin E, AKT(PKB)",
1126,Upregulation of MITF in melanoma,36,6.472E-01,8.081E-01,6.472E-01,8.081E-01,3,"SOX10, HGF receptor (Met), p16INK4",
1127,G-protein signaling_G-Protein alpha-s signaling cascades,36,6.472E-01,8.081E-01,6.472E-01,8.081E-01,3,"B-Raf, RGS2, c-Src",
1128,Angiotensin II Signaling in Cardiac Hypertrophy,72,6.481E-01,8.084E-01,6.481E-01,8.084E-01,6,"TRPC3, PKC-alpha, NCX1, TRPC6, G-protein alpha-q/11, Angiotensin II",
1129,Dual role of TGF-beta 1 in HCC ,24,6.547E-01,8.130E-01,6.547E-01,8.130E-01,2,"TGF-beta receptor type II, p15",
1130,"Triacylglycerol biosynthesis in obesity and diabetes mellitus, type II",24,6.547E-01,8.130E-01,6.547E-01,8.130E-01,2,"MOGAT1, PLCD",
1131,Development_Signaling of Beta-adrenergic receptors via Beta-arrestins,24,6.547E-01,8.130E-01,6.547E-01,8.130E-01,2,"Beta-2 adrenergic receptor, c-Src",
1132,"Mechanism of action of DGAT1 inhibitors in obesity and diabetes mellitus, type II (Variant 1)",24,6.547E-01,8.130E-01,6.547E-01,8.130E-01,2,"MOGAT1, PLCD",
1133,Huntingtin-depended transcription deregulation in Huntington's Disease,24,6.547E-01,8.130E-01,6.547E-01,8.130E-01,2,"NGFR(TNFRSF16), Enkephalin A",
1134,Induction of mucin secretion in  airway goblet cells by purinergic receptors,61,6.608E-01,8.199E-01,6.608E-01,8.199E-01,5,"iNOS, PKC-alpha, Actin cytoskeletal, G-protein alpha-q/11, TNF-alpha",
1135,Axonal degeneration in multiple sclerosis,49,6.618E-01,8.204E-01,6.618E-01,8.204E-01,4,"iNOS, GluR6, NCX1, SCN2A",
1136,Transcription_CoREST complex-mediated epigenetic gene silencing,37,6.658E-01,8.232E-01,6.658E-01,8.232E-01,3,"GFI1B, SCN2A, GFI-1",
1137,Cholesterol and Sphingolipid transport / Transport from Golgi and ER to the apical membrane (normal and CF),37,6.658E-01,8.232E-01,6.658E-01,8.232E-01,3,"CES1, Caveolin-1, CETP",
1138,Immune response_Oncostatin M signaling via MAPK,37,6.658E-01,8.232E-01,6.658E-01,8.232E-01,3,"MMP-13, CCL2, OSMR",
1139,Regulation of microRNAs in colorectal cancer,62,6.750E-01,8.296E-01,6.750E-01,8.296E-01,5,"EGFR, MECOM, AKT(PKB), HGF receptor (Met), c-Src",
1140,Development_Gastrin in cell growth and proliferation,62,6.750E-01,8.296E-01,6.750E-01,8.296E-01,5,"PI3K cat class IA, PKC-alpha, EGFR, G-protein alpha-q/11, c-Src",
1141,Regulation of CFTR activity (normal and CF),62,6.750E-01,8.296E-01,6.750E-01,8.296E-01,5,"Syk, Adenosine A2b receptor, G-protein alpha-i family, Adenylate cyclase, Beta-2 adrenergic receptor",
1142,Role of Nicotine-induced Leptin resistance in hypothalamus in development of obesity,25,6.768E-01,8.296E-01,6.768E-01,8.296E-01,2,"NPY, AKT(PKB)",
1143,Development_Glucocorticoid receptor signaling,25,6.768E-01,8.296E-01,6.768E-01,8.296E-01,2,"MMP-13, STAT5",
1144,Apoptosis and survival_Apoptotic Activin A signaling,25,6.768E-01,8.296E-01,6.768E-01,8.296E-01,2,"Activin A, AKT(PKB)",
1145,Defective macrophage-mediated bacterial phagocytosis in COPD,25,6.768E-01,8.296E-01,6.768E-01,8.296E-01,2,"AKT(PKB), MARCO",
1146,Transcription_Transcription regulation of aminoacid metabolism,25,6.768E-01,8.296E-01,6.768E-01,8.296E-01,2,"NF-E2 (45 kDa), PKC",
1147,Putative pathways of hormone action in neurofibromatosis type 1,25,6.768E-01,8.296E-01,6.768E-01,8.296E-01,2,"EGR2 (Krox20), PI3K cat class IA",
1148,Neurophysiological process_Leptin signaling in neurons,50,6.775E-01,8.296E-01,6.775E-01,8.296E-01,4,"TRPC5, IRS-2, NPY, AKT(PKB)",
1149,Immune response_Production and main functions of biologically active leukotrienes and Lipoxin A4,50,6.775E-01,8.296E-01,6.775E-01,8.296E-01,4,"FPRL1, ABCA8, cPLA2, MDP1",
1150,Transport_Macropinocytosis,12,6.813E-01,8.335E-01,6.813E-01,8.335E-01,1,Actin cytoskeletal,
1151,Cortisol biosynthesis from Cholesterol,38,6.836E-01,8.342E-01,6.836E-01,8.342E-01,3,"CYP17, CYP21A2, CYP11A1",
1152,Aldosterone biosynthesis and metabolism,38,6.836E-01,8.342E-01,6.836E-01,8.342E-01,3,"CYP21A2, UGT2B7, HSD11B1",
1153,HDL dyslipidemia in type 2 diabetes and metabolic syndrome X,38,6.836E-01,8.342E-01,6.836E-01,8.342E-01,3,"S1P1 receptor, LIPE, CETP",
1154,Transcription_PPAR Pathway,63,6.888E-01,8.391E-01,6.888E-01,8.391E-01,5,"COX-2 (PTGS2), PI3K cat class IA, PTGIS, AKT(PKB), PDGF receptor",
1155,Lacto-series GSL Metabolism,63,6.888E-01,8.391E-01,6.888E-01,8.391E-01,5,"B3GNT5, ABO system transferase, SIA7E, B3GT2, B3GT1",
1156,Anti-apoptotic action of ErbB2 in breast cancer,51,6.927E-01,8.431E-01,6.927E-01,8.431E-01,4,"EGFR, AKT(PKB), ITGA5, c-Src",
1157,Neurophysiological process_GABA-B receptor signaling at postsynaptic sides of synapses,26,6.978E-01,8.470E-01,6.978E-01,8.470E-01,2,"Kir3.4, G-protein alpha-i family",
1158,Cell cycle_Initiation of mitosis,26,6.978E-01,8.470E-01,6.978E-01,8.470E-01,2,"MYRL2, AKT(PKB)",
1159,Glyoxylate metabolism,26,6.978E-01,8.470E-01,6.978E-01,8.470E-01,2,"MCT1 (SLC16A1), HAOX1",
1160,Aminoglycoside- and cisplatin-induced hair cell death,112,6.988E-01,8.470E-01,6.988E-01,8.470E-01,9,"COX-2 (PTGS2), IL-1 beta, iNOS, PKC, IL-6, FasL(TNFSF6), Caspase-1, TRPA1, TNF-alpha",
1161,Keratan sulfate metabolism p.2,39,7.008E-01,8.470E-01,7.008E-01,8.470E-01,3,"CHST3, CHST4, SIAT4B",
1162,Nicotine signaling in GABAergic neurons,39,7.008E-01,8.470E-01,7.008E-01,8.470E-01,3,"GABA-A receptor, G-protein alpha-i family, GAT1",
1163,Apoptosis and survival_APRIL and BAFF signaling,39,7.008E-01,8.470E-01,7.008E-01,8.470E-01,3,"COX-2 (PTGS2), BFL1, CD21",
1164,Deregulation of Ca2+-dependent neuronal cell survival in Huntington's disease,39,7.008E-01,8.470E-01,7.008E-01,8.470E-01,3,"PI3K cat class IA, AKT(PKB), nNOS",
1165,Mechanism of gemcitabine action in pancreatic cancer,52,7.074E-01,8.536E-01,7.074E-01,8.536E-01,4,"CDD, CNT3 (SLC28A3), 5'-NT1A, CNT1",
1166,Development_TGF-beta receptor signaling,52,7.074E-01,8.536E-01,7.074E-01,8.536E-01,4,"TGF-beta receptor type II, p15, Caveolin-1, ER81",
1167,Vitamin B3 and NAD+ metabolism,125,7.094E-01,8.553E-01,7.094E-01,8.553E-01,10,"PAM, BST1, CD38, Xanthine oxidase, NNMT, ENPP3, ALPL, 5'-NTD, ALPP, MCT1 (SLC16A1)",
1168,Transcription_Role of heterochromatin protein 1 (HP1) family in transcriptional silencing,40,7.172E-01,8.601E-01,7.172E-01,8.601E-01,3,"HDAC9, Cyclin E, MEF2",
1169,Reproduction_Progesterone-mediated oocyte maturation,40,7.172E-01,8.601E-01,7.172E-01,8.601E-01,3,"G-protein alpha-i family, Adenylate cyclase, c-Src",
1170,Role of Ghrelin in activation eating behavior in obesity,40,7.172E-01,8.601E-01,7.172E-01,8.601E-01,3,"NPY, G-protein alpha-q/11, Adenylate cyclase type VII",
1171,Recurrent gene fusions in Prostate Cancer,40,7.172E-01,8.601E-01,7.172E-01,8.601E-01,3,"DGK-beta, ER81, ERM",
1172,Brca1 in ovarian cancer,27,7.177E-01,8.601E-01,7.177E-01,8.601E-01,2,"Maspin, AKT(PKB)",
1173,HCV-dependent cytoplasmic signaling leading to HCC,27,7.177E-01,8.601E-01,7.177E-01,8.601E-01,2,"PKC, AKT(PKB)",
1174,Triacylglycerol metabolism p.2,27,7.177E-01,8.601E-01,7.177E-01,8.601E-01,2,"LIPE, LPL",
1175,Neurophysiological process_Long-term depression in cerebellum,53,7.216E-01,8.641E-01,7.216E-01,8.641E-01,4,"PKC-alpha, P/Q-type calcium channel alpha-1A subunit, cPLA2, PA24A",
1176,Development_Growth hormone-releasing hormone (GH-RH) signaling,41,7.329E-01,8.738E-01,7.329E-01,8.738E-01,3,"GH-RH receptor, cPKC (conventional), Adenylate cyclase",
1177,Neurophysiological process_Glucose-inhibited neurons of ventromedial and arcuate nuclei (rodent model),41,7.329E-01,8.738E-01,7.329E-01,8.738E-01,3,"Glucagon, NPY, nNOS",
1178,L-Arginine metabolism,79,7.347E-01,8.738E-01,7.347E-01,8.738E-01,6,"KCRM, iNOS, OTC, AL1A1, ADC, nNOS",
1179,Development_FGFR signaling pathway,54,7.352E-01,8.738E-01,7.352E-01,8.738E-01,4,"PI3K cat class IA, FGF2, AKT(PKB), Syndecan-2",
1180,Translation_Regulation of EIF4F activity,54,7.352E-01,8.738E-01,7.352E-01,8.738E-01,4,"PI3K cat class IA, TGF-beta receptor type II, EGFR, AKT(PKB)",
1181,Neurophysiological process_GABA-B receptor signaling in presynaptic nerve terminals,28,7.365E-01,8.738E-01,7.365E-01,8.738E-01,2,"P/Q-type calcium channel alpha-1A subunit, G-protein alpha-i family",
1182,Role of Diethylhexyl Phthalate and Tributyltin in fat cell differentiation ,28,7.365E-01,8.738E-01,7.365E-01,8.738E-01,2,"PPARGC1 (PGC1-alpha), LPL",
1183,Neurophysiological process_Role of CDK5 in presynaptic signaling,28,7.365E-01,8.738E-01,7.365E-01,8.738E-01,2,"P/Q-type calcium channel alpha-1A subunit, Endophilin A1",
1184,Pro-oncogenic action of Androgen receptor in ovarian cancer,28,7.365E-01,8.738E-01,7.365E-01,8.738E-01,2,"GSTP1, TGF-beta receptor type II",
1185,Riboflavin metabolism,14,7.366E-01,8.738E-01,7.366E-01,8.738E-01,1,ENPP3,
1186,Asthma-specific pathways of airway smooth muscle cell proliferation,14,7.366E-01,8.738E-01,7.366E-01,8.738E-01,1,PPARGC1 (PGC1-alpha),
1187,L-Tryptophan metabolism (part 1),80,7.457E-01,8.827E-01,7.457E-01,8.827E-01,6,"IDO1, IDO2, AL1A1, ALDR, MAOB, SLC6A19",
1188,Apoptosis and survival_BAD phosphorylation,42,7.479E-01,8.827E-01,7.479E-01,8.827E-01,3,"PI3K cat class IA, EGFR, AKT(PKB)",
1189,Disruption of methionine metabolism in induction and progression of HCC,42,7.479E-01,8.827E-01,7.479E-01,8.827E-01,3,"ADH1, ADH4, BHMT",
1190,Development_Growth hormone signaling via PI3K/AKT and MAPK cascades,42,7.479E-01,8.827E-01,7.479E-01,8.827E-01,3,"IRS-2, AKT(PKB), c-Src",
1191,Translation_Insulin regulation of translation,42,7.479E-01,8.827E-01,7.479E-01,8.827E-01,3,"PI3K cat class IA, IRS-2, AKT(PKB)",
1192,Apoptosis and survival_Lymphotoxin-beta receptor signaling,42,7.479E-01,8.827E-01,7.479E-01,8.827E-01,3,"VCAM1, IL-8, LIGHT(TNFSF14)",
1193,Cholesterol and Sphingolipid transport / Recycling to plasma membrane in lung (normal and CF),29,7.541E-01,8.864E-01,7.541E-01,8.864E-01,2,"PA24A, Caveolin-1",
1194,Development_SSTR1 in regulation of cell proliferation and migration,29,7.541E-01,8.864E-01,7.541E-01,8.864E-01,2,"PI3K reg class IB (p101), c-Src",
1195,Cholesterol and Sphingolipid transport / Influx to the early endosome in lung (normal and CF),29,7.541E-01,8.864E-01,7.541E-01,8.864E-01,2,"Caveolin-2, Caveolin-1",
1196,Vitamin D2 (ergocalciferol) metabolism,29,7.541E-01,8.864E-01,7.541E-01,8.864E-01,2,"CYP27A1, CYP24A1",
1197,Neurophysiological process _Visual perception,29,7.541E-01,8.864E-01,7.541E-01,8.864E-01,2,"Rhodopsin kinase (GRK1), Recoverin",
1198,Development_Keratinocyte differentiation,56,7.610E-01,8.918E-01,7.610E-01,8.918E-01,4,"Fra-1, PKC-alpha, G-protein alpha-q/11, c-Src",
1199,Muscle contraction_Regulation of eNOS activity in cardiomyocytes,56,7.610E-01,8.918E-01,7.610E-01,8.918E-01,4,"AKAP6, G-protein alpha-i family, PDE2A, PDE3A",
1200,Regulation of metabolism_Role of Adiponectin in regulation of metabolism,43,7.622E-01,8.918E-01,7.622E-01,8.918E-01,3,"PPCKC, H-FABP, PPARGC1 (PGC1-alpha)",
1201,Apoptosis and survival_TNFR1 signaling pathway,43,7.622E-01,8.918E-01,7.622E-01,8.918E-01,3,"c-IAP2, Caspase-10, TNF-alpha",
1202,Apoptosis and survival_TNF-alpha-induced Caspase-8 signaling,43,7.622E-01,8.918E-01,7.622E-01,8.918E-01,3,"CLIP3, AKT(PKB), TNF-alpha",
1203,Transcription_Negative regulation of HIF1A function,69,7.631E-01,8.918E-01,7.631E-01,8.918E-01,5,"FHL3, p14ARF, HIF3A, FHL1 (SLIM1), RUNX3",
1204,Role of microRNAs in cell proliferation in colorectal cancer,69,7.631E-01,8.918E-01,7.631E-01,8.918E-01,5,"p57, RhoE, FLI1, HGF receptor (Met), CDK6",
1205,Androgen biosynthetic pathways,82,7.668E-01,8.926E-01,7.668E-01,8.926E-01,6,"AKR1C3, AKR1C1, CYP17, AKR1C2, HSD11B1, CYP11A1",
1206,Protein folding and maturation_POMC processing,30,7.708E-01,8.926E-01,7.708E-01,8.926E-01,2,"PAM, PC1",
1207,"Regulation of lipid metabolism_RXR-dependent regulation of lipid metabolism via PPAR, RAR and VDR",30,7.708E-01,8.926E-01,7.708E-01,8.926E-01,2,"ADHG, CYP24A1",
1208,Stem cells_Neovascularization of glioblastoma in response to hypoxia,30,7.708E-01,8.926E-01,7.708E-01,8.926E-01,2,"PKC-alpha, c-Src",
1209,Apoptosis and survival_Granzyme A signaling,30,7.708E-01,8.926E-01,7.708E-01,8.926E-01,2,"Granzyme A, Perforin",
1210,Transport_Aldosterone-mediated regulation of ENaC sodium transport,30,7.708E-01,8.926E-01,7.708E-01,8.926E-01,2,"SGK1, AKT(PKB)",
1211,Production of arachidonic acid derivatives by mast cells in asthma,30,7.708E-01,8.926E-01,7.708E-01,8.926E-01,2,"COX-2 (PTGS2), cPLA2",
1212,Neurophysiological process_nNOS signaling in neuronal synapses,30,7.708E-01,8.926E-01,7.708E-01,8.926E-01,2,"NR2, nNOS",
1213,Signal transduction_Additional pathways of NF-kB activation (in the nucleus),30,7.708E-01,8.926E-01,7.708E-01,8.926E-01,2,"Adenylate cyclase, CDK6",
1214,Putative pathways of Oleic acid sensing in ventromedial hypothalamus in obesity (rodent model),30,7.708E-01,8.926E-01,7.708E-01,8.926E-01,2,"ACSL6, ACSL4",
1215,Cytoskeleton remodeling_RalA regulation pathway,30,7.708E-01,8.926E-01,7.708E-01,8.926E-01,2,"F-Actin cytoskeleton, FPR",
1216,Development_Non-genomic action of Retinoic acid in cell differentiation,57,7.732E-01,8.939E-01,7.732E-01,8.939E-01,4,"COX-2 (PTGS2), PKC-alpha, AKT(PKB), c-Src",
1217,Regulation of lipid metabolism_Insulin regulation of glycogen metabolism ,57,7.732E-01,8.939E-01,7.732E-01,8.939E-01,4,"PI3K cat class IA, IRS-2, GYS2, AKT(PKB)",
1218,Proliferative action of Gastrin in pancreatic cancer,44,7.758E-01,8.955E-01,7.758E-01,8.955E-01,3,"PI3K cat class IA, PKC-alpha, c-Src",
1219,Regulation of metabolism_Triiodothyronine and Thyroxine signaling,44,7.758E-01,8.955E-01,7.758E-01,8.955E-01,3,"Calcipressin 2, OATP-F, Beta-2 adrenergic receptor",
1220,c-Myc in multiple myeloma,16,7.823E-01,9.022E-01,7.823E-01,9.022E-01,1,IL-6,
1221,Immune response_CCR5 signaling in macrophages and T lymphocytes,58,7.848E-01,9.044E-01,7.848E-01,9.044E-01,4,"PKC-alpha, G-protein alpha-i family, AKT(PKB), PI3K reg class IB (p101)",
1222,"SREBP1 cross-talk with PXR, CAR and LXR/ Rodent version",31,7.864E-01,9.047E-01,7.864E-01,9.047E-01,2,"PPARGC1 (PGC1-alpha), CYP7A1",
1223,Inhibition of TGF-beta signaling in lung cancer,31,7.864E-01,9.047E-01,7.864E-01,9.047E-01,2,"TGF-beta receptor type II, p15",
1224,Stem cells_Excitotoxicity of Glutamate in glioblastoma,45,7.888E-01,9.060E-01,7.888E-01,9.060E-01,3,"G-protein alpha-i family, SLC7A11, GLAST1/EAAT1",
1225,Development_EPO-induced MAPK pathway,45,7.888E-01,9.060E-01,7.888E-01,9.060E-01,3,"Syk, PKC-alpha, Lyn",
1226,Regulation of lipid metabolism_Stimulation of Arachidonic acid production by ACM receptors,72,7.949E-01,9.122E-01,7.949E-01,9.122E-01,5,"PKC, PKC-alpha, cPLA2, c-Src, ACM3",
1227,Cell cycle_Role of Nek in cell cycle regulation,32,8.011E-01,9.161E-01,8.011E-01,9.161E-01,2,"Tubulin beta, PI3K cat class IA",
1228,DNA damage_ATM/ATR regulation of G1/S checkpoint,32,8.011E-01,9.161E-01,8.011E-01,9.161E-01,2,"Cyclin E, Cyclin A",
1229,Niacin-HDL metabolism,46,8.012E-01,9.161E-01,8.012E-01,9.161E-01,3,"PAM, NNMT, HDL proteins",
1230,Apoptosis and survival_IL-17-induced CIKS-independent signaling pathways,46,8.012E-01,9.161E-01,8.012E-01,9.161E-01,3,"PI3K cat class IA, Fra-1, STAT4",
1231,DNA damage_Role of SUMO in p53 regulation,17,8.021E-01,9.161E-01,8.021E-01,9.161E-01,1,AKT(PKB),
1232,G-protein signaling_Rac3 regulation pathway,17,8.021E-01,9.161E-01,8.021E-01,9.161E-01,1,F-Actin,
1233,Chondroitin sulfate and dermatan sulfate metabolism,60,8.067E-01,9.205E-01,8.067E-01,9.205E-01,4,"CHST3, SART2, CHSS3, CGAT1",
1234,Regulation of lipid metabolism_Insulin signaling: generic cascades,47,8.129E-01,9.239E-01,8.129E-01,9.239E-01,3,"PI3K cat class IA, IRS-2, AKT(PKB)",
1235,Neurophysiological process_Circadian rhythm,47,8.129E-01,9.239E-01,8.129E-01,9.239E-01,3,"PACAP receptor 1, PACAP, nNOS",
1236,wtCFTR and deltaF508 traffic / Membrane expression (normal and CF),47,8.129E-01,9.239E-01,8.129E-01,9.239E-01,3,"HGF, Beta-2 adrenergic receptor, HGF receptor (Met)",
1237,Immune response_Distinct metabolic pathways in naive and effector CD8+ T cells,74,8.141E-01,9.239E-01,8.141E-01,9.239E-01,5,"PI3K cat class IA, GLSK, STAT5, Fyn, AKT(PKB)",
1238,Phospholipid metabolism p.3,33,8.149E-01,9.239E-01,8.149E-01,9.239E-01,2,"LRAT, PA24A",
1239,Development_EGFR signaling via small GTPases,33,8.149E-01,9.239E-01,8.149E-01,9.239E-01,2,"PI3K cat class IA, EGFR",
1240,Apoptosis and survival_Granzyme B signaling,33,8.149E-01,9.239E-01,8.149E-01,9.239E-01,2,"Caspase-10, Perforin",
1241,Cytoskeleton remodeling_Thyroliberin in cytoskeleton remodeling,33,8.149E-01,9.239E-01,8.149E-01,9.239E-01,2,"PKC-alpha, Adenylate cyclase",
1242,Neolacto-series GSL Metabolism p.2,61,8.169E-01,9.255E-01,8.169E-01,9.255E-01,4,"B3GNT5, SIA10, CHST4, SIA7E",
1243,Stem cells_CD30 signaling in transformed embryonic stem cells,18,8.201E-01,9.283E-01,8.201E-01,9.283E-01,1,Oct-3/4,
1244,Globo-(isoglobo) series GSL Metabolism,48,8.241E-01,9.321E-01,8.241E-01,9.321E-01,3,"ABO system transferase, SIA7E, G3ST1",
1245,Development_Histone acetylation in embryonic stem cells,34,8.278E-01,9.341E-01,8.278E-01,9.341E-01,2,"Oct-3/4, HNF3-beta",
1246,Development_CNTF receptor signaling,34,8.278E-01,9.341E-01,8.278E-01,9.341E-01,2,"PI3K cat class IA, AKT(PKB)",
1247,Oxidative stress_ROS-mediated activation of MAPK via inhibition of phosphatases,34,8.278E-01,9.341E-01,8.278E-01,9.341E-01,2,"EGFR, PDGF-R-beta",
1248,HCV-mediated liver damage and predisposition to HCC via cell stress,63,8.361E-01,9.418E-01,8.361E-01,9.418E-01,4,"IL-1 alpha, IL-6, c-Src, TNF-alpha",
1249,Transcription_Sirtuin6 regulation and functions ,63,8.361E-01,9.418E-01,8.361E-01,9.418E-01,4,"PPCKC, c-IAP2, ICAM1, PPARGC1 (PGC1-alpha)",
1250,NF-kB pathway in multiple myeloma,35,8.400E-01,9.447E-01,8.400E-01,9.447E-01,2,"c-IAP2, IL-6",
1251,Keratan sulfate metabolism p.1,35,8.400E-01,9.447E-01,8.400E-01,9.447E-01,2,"CHST3, CHST6",
1252,Development_IGF-1 receptor signaling,50,8.447E-01,9.485E-01,8.447E-01,9.485E-01,3,"PI3K cat class IA, IRS-2, AKT(PKB)",
1253,Suppression of p53 signaling in multiple myeloma,50,8.447E-01,9.485E-01,8.447E-01,9.485E-01,3,"p14ARF, FasR(CD95), IL-6",
1254,Interconnectivity between Folic acid and Fluorouracil pathways in gastric cancer,91,8.457E-01,9.488E-01,8.457E-01,9.488E-01,6,"CES1, UDP, DPYD, DPYS, CDD, Aquaporin 9",
1255,Urea cycle,36,8.513E-01,9.499E-01,8.513E-01,9.499E-01,2,"OTC, Aquaporin 9",
1256,G-protein signaling_Rac2 regulation pathway,36,8.513E-01,9.499E-01,8.513E-01,9.499E-01,2,"iNOS, Rac2",
1257,Regulation of degradation of wtCFTR,20,8.514E-01,9.499E-01,8.514E-01,9.499E-01,1,BAG-2,
1258,HBV mediates angiogenesis in HCC,20,8.514E-01,9.499E-01,8.514E-01,9.499E-01,1,c-Src,
1259,Mechanisms of hapten presentation to T cells in allergic contact dermatitis,20,8.514E-01,9.499E-01,8.514E-01,9.499E-01,1,MHC class II,
1260,Development_TGF-beta-induction of EMT via ROS,20,8.514E-01,9.499E-01,8.514E-01,9.499E-01,1,TGF-beta receptor type II,
1261,Protein folding and maturation_Insulin processing,20,8.514E-01,9.499E-01,8.514E-01,9.499E-01,1,PC1,
1262,Immune response_BAFF-induced signaling,51,8.542E-01,9.516E-01,8.542E-01,9.516E-01,3,"AKT(PKB), TRIM2, PI3K cat class IA (p110-delta)",
1263,microRNA in Prostate Cancer,51,8.542E-01,9.516E-01,8.542E-01,9.516E-01,3,"GLSK, CD44, CDK6",
1264,G-protein signaling_RAC1 in cellular process,37,8.619E-01,9.582E-01,8.619E-01,9.582E-01,2,"F-Actin cytoskeleton, Actin cytoskeletal",
1265,Gamma-aminobutyrate (GABA) biosynthesis and metabolism,52,8.632E-01,9.582E-01,8.632E-01,9.582E-01,3,"GAD2, GAD1, MAOB",
1266,CoA biosynthesis,52,8.632E-01,9.582E-01,8.632E-01,9.582E-01,3,"ACSL6, VNN1, ACSL4",
1267,Alcohol metabolism predisposition of HCC development,52,8.632E-01,9.582E-01,8.632E-01,9.582E-01,3,"ADHG, ADH1, ADH4",
1268,Role of prenatal nicotine exposure in inhibition of pancreatic beta cells differentiation and function,21,8.649E-01,9.582E-01,8.649E-01,9.582E-01,1,PAX6,
1269,HCV-dependent transcription regulation leading to HCC,21,8.649E-01,9.582E-01,8.649E-01,9.582E-01,1,Cyclin E,
1270,Cell cycle_Chromosome condensation in prometaphase,21,8.649E-01,9.582E-01,8.649E-01,9.582E-01,1,Cyclin A,
1271,Translation_Translation regulation by Alpha-1 adrenergic receptors,53,8.717E-01,9.643E-01,8.717E-01,9.643E-01,3,"Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor, c-Src",
1272,G-protein signaling_G-Protein alpha-12 signaling pathway,38,8.718E-01,9.643E-01,8.718E-01,9.643E-01,2,"PI3K cat class IA, M-Ras",
1273,Development_S1P4 receptor signaling pathway,22,8.772E-01,9.665E-01,8.772E-01,9.665E-01,1,G-protein alpha-i family,
1274,Transcription_CREM signaling in testis,22,8.772E-01,9.665E-01,8.772E-01,9.665E-01,1,KIF17,
1275,Development_Dopamine-induced expression of CNTF in adult neurogenesis,22,8.772E-01,9.665E-01,8.772E-01,9.665E-01,1,G-protein alpha-i family,
1276,Cell cycle_Role of 14-3-3 proteins in cell cycle regulation,22,8.772E-01,9.665E-01,8.772E-01,9.665E-01,1,AKT(PKB),
1277,Development_Mu-type opioid receptor signaling via Beta-arrestin,22,8.772E-01,9.665E-01,8.772E-01,9.665E-01,1,G-protein alpha-i family,
1278,Androstenedione and testosterone biosynthesis and metabolism p.1,54,8.797E-01,9.669E-01,8.797E-01,9.669E-01,3,"CYP1A1, CYP3A7, CYP17",
1279,Atorvastatin in treatment of type 2 diabetes and metabolic syndrome X,39,8.810E-01,9.669E-01,8.810E-01,9.669E-01,2,"OATP8, CETP",
1280,Transport_Regulation of ATP-binding transporters by Retinoic acid and orphan nuclear receptor PXR,39,8.810E-01,9.669E-01,8.810E-01,9.669E-01,2,"APOA2, MDR1",
1281,Transcription_p53 signaling pathway,39,8.810E-01,9.669E-01,8.810E-01,9.669E-01,2,"p14ARF, MMP-2",
1282,Apoptosis and survival_Ubiquitination and phosphorylation in TNF-alpha-induced NF-kB signaling,39,8.810E-01,9.669E-01,8.810E-01,9.669E-01,2,"c-IAP2, TNF-alpha",
1283,Transport_Intracellular cholesterol transport,83,8.835E-01,9.688E-01,8.835E-01,9.688E-01,5,"CES1, Caveolin-2, VLDLR, Caveolin-1, CETP",
1284,Proteolysis_Putative ubiquitin pathway,23,8.884E-01,9.735E-01,8.884E-01,9.735E-01,1,Synphilin 1,
1285,Neurophysiological process_Netrin-1 in regulation of axon guidance,40,8.897E-01,9.741E-01,8.897E-01,9.741E-01,2,"Fyn, DARPP-32",
1286,Nicotine metabolism in liver,56,8.945E-01,9.786E-01,8.945E-01,9.786E-01,3,"FMO3, UGT2B7, UGT1A4",
1287,Glutathione metabolism,71,8.966E-01,9.795E-01,8.966E-01,9.795E-01,4,"GSTP1, GSTA5, GPX7, CD13",
1288,Transport_Clathrin-coated vesicle cycle,71,8.966E-01,9.795E-01,8.966E-01,9.795E-01,4,"AP180, BIN1 (Amphiphysin II), Actin cytoskeletal, Actin",
1289,Possible pathway of TGF-beta 1-dependent inhibition of CFTR expression,41,8.977E-01,9.799E-01,8.977E-01,9.799E-01,2,"TGF-beta receptor type II, Beta-2 adrenergic receptor",
1290,Prostaglandin 1 biosynthesis and metabolism,57,9.012E-01,9.829E-01,9.012E-01,9.829E-01,3,"COX-2 (PTGS2), PTGIS, Acyl-CoA synthetase",
1291,CFTR-dependent regulation of ion channels in CF,42,9.052E-01,9.865E-01,9.052E-01,9.865E-01,2,"Actin cytoskeletal, G-protein alpha-q/11",
1292,Transport_RAB5A regulation pathway,25,9.078E-01,9.886E-01,9.078E-01,9.886E-01,1,EGFR,
1293,Vitamin D3 metabolic C-23 and C-24 pathways,43,9.122E-01,9.926E-01,9.122E-01,9.926E-01,2,"CYP27A1, CYP24A1",
1294,CREB1-dependent transcription deregulation in Huntington's Disease,26,9.162E-01,9.931E-01,9.162E-01,9.931E-01,1,PPARGC1 (PGC1-alpha),
1295,G-protein signaling_Ras family GTPases in kinase cascades,26,9.162E-01,9.931E-01,9.162E-01,9.931E-01,1,B-Raf,
1296,Development_NOTCH1-mediated pathway for NF-KB activity modulation,26,9.162E-01,9.931E-01,9.162E-01,9.931E-01,1,Jagged1,
1297,"SREBP1 cross-talk with PXR, CAR and LXR",26,9.162E-01,9.931E-01,9.162E-01,9.931E-01,1,PPARGC1 (PGC1-alpha),
1298,Cell cycle_Transition and termination of DNA replication,26,9.162E-01,9.931E-01,9.162E-01,9.931E-01,1,Cyclin A,
1299,Transport_cAMP/ Ca(2+)-dependent Insulin secretion,44,9.187E-01,9.933E-01,9.187E-01,9.933E-01,2,"Adenylate cyclase type VIII, PKC-alpha",
1300,Oxidative stress_Role of Sirtuin1 and PGC1-alpha in activation of antioxidant defense system,60,9.191E-01,9.933E-01,9.191E-01,9.933E-01,3,"GSTP1, SLC7A11, PPARGC1 (PGC1-alpha)",
1301,Apoptosis and survival_TNF-alpha-induced ROS-dependent Caspase-3 signaling,60,9.191E-01,9.933E-01,9.191E-01,9.933E-01,3,"Rac2, PI3K cat class IA (p110-delta), TNF-alpha",
1302,Transcription_Effect of Folic acid on genome stability,60,9.191E-01,9.933E-01,9.191E-01,9.933E-01,3,"ADH6, ADH1, ADH4",
1303,Histamine metabolism,27,9.238E-01,9.952E-01,9.238E-01,9.952E-01,1,MAOB,
1304,Neurophysiological process_GABA-B receptor-mediated regulation of glutamate signaling in Purkinje cells,27,9.238E-01,9.952E-01,9.238E-01,9.952E-01,1,G-protein alpha-i family,
1305,Neurophysiological process_Sweet taste signaling,27,9.238E-01,9.952E-01,9.238E-01,9.952E-01,1,TRPM5,
1306,Insulin-dependent stimulation of SREBP-1 in type 2 diabetes in liver,27,9.238E-01,9.952E-01,9.238E-01,9.952E-01,1,IRS-2,
1307,Mitochondrial unsaturated fatty acid beta-oxidation,45,9.247E-01,9.955E-01,9.247E-01,9.955E-01,2,"ACSL6, ACSL4",
1308,Anandamide biosynthesis and metabolism,46,9.303E-01,9.989E-01,9.303E-01,9.989E-01,2,"PA24A, PTPN22",
1309,Mitogenic action of Estradiol / ESR1 (nuclear) in breast cancer,28,9.307E-01,9.989E-01,9.307E-01,9.989E-01,1,Cyclin E,
1310,Neurophysiological process_Bitter taste signaling,28,9.307E-01,9.989E-01,9.307E-01,9.989E-01,1,TRPM5,
1311,DNA damage_ATM / ATR regulation of G2 / M checkpoint,28,9.307E-01,9.989E-01,9.307E-01,9.989E-01,1,Cyclin A,
1312,Regulation of lipid metabolism_PPAR regulation of lipid metabolism,47,9.355E-01,9.996E-01,9.355E-01,9.996E-01,2,"I-FABP, Fatty acid-binding protein",
1313,Renal secretion of drugs / Rodent version ,47,9.355E-01,9.996E-01,9.355E-01,9.996E-01,2,"SLC22A3, MDR1",
1314,Transport_GPR40 signaling pathway in beta cells,47,9.355E-01,9.996E-01,9.355E-01,9.996E-01,2,"Kv2.2, G-protein alpha-q/11",
1315,Cell cycle_Role of SCF complex in cell cycle regulation,29,9.370E-01,9.996E-01,9.370E-01,9.996E-01,1,Cyclin E,
1316,Cigarette smoke-mediated regulation of NRF2-antioxidant pathway in airway epithelial cells,29,9.370E-01,9.996E-01,9.370E-01,9.996E-01,1,UGT1A4,
1317,Histone deacetylases in Prostate Cancer,29,9.370E-01,9.996E-01,9.370E-01,9.996E-01,1,HDAC9,
1318,Apoptosis and survival_p53-dependent apoptosis,29,9.370E-01,9.996E-01,9.370E-01,9.996E-01,1,p14ARF,
1319,Proteolysis_Putative SUMO-1 pathway,29,9.370E-01,9.996E-01,9.370E-01,9.996E-01,1,FasR(CD95),
1320,Polyamine metabolism,64,9.384E-01,9.999E-01,9.384E-01,9.999E-01,3,"ADC, Spermine oxidase, MAOB",
1321,Histidine-glutamate-glutamine metabolism,95,9.406E-01,9.999E-01,9.406E-01,9.999E-01,5,"AMDHD1, GAD2, GLSK, GFPT2, GAD1",
1322,Fatty Acid Omega Oxidation,30,9.428E-01,9.999E-01,9.428E-01,9.999E-01,1,ADH4,
1323,L-Carnitine biosynthesis,30,9.428E-01,9.999E-01,9.428E-01,9.999E-01,1,SLC22A16,
1324,Linoleic acid metabolism,31,9.480E-01,9.999E-01,9.480E-01,9.999E-01,1,PA24A,
1325,Cell cycle_Role of APC in cell cycle regulation,32,9.527E-01,9.999E-01,9.527E-01,9.999E-01,1,Cyclin A,
1326,Acetylcholine biosynthesis and metabolism,32,9.527E-01,9.999E-01,9.527E-01,9.999E-01,1,PA24A,
1327,Immune response_BAFF-induced non-canonical NF-kB signaling,32,9.527E-01,9.999E-01,9.527E-01,9.999E-01,1,c-IAP2,
1328,Stem cells_Role of ion channels in glioblastoma cell invasion,32,9.527E-01,9.999E-01,9.527E-01,9.999E-01,1,GluR1,
1329,Cell cycle_Start of DNA replication in early S phase,32,9.527E-01,9.999E-01,9.527E-01,9.999E-01,1,Cyclin E,
1330,Neolacto-series GSL Metabolism p.3,68,9.534E-01,9.999E-01,9.534E-01,9.999E-01,3,"B3GNT5, SIA10, ABO system transferase",
1331,TTP metabolism,68,9.534E-01,9.999E-01,9.534E-01,9.999E-01,3,"UDP, DPYD, DPYS",
1332,Impaired NO signaling in CF airways,52,9.565E-01,9.999E-01,9.565E-01,9.999E-01,2,"iNOS, nNOS",
1333,Cell cycle_Spindle assembly and chromosome separation,33,9.570E-01,9.999E-01,9.570E-01,9.999E-01,1,"Dynein 1, cytoplasmic, intermediate chains",
1334,Aflatoxin B1-dependent induction of HCC,33,9.570E-01,9.999E-01,9.570E-01,9.999E-01,1,TNF-alpha,
1335,Prostaglandin 2 biosynthesis and metabolism,86,9.594E-01,9.999E-01,9.594E-01,9.999E-01,4,"COX-2 (PTGS2), PTGIS, AKR1C3, PGDS",
1336,Tyrosine metabolism p.1 (dopamine) ,70,9.595E-01,9.999E-01,9.595E-01,9.999E-01,3,"AL1A1, DBH, MAOB",
1337,Regulation of CFTR gating (normal and CF),34,9.609E-01,9.999E-01,9.609E-01,9.999E-01,1,Adenylate cyclase,
1338,Vitamin B6 metabolism,34,9.609E-01,9.999E-01,9.609E-01,9.999E-01,1,ALPL,
1339,Role of ER stress in obesity and type 2 diabetes,54,9.629E-01,9.999E-01,9.629E-01,9.999E-01,2,"PI3K cat class IA, IRS-2",
1340,Anti-apoptotic action of Gastrin in gastric cancer,35,9.645E-01,9.999E-01,9.645E-01,9.999E-01,1,PKC-alpha,
1341,Neolacto-series GSL Metabolism p.1,72,9.649E-01,9.999E-01,9.649E-01,9.999E-01,3,"B3GNT5, SIA10, ABO system transferase",
1342,Aspartate and asparagine metabolism,73,9.673E-01,9.999E-01,9.673E-01,9.999E-01,3,"GAD2, OTC, GAD1",
1343,Arachidonic acid production,74,9.696E-01,9.999E-01,9.696E-01,9.999E-01,3,"ACSL4, PLC-eta 2, PA24A",
1344,L-Phenylalanine metabolism,74,9.696E-01,9.999E-01,9.696E-01,9.999E-01,3,"AL1A1, MAOB, SLC6A19",
1345,Immune response_IL-6 signaling pathway via MEK/ERK and PI3K/AKT cascades,74,9.696E-01,9.999E-01,9.696E-01,9.999E-01,3,"PI3K cat class IA, IL-6, AKT(PKB)",
1346,Glycogen metabolism,37,9.707E-01,9.999E-01,9.707E-01,9.999E-01,1,GYS2,
1347,Apoptosis and survival_Anti-apoptotic action of nuclear ESR1 and ESR2,37,9.707E-01,9.999E-01,9.707E-01,9.999E-01,1,nNOS,
1348,CTP/UTP metabolism,107,9.712E-01,9.999E-01,9.712E-01,9.999E-01,5,"UDP, DPYD, DPYS, CDD, PCY1B",
1349,Catecholamine metabolism,75,9.717E-01,9.999E-01,9.717E-01,9.999E-01,3,"AL1A1, DBH, MAOB",
1350,Activation of Ca2+-dependent neuronal cell death in Huntington's disease,38,9.733E-01,9.999E-01,9.733E-01,9.999E-01,1,nNOS,
1351,"Regulation of lipid metabolism_Regulation of lipid metabolism via LXR, NF-Y and SREBP",38,9.733E-01,9.999E-01,9.733E-01,9.999E-01,1,Caveolin-1,
1352,Mitochondrial beta-oxidation of long-chain saturated fatty acids,125,9.755E-01,9.999E-01,9.755E-01,9.999E-01,6,"ACSL6, H-FABP, ACSL4, I-FABP, VLCSH1, ACADL",
1353,Butanoic acid metabolism,39,9.758E-01,9.999E-01,9.758E-01,9.999E-01,1,MCT1 (SLC16A1),
1354,Bile Acid Biosynthesis,94,9.761E-01,9.999E-01,9.761E-01,9.999E-01,4,"CYP27A1, CYP7A1, BSEP, VLCSH1",
1355,Aminosugar metabolism,60,9.772E-01,9.999E-01,9.772E-01,9.999E-01,2,"GFPT2, UDP-GlcNAc- 2-epimerase",
1356,Antioxidant effects of statins in COPD,60,9.772E-01,9.999E-01,9.772E-01,9.999E-01,2,"Rac2, Caveolin-1",
1357,Neurophysiological process_Glucose-excited neurons of arcuate nucleus (rodent model),40,9.780E-01,9.999E-01,9.780E-01,9.999E-01,1,SLC5A1,
1358,Leukotriene 4 biosynthesis and metabolism,40,9.780E-01,9.999E-01,9.780E-01,9.999E-01,1,MDP1,
1359,Translation_(L)-selenoaminoacids incorporation in proteins during translation,41,9.800E-01,9.999E-01,9.800E-01,9.999E-01,1,Selenoprotein V,
1360,Heparan sulfate/heparin metabolism,62,9.806E-01,9.999E-01,9.806E-01,9.999E-01,2,"Exostosin-1, 3-OST1",
1361,Fructose metabolism,81,9.818E-01,9.999E-01,9.818E-01,9.999E-01,3,"ALDR, AK1BA, AMYS",
1362,Galactose metabolism,63,9.821E-01,9.999E-01,9.821E-01,9.999E-01,2,"GYS2, ALD2",
1363,n-3 Polyunsaturated fatty acid biosynthesis,63,9.821E-01,9.999E-01,9.821E-01,9.999E-01,2,"ACSL6, ACSL4",
1364,Immune response_BAFF-induced canonical NF-kB signaling,43,9.835E-01,9.999E-01,9.835E-01,9.999E-01,1,CARD11,
1365,N-Glycan biosynthesis p2,43,9.835E-01,9.999E-01,9.835E-01,9.999E-01,1,GNT-III,
1366,"Leucine, isoleucine and valine metabolism",43,9.835E-01,9.999E-01,9.835E-01,9.999E-01,1,BCAT1,
1367,Plasmalogen biosynthesis,64,9.835E-01,9.999E-01,9.835E-01,9.999E-01,2,"PLA2, PLCD",
1368,Unsaturated fatty acid biosynthesis,65,9.848E-01,9.999E-01,9.848E-01,9.999E-01,2,"ACSL6, ACSL4",
1369,Role of mevalonate pathway in multiple myeloma,44,9.850E-01,9.999E-01,9.850E-01,9.999E-01,1,PI3K cat class IA,
1370,Metabolism in pancreatic cancer cells,66,9.860E-01,9.999E-01,9.860E-01,9.999E-01,2,"GLSK, SLC7A11",
1371,Neurophysiological process_Glutamic acid regulation of Dopamine D1A receptor signaling,45,9.863E-01,9.999E-01,9.863E-01,9.999E-01,1,DARPP-32,
1372,SCAP/SREBP Transcriptional Control of Cholesterol and FA Biosynthesis,45,9.863E-01,9.999E-01,9.863E-01,9.999E-01,1,TNF-alpha,
1373,"Metabolism of L-cysteine, D-cysteine and L-cystine",119,9.866E-01,9.999E-01,9.866E-01,9.999E-01,5,"Ceruloplasmin, SLC7A11, SLC38A4, GLAST1/EAAT1, SLC6A19",
1374,L-Alanine and L-cysteine metabolism,46,9.876E-01,9.999E-01,9.876E-01,9.999E-01,1,HAOX1,
1375,Cholesterol metabolism,87,9.884E-01,9.999E-01,9.884E-01,9.999E-01,3,"CYP27A1, CYP7A1, CYP7B1",
1376,Phospholipid metabolism p.2,47,9.887E-01,9.999E-01,9.887E-01,9.999E-01,1,PCY1B,
1377,ATP/ITP metabolism,123,9.897E-01,9.999E-01,9.897E-01,9.999E-01,5,"ADA, 5'-NTD, ALPP, ADAR3, 5'-NT1A",
1378,Regulation of lipid metabolism_Insulin regulation of fatty acid metabolism,89,9.900E-01,9.999E-01,9.900E-01,9.999E-01,3,"PI3K cat class IA, IRS-2, AKT(PKB)",
1379,GTP-XTP metabolism,90,9.907E-01,9.999E-01,9.907E-01,9.999E-01,3,"Xanthine oxidase, Guanine deaminase, 5'-NTD",
1380,L-Threonine metabolism,50,9.915E-01,9.999E-01,9.915E-01,9.999E-01,1,SLC38A4,
1381,Metabolism of L-Proline and derivatives,74,9.928E-01,9.999E-01,9.928E-01,9.999E-01,2,"PRODH2, SLC6A19",
1382,Ganglioside Metabolism p1,54,9.942E-01,9.999E-01,9.942E-01,9.999E-01,1,SIAT8A,
1383,Arsenite metabolism and transport,54,9.942E-01,9.999E-01,9.942E-01,9.999E-01,1,Aquaporin 9,
1384,Oxidative stress_Role of ASK1 under oxidative stress,55,9.948E-01,9.999E-01,9.948E-01,9.999E-01,1,c-Src,
1385,Apoptosis and survival_Endoplasmic reticulum stress response pathway,56,9.952E-01,9.999E-01,9.952E-01,9.999E-01,1,Caspase-12,
1386,Transcription_Epigenetic regulation of gene expression,57,9.957E-01,9.999E-01,9.957E-01,9.999E-01,1,HDAC9,
1387,Vitamin E (alfa-tocopherol) metabolism,81,9.960E-01,9.999E-01,9.960E-01,9.999E-01,2,"ACSL6, ACSL4",
1388,Phospholipid metabolism p.1,58,9.961E-01,9.999E-01,9.961E-01,9.999E-01,1,PHL1,
1389,HETE and HPETE biosynthesis and metabolism,82,9.963E-01,9.999E-01,9.963E-01,9.999E-01,2,"COX-2 (PTGS2), PTGIS",
1390,Tyrosine metabolism p.2 (melanin),83,9.966E-01,9.999E-01,9.966E-01,9.999E-01,2,"Xanthine oxidase, MAOB",
1391,Cigarette smoke-induced oxidative stress and apoptosis in airway epithelial cells,60,9.967E-01,9.999E-01,9.967E-01,9.999E-01,1,FasL(TNFSF6),
1392,Signal transduction_mTORC1 downstream signaling,60,9.967E-01,9.999E-01,9.967E-01,9.999E-01,1,SGK1,
1393,n-6 Polyunsaturated fatty acid biosynthesis,61,9.970E-01,9.999E-01,9.970E-01,9.999E-01,1,ACSL4,
1394,Sphingolipid metabolism,107,9.975E-01,9.999E-01,9.975E-01,9.999E-01,3,"UGT8, G3ST1, B4G6",
1395,Folic acid metabolism,64,9.978E-01,9.999E-01,9.978E-01,9.999E-01,1,ALDH1L2,
1396,Immune response_The effect of IDO1 on T cell metabolism,89,9.980E-01,9.999E-01,9.980E-01,9.999E-01,2,"IDO1, GLSK",
1397,Pyruvate metabolism,66,9.982E-01,9.999E-01,9.982E-01,9.999E-01,1,MCT1 (SLC16A1),
1398,Glycine and L-Serine metabolism,133,9.985E-01,9.999E-01,9.985E-01,9.999E-01,4,"SLC38A4, BHMT, PSAT, SLC6A19",
1399,L-Lysine metabolism,93,9.986E-01,9.999E-01,9.986E-01,9.999E-01,2,"SLC38A4, SLC7A7",
1400,dATP/dITP metabolism,94,9.987E-01,9.999E-01,9.987E-01,9.999E-01,2,"ADA, 5'-NTD",
1401,L-Tryptophan metabolism (part 2),97,9.990E-01,9.999E-01,9.990E-01,9.999E-01,2,"3HAO, SULT1B1",
1402,dCTP/dUTP metabolism,74,9.991E-01,9.999E-01,9.991E-01,9.999E-01,1,CDD,
1403,Peroxysomal straight-chain fatty acid beta-oxidation,74,9.991E-01,9.999E-01,9.991E-01,9.999E-01,1,ACSL4,
1404,Peroxisomal branched chain fatty acid oxidation,84,9.997E-01,9.999E-01,9.997E-01,9.999E-01,1,ACADL,
1405,Phosphatidylinositol metabolism,85,9.997E-01,9.999E-01,9.997E-01,9.999E-01,1,INPP,
1406,Glycolysis and gluconeogenesis,94,9.999E-01,9.999E-01,9.999E-01,9.999E-01,1,PPCKC,
1407,Signal transduction_Amino acid-dependent mTORC1 activation,96,9.999E-01,9.999E-01,9.999E-01,9.999E-01,1,GLSK,
,,,,,,,,,
